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This study describes the effect of allogeneic immune responses on immunisation against Theileria annulata with a
parasite infected cell line. The dynamics of lymphocyte populations during development of the immune response against the
parasite after cell line immunisation and sporozoite challenge were investigated in peripheral blood, and lymph efferent from
the lymph node draining the site of infection.
T. annulata infected cell lines have been used as vaccines against tropical theileriosis in several countries. Inoculated
animals produce a strong response against the allogeneicMHC antigens of the immunising cell line followed by an and parasite
response. There is evidence that immunity to the parasite wanes in the absence of challenge and reimmunisation is often
recommended. However, the effect of pre-existing allogeneic responses generated after first immunisation with T. annulata
infected cell lines upon development of immunity against the parasite at the time of reimmunisation, is not known. To
investigate this, an allogeneic response was first generated in the animals followed by immunisation with a T. annulata infected
cell line of the same BoLA type. A mild allogeneic response generated by inoculation of uninfected leucocytes did not affect
the development of immunity during cell line immunisation. However, a strong anti MHC response generated by skin grafting
interfered with the development of a parasite specific immune response when the animals were immunised with lxlO6 cells.
The effect of the allogeneic response was more marked when vaccination was carried out with a lower cell dose of 1 xlO4 cells,
where the development of immunity against T. annulata was completely blocked. These observations are of immediate
importance in endemic areas where T. annulata infected cell lines are being used as vaccines to control the disease.
The kinetics of various leucocyte subpopulations in the peripheral blood of animals revealed that leucopenia in response
to T. annulata infection was caused by decline in the number of circulating neutrophils and lymphocytes. Lymphocytopaenia
was caused mainly by reduction in the levels of circulating CD4+ cells and B cells, and to a lesser degree of CD8+ cells and
7<5 T cells. Cells of the monocyte/macrophage lineage were least affected. The severity of leucopenia was related to the ensuing
parasitological reactions after immunisation with cell line or challenge with sporozoites. The recovery and development of
immunity in animals after cell line immunisation and sporozoite challenge was associated with an increase in CD25+ cells in
the peripheral blood. A transient increase in the levels of CD8+ cells initially followed by a sustained increase in monocytes
was associated with recovery indicating that immunity to T. annulata is mainly mediated by mechanisms involving cells of these
two types. These cellular changes were not observed in animals undergoing cell line immunisation where the pre-existing
allogeneic responses blocked development of parasite specific immune responses.
As initial pathology takes place in the lymph node draining the site of T. annulata infection, further studies
concentrated on parasite dissemination and T cell activation in the draining efferent lymphatics following sporozoite infection
or allogeneic cell line immunisation. During lethal sporozoite infection in the naive animals, the parasite induced strong
lymphoproliferation. There was a massive increase in the output of blasting cells in efferent lymph from day 6 with a 5-10 fold
increase in the flow rate and cell output. Efferent lymph contained very high levels of interferon-7 between day 5 to 9 after
acute sporozoite infection. Parasite infected cells were seen from day 6 onwards. An initial increase in the percentage of CD2+
cells corresponding with an increase in CD4+ cells was observed from day 5. Many CD4+ cells expressed CD25 transiently
and became MHC class II+. This was followed by increased output of blasting CD8+ cells with high MHC class II expression.
Blasting CD4+ and CD8+ cells gradually lost CD2 expression with the progression of infection. These cells were MHC class
II+ but had lost CD25 expression suggesting an inappropriate activation of T cells in response to the parasite. Efferent lymph
cells were less responsive to Con. A or exogenous IL-2 stimulation in vitro during the later stages of infection. The cells did
not proliferate in vitro in response to autologous parasite infected cells and did not kill autologous parasite infected cells
suggesting lymphocyte unresponsiveness.
Animals immunised with lxlO6 T. annulata infected cells exhibited a 2-4 fold increase in the flow rate and cell output
in efferent lymph. Parasite infected cells of the recipient origin were isolated from day 11 onwards, but cells of donor origin
were never isolated. Two peaks of blasting cells were observed. The first corresponded to an allogeneic response against MHC
antigens of the immunising cell line and the second was associated with the parasite specific response. However, a few CD4+
and CD8+ cells not expressing CD2 were also observed during the second parasite specific phase of the response. At this stage,
CD25 and MHC class II expression on T cells increased. The inhibition of parasite development after cell line immunisation
as a result of the pre-existing allogeneic response was not associated with any of these changes.
The results indicate that infection with T. annulata sporozoites leading to acute theileriosis induces an inappropriate
proliferation and nonspecific activation of T cells in the efferent lymph. T cells initially express normal activation markers but
lose CD2, a very important adhesion molecule with the progression of the disease. Both specific and some non-specific T cell
activation is initiated after immunisation with T. annulata infected allogeneic cell lines which induce immunity to sporozoite
challenge.
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Rapid population increase in the third world countries necessitates a gigantic
growth in food production through improved agriculture and livestock farming. Future
growth is likely to occur in the tropical and sub-tropical regions of the world because
of the presence of unexploited areas with potential for expanding animal production.
Cattle are currently the most important animal resource of food in the form of meat
and milk. Productivity of cattle is quite low in the tropics and concentrated attempts
for its enhancement are constrained by factors such as: climate, nutrition,
management, genetic productivity limits of local breeds and, last but not least,
diseases (Pino, 1981).
Infectious blood diseases constitute the greatest single deterrent to the growth
of cattle production in the tropics. The most important tick-borne diseases of cattle
responsible for the economic losses are theileriosis and babesiosis (Uilenberg et al.,
1993). Efforts to improve the productivity of local indigenous cattle in Africa, Asia
and the Middle East, by crossbreeding programmes with exotic European cattle of
exquisite performance traits, are seriously hampered because of very high
susceptibility of both the exotic animals and their crossbreds to tick-borne
haemoprotozoan diseases (Gill et al., 1980). Indigenous animals are relatively
resistant, probably because they have been living with the parasites for centuries. The
initial importation of exotic cattle to the tropical countries sometimes ended up in
100% mortalities particularly because of theileriosis. Crossbreds produced from the
imported cattle are also highly susceptible (Oudich et al., 1993).
Bovine tropical theileriosis (Mediterranean Coast fever) and East Coast fever
are the two important haemoprotozoan diseases of cattle caused by Theileria annulata
and Theileria parva, respectively. Morbidity and mortality rates of these two diseases
in exotic and crossbred animals are very high. Although indigenous animals may be
inured to the effects of these diseases, their productivity potential is reduced (Irvin
& Morrison, 1987; Brown, 1990). Studies on Theileria parasites are also important
because of their striking similarities with other apicomplexan parasites, like Babesia
which infect a number of species, and Plasmodium which cause malaria and affect
almost 300 million people every year. Malaria infections of man and theileriosis of
cattle are thought to be the diseases of greatest significance in the context of third
World development (McKeever et al., 1994).
2
Over 250 million cattle were estimated to be at risk from this disease in 1982
(Robinson, 1982). The disease occurs across a wide zone of tropics in Africa, Europe
and Asia which stretches from Morocco to China. The precise economic losses caused
by the disease are difficult to calculate as extensive studies on incidence, loss of
production and mortality are not available. A recent report from one part of India
(Kaira district) where tropical theileriosis is endemic may give an idea of the
magnitude of the losses. Out of 40,000 adult crossbred cattle in that district, 3,800
clinical cases of the disease were recorded in the year 1988-89 (Singh, 1991). In
addition to direct costs of treatment which are very expensive and unaffordable for
many livestock owners in endemic areas, enormous costs are incurred in attempting
to control the vector ticks by use of acaricides. Apart from these expenses, losses due
to loss of production and mortality are tremendous and difficult to estimate.
T. annulata is transmitted by infected ticks to cattle while feeding. The
inoculated sporozoites invade host cells and develop into macroschizonts in the
draining lymph node inducing the host cells to become blastoid which divide in
synchrony with the macroschizont. As the infection progresses, microschizonts are
observed which give rise to merozoites by destruction of the infected cells.
Merozoites invade erythrocytes to form piroplasms. Both macroschizonts and
piroplasms perhaps contribute to the pathogenesis of the disease leading to severe
leucopenia and anaemia (Neitz, 1957; Sharma & Gautam, 1971; Hooshmand-Rad,
1976; Preston et al., 1992a).
The macroschizont stage of the parasite can be cultured in vitro leading to
attenuation of the parasite (Brown, 1983). Continuously growing allogeneic T.
annulata infected cell lines have been successfully used as live vaccines in endemic
areas (Hashemi-Fesharki & Shad-Del, 1973; Wenshun et al., 1973; Pipano,1981;
Singh et al., 1993). Parasite specific cytotoxic T cell activity (Preston et al., 1983;
Innes et al., 1989a) and macrophage mediated cytostasis (Preston & Brown, 1988)
against parasite infected cells, and humoral responses in the form of antibodies
against sporozoites, schizonts and piroplasms (Preston & Brown, 1985; Kachani et
al., 1992a) have been observed in the peripheral blood of cell line immunised animals
or after drug treatment in sporozoite infected animals. The natural infection with
sporozoites in susceptible animals leads to severe disease symptoms and death in 40-
60% of the cases without development of protective immune responses. However,
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the involvement of various lymphocyte sub-populations and activation of T cells for
the development of immunity after infection with T. annulata sporozoites or
immunisation with parasite infected cell lines is not well understood. Precise
knowledge of the mechanisms involved in the induction of protective immunity within
the bovine host is an essential pre-requisite for development of effective methods of
prophylaxis.
A cell culture vaccine introduces the parasite to the recipient animal in the
context of a foreign graft as infected cells express BoLA (Bovine leucocyte antigens)
haplotypes identical to those of the original animal from whose lymphocytes they
were derived (Spooner & Brown, 1980). Inoculation of T. annulata infected cell lines
produces a strong allogeneic response against MHC (Major Histocompatibility
Complex) antigens of the immunising cell line followed by a parasite specific immune
response. Development of protective immunity is associated with the establishment
of parasite within the cells of the recipient (Innes et al., 1989a). Duration of
immunity after cell line immunisation is poorly defined. There is evidence that
immunity against the parasite wanes (Pipano, 1977; Ouhelli et al., 1994) particularly
in the absence of the natural tick challenge in the field and there may be need to boost
the immunity. Some evidence from both Morocco and Israel suggests that
reimmunisation with the same cell line does not boost immunity. This could arise
because of the allogeneic responses induced after first cell line immunisation giving
rise to a graft rejection response at the time of revaccination. The effect of pre¬
existing allogeneic responses on the development of immunity against the parasite at
the time of second immunisation with the same cell line is not known. Keeping these
points in view, the work in this thesis was undertaken with the following objectives:
a. To study the effect of a previously generated allogeneic immune response on
immunisation against T. annulata with parasite infected cell lines in the context
of a need for repeated immunisation against tropical theileriosis.
b. To investigate the dynamics of various lymphocyte populations, in the peripheral
blood and efferent lymph from the draining node, during development of an
immune response after inoculation with sporozoites or parasite infected cell lines.
c. To characterise and compare the activation of T cells in the lymph efferent from
the node draining the site of sporozoite infection or cell line immunisation and





This chapter provides a general background of bovine tropical theileriosis
caused by Theileria annulata. A brief description of various bovine leucocyte markers
relevant to this thesis and general organisation of bovine immune system at the lymph
node level is given. This is followed by a review on the current state of knowledge
on immunisation and development of immune responses against tropical theileriosis.
The diseases caused by various Theileria species (spp.) have been recognised
since the beginning of this century. Considerable research has been undertaken on
these parasites. The main economically important theilerial species for cattle are T.
annulata and T. parva and to a lesser degree T. sergenti. This review is mainly
concerned with the first two species. More emphasis is laid on T. annulata with some
aspects of T. parva as well for comparison.
2.1 THEILERIOSIS- GENERAL DESCRIPTION
Theilerial parasites are tick transmitted, blood borne protozoa which affect a
wide range of mammals mainly ruminants and are particularly important for domestic
cattle, sheep and goats in tropical and subtropical countries. Various Theileria species
have been reviewed from time to time (Sergent et al., 1945; Neitz, 1957; Barnett,
1968; Barnett, 1977; Purnell, 1977; Irvin, 1987; Irvin & Morrison, 1987; Norval et
al., 1992 ).
2.1.1 Historical background and taxonomy
The parasite of the genus Theileria was first recognised by Koch in 1897 and
were initially assumed to be immature forms of Babesia bigemina (Koch, 1903).
However these intraerythrocytic organisms were recognised to be distinct from B.
bigemina when large numbers of cattle suffered from East Coast fever in Rhodesia
(Zimbabwe) and Southern Africa. The parasite was then named as Piroplasma parvum
(Theiler, 1904). The exo-erythrocytic schizont stage inside lymphocytes was
discovered by Koch in 1906 and subsequently the parasite was named Theileria parva
(Bettencourt et al., 1907). Simultaneously, Dschunkowsky and Luhs (1904)
discovered a fatal disease in cattle in Southern Russia and called it tropical
piroplasmosis caused by Piroplasma annulatum, which was also placed later under
the new genus Theileria and named T. annulata (Bettencourt et al., 1907). Further
investigations in North Africa, Asia and Europe over the years showed many
unidentified types of theilerial parasites widely distributed in these continents (Neitz,
6
1957). With the passage of time, some of these Theileria spp. were defined as new
species. The taxonomy of Theileria has been a subject of controversy from the very
beginning with species being split up, recombined or shifted from one genus to the
other with the advancement of knowledge. On the basis of the recent classification of









Taxonomy of the genus Theileria has been reviewed by Uilenberg (1981a).
Levine (1988) reported 34 species of Theileria, but many of these are likely to be
synonyms (Irvin, 1987). The main Theileria species which affect cattle, as described
by Uilenberg et al. (1993) and Norval et al. (1992), are described in table 2.1.
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Amblyomnia spp. Non-pathogenic Uilenberg, 1964
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The naming of T. parva and the diseases it causes has been recently reviewed
(Perry & Young, 1993). Some scientists advocate sub-speciation of T. parva into T.p.
parva (East Coast fever) for the parasite causing acute classical disease, T.p. bovis
(January disease) for the parasite causing mild disease in Zimbabwe and T.p.
lawrencei (Corridor disease) for the buffalo derived parasite (Lawrence, 1979;
Uilenberg, 1981a; Uilenberg etal., 1993). However, this trinomial classification may
not be valid as some of the field isolates cross-protected in challenge experiments
(Irvin et al., 1989). Further, oligonucleotide probes generated on the basis of the
variable region sequence of the subunit ribosomal RNA genes of different Theileria
spp. were unable to distinguish between various T. parva subspecies (Allsopp et al.,
1993). There has been confusion over the status of T. orientalis as well. Uilenberg
(1981a), Uilenberg et al. (1985) and Uilenberg et al. (1993) considered that T.
sergenti from Japan, T. buffeli from Australia and T. orientalis from Europe as
different forms of one species and named it as T. orientalis. However, Fujisaki et al.
(1994) have shown that T. sergenti is a different species from T. orientalis and T.
buffeli on the basis of 33 kilodalton (kd) piroplasm protein. Recently, a new Theileria
parasite was isolated from Kenya which could not be transmitted by ticks of the genus
Rhipicephalus and Amblyomma (Ngumi et al., 1994). This species has not yet been
fully characterised.
Identification of various species and stocks of Theileria was previously based
on the morphological characteristics of different parasite stages, geographical
distribution, vector specificity, host specificity, cross-immunity and pathological,
epidemiological and serological characterisation. More sophisticated techniques are
now being used which should help in resolving these controversies. These techniques
include the use of monoclonal antibodies (Pinder & Hewett, 1980; Williamson et al.,
1989; Musoke & Nene, 1990), characterisation of isoenzyme pattern (Melrose &
Brown, 1978; Ben Miled et al., 1994) analysis of protein antigens (Creemers, 1983),
use of cDNA probes (Allsopp et al., 1989; Allsopp et al., 1993; de Kok et al., 1993;
Fujisaki et al., 1994) and restriction fragment length polymorphism (RFLP)
(Morzaria et al., 1990).
2.1.2 Distribution
Bovine tropical theileriosis occurs mainly in tropical and subtropical regions
from Portugal, Spain and Morocco in the west, through the Mediterranean coast of
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Europe and North Africa, southwards into the Sudan and Eritrea and eastwards into
south-east Europe, the Near East and Middle East, southern Russia and Siberia and
across the Indian subcontinent through to China and the Far East (Purnell, 1978,
Robinson, 1982). T. parva is comparatively less widespread than T. annulata and is
limited to eastern, central and southern Africa (Norval et al., 1992; Uilenberg et al.,
1993). Distribution of the two parasites does not overlap except in Sudan where both
the parasites cause disease (Norval et al., 1992). Distinct distribution of the two
parasites is probably because of the difference in their tick vectors. Figure 2.1 gives
an overview of the distribution of these two parasites.
2.1.3 Transmission
Theileria parasites are transmitted trans-stadially by two and three host ticks
(from larva to nymph or nymph to adult). Transmission of T. annulata has been
reviewed by Robinson (1982). T. annulata is transmitted exclusively by ticks of the
genus Hyalomma. The three host tick H. anatolicum anatolicum and the two host tick
H. detritum are the main vectors. H. a. anatolicum occurs from northwest Africa
eastwards to India. It is replaced by another three host tick H. lusitanicum in the
southwest mediterranean region and Spain (Barnett, 1977). H. detritum ranges from
Manchuria through China and India, former southern Soviet Union, south eastern
Europe, the Middle East and the Mediterranean littoral of Africa (Norval et al.,
1992). Other Hyalomma species such as H. dromedarii, H. a. excavatum, H.
marginatum and H. scupense have been shown to transmit the disease in experimental
conditions (Barnett, 1977; Uilenberg, 1981a). Ten Rhipicephalus and three Hyalomma
species have been shown experimentally to be possible vectors of T. parva. However,
the most common vector is Rhipicephalus appendiculatus (Norval et al., 1992).
Transmission of the sporozoites from tick to bovine host occurs two to four
days after attachment of the tick for feeding on a susceptible host, as the stimulus of
a blood meal is required to induce maturation of the parasite in the tick salivary gland
(Purnell etal., 1973; Samish & Pipano, 1978; Singh et al., 1979). However, increase
in the temperature and relative humidity also leads to maturation of parasites in the
salivary glands without any blood meal (Samish, 1977; Young et al., 1979). This
suggests that maturation of the parasite in the salivary glands of ticks may occur
earlier under natural conditions in hot areas and ticks may transmit the infection as
soon as they attach to a susceptible host. Engorgement of an infected tick on a clean
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Figure2.1:DistributionofTheileriaannulatadTheil iparva.
susceptible host makes it clear of the infection in the following instar. However,
infection in the tick persists into the following instar if feeding takes place on a non-
susceptible host such as rabbits (Bhattacharyulu et al., 1975).
2.1.4 Susceptibility
T. annulata infection mainly causes severe disease in exotic Bos taurus breeds
of cattle and their crosses, whereas local Zebu and taurine breeds reared in the
endemic areas are usually resistant. This has been observed in most of the endemic
areas (Singh, 1990; Hashemi-Fesharki, 1991; Flach & Ouhelli, 1992). Young Bos
indicus calves also suffer from the disease. Adult Bos indicus and indigenous taurine
breeds are thought to be relatively resistant. Similarly, local breeds were shown to
be more resistant than exotic taurine breeds in East Coast fever endemic areas
(Guilbride & Opwata, 1963). Moll et al. (1986) demonstrated that low numbers of
Zebu calves died in endemically stable areas with T. parva infection although high
numbers of improved taurine cattle would die if introduced to these areas. Recently,
Preston et al. (1992a) showed that Bos taurus x Sahiwal (Bos indicus) calves were
relatively more resistant to tropical theileriosis than taurine calves.
Hard evidence for genetic control of resistance to tropical theileriosis or East
Coast fever is lacking (Spooner & Brown, 1991). In some reports, local cattle reared
in disease free conditions for some years suffered more than imported cattle after
challenge with T. annulata (Sergent et al., 1945). However, recent epidemiological
studies in Morocco clearly show that local cattle are more resistant than exotic
animals and their crossbreds (Oudich et al., 1993). It is not clear whether the
resistance observed in local breeds in endemic areas is because of some genetic
factors due to selection over the years of their association with the parasite or because
of early exposure of young animals to the parasite making them pre-immune. Valid
evidence for genetic resistance can only be obtained from studies within families with
the use of highly quantified tick stabdate and clearly definable tests to estimate the
level of resistance (Spooner, 1993).
Observations from India suggest that clinical theileriosis in new-born calves
up to 8 weeks of age is a serious problem (Grewal et al. 1991; Mishra et al., 1994;
R.D. Sharma, unpublished observations). In Pakistan, young animals below nine
months of age were reported to suffer mostly from clinical theileriosis with the worst
affected animals between 2-4 months of age (Hussain et al., 1991). Observations in
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Morocco suggest that very young calves are less affected (Flach & Ouhelli, 1992).
These differences could be because of different animal management and tick control
practices. The second important factor could be the tick vector. In areas where the
disease is transmitted by two host ticks, only the adult stage of the tick is capable of
transmitting the infection. Adult ticks feed more preferentially on adults than young
calves and hence young calves are less affected. In areas where the disease is
transmitted by three host ticks, both nymphs and adult ticks can transmit the disease.
Immature ticks feed equally well on adult and young animals and, therefore, young
animals are infected.
2.1.5 Life cycle
The life cycle of the parasite is illustrated schematically in figure 2.2. Two
main stages in the tick: gametogony and sporogony, have been described in detail by
Cowdry & Ham (1932) and Mehlhorn & Schein (1984). The life cycle of Theileria
has also been reviewed by Sergent et al. (1945), Neitz (1957), Schein (1975),
Uilenberg (1981b) and Mehlhorn & Schein (1993).
The bovine host is infected through inoculation of sporozoites by the saliva of
infected ticks during feeding which invade leucocytes probably within 5-60 minutes
(min.) as observed during in vitro studies on T. annulata (Jura et al., 1983) and T.
parva (Fawcett & Stagg, 1986; Shaw et al., 1991). It is not known where and when
the parasite encounters the bovine target cells for invasion in vivo. It could be in the
mouth parts of the tick, the tick attachment lesion or the pool of cells and fluids that
develops below this lesion (Walker & Fletcher, 1986). It could take place in the
afferent lymph draining to the node from the site of the tick bite or in the node.
Sporozoites probably come in contact with the target cells through a receptor-ligand
driven process (Tait & Sacks, 1988) and enter by invaginating the plasma membrane
of the target cell in an active temperature dependent process (Jura et al., 1983).
After entry into the host cell, the sporozoite develops into a multi-nucleate
trophozoite which after nuclear division develops into a macroschizont transforming
the host cell and inducing it to become a large blast cell. Presence of the parasite
stimulates the host cell to divide giving rise to a large population of infected cells in
the animal. During host cell division, the theilerial particles also divide and are
distributed by the host cell spindle apparatus to each of the daughter cells (Hulliger
et al., 1964; Hulliger, 1965). After several cycles of clonal expansion, schizonts
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Figure 2,2= Life cycle of Theileria sp.
Adapted from "Goddeeris, B.M., Ph.D. thesis, 1986".
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differentiate into microschizonts and start producing merozoites in vivo in response
to some unknown stimuli. One of these stimuli could be fever in the affected animals
as merogony can be induced in vitro in continuously growing T. annulata cell lines
by raising the temperature of the culture to 41°C.
Differentiation to the merozoite stage (merogony) takes place within the host
cell by increased nuclear division and generation of rhoptry and microneme organelles
(Schein et al., 1978; Mehlhorn & Schein, 1984). This process results in significant
changes in the antigenic profiles of the parasite, indicating that it is a major point of
differentiation in the mammalian phase of the parasite life cycle and involves both
positive and negative regulation of gene expression (Glascodine et al., 1990).
Efficiency of differentiation from schizont infected cell to merozoite has been shown
to be variable in cloned T. annulata cell lines. Differentiation to the merozoite stage
was found to be a two step process, with a preliminary reversible phase of
differentiation leading to a second irreversible phase. This was associated with an
increased number of theilerial particles per cell generated by a disruption in the
synchrony between parasite growth and host cell division (Shiels et al., 1992). This
development leads to destruction of the host cell and release of merozoites into the
extracellular environment.
Free merozoites invade erythrocytes and develop into piroplasms which can
be detected nine to ten days after experimental infection with ground up tick
supernates (GUTS) (Preston et al., 1992a) and slightly later with feeding ticks. The
mechanism of penetration of merozoites into erythrocytes is not known and is
presumed to be similar to the entry of sporozoites into host cells. The piroplasms
undergo division within the erythrocytes by binary fission (Mehlhorn & Schein, 1984)
or schizogony (Conrad et al., 1985). Both schizont and piroplasm stages probably
contribute to the development of leucopenia and anaemia, which are the main
pathogenic features in tropical theileriosis (Sharma & Gautam, 1971; Hooshmand-
Rad, 1976; Laiblin, 1978; Preston et al., 1992a). However, the mechanism of
development of anaemia and leucopenia is not understood. The erythrocytic parasites
persist throughout life in recovered animals (Sergent et al., 1945).
Apart from asexual multiplication of parasite in the bovine host, development
of the sexual stages of both T. annulata (Sergent et al., 1945; Neitz, 1957; Schein,
1975) and T. parva (Cowdry & Ham, 1932; Mehlhorn & Schein, 1984) occur within
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the tick. Piroplasm infected erythrocytes ingested by the tick during engorgement are
lysed within the gut lumen, giving rise to sexual stages (gametes) which combine to
form a zygote. The zygote enters gut epithelial cells and develops into a motile club
shaped kinete by day 7 after engorgement (Reid & Bell, 1984). There is some
synchronisation of kinete formation, which may be controlled by the process of
moulting in the tick (Young & Leitch, 1980), as salivary glands are only available for
infection by the kinete at the time they re-develop after each moult (Fawcett et al.,
1981). Such a mechanism would ensure that the kinete penetrates the salivary gland
acini when these would be in a suitable state for development (Reid & Bell, 1984).
Kinetes develop in the cells of type II or type III acini (Schein & Friedhoff, 1978).
It rounds up forming a sporoblast which can be detected one or two days after the
tick completes moulting. When the tick attaches to a new host and commences
feeding, nuclear division in the sporoblast (sporogony) produces infective uninuclear
sporozoites which are released in the tick saliva and injected into the new host
(Fawcett et al., 1985). The number of sporozoites developing in one acinar cell were
estimated to be about 50,000. This amounts to an enormous inoculum from one tick,
when many acini of the salivary gland are infected (Mehlhorn & Schein, 1993).
2.1.6 Host target cells for invasion by sporozoites
The nature of target cells infected by sporozoites of T. annulata and T. parva,
after inoculation into an animal or in vitro, has been a matter of controversy for many
years mainly because of lack of suitable reagents to identify populations of potential
target cells. Development ofmonoclonal antibodies (mAbs) which distinguish specific
bovine lymphocyte populations (Lalor et al., 1986) has facilitated identification of
potential targets for in vitro infection by sporozoites. Various cell sub-populations
were separated using specific mAbs and infected in vitro with sporozoites. T.
annulata sporozoites infected and transformed cells of monocyte and macrophage
lineage and to a lesser degree B cells, but not T cells. On the other hand, T. parva
sporozoites transformed T cells and B cells, but not monocytes/macrophages (Spooner
et al., 1989). Mammary gland macrophages were permissive to infection by T.
annulata but only to a limited extent by T. parva. T. annulata preferentially infected
MHC class II+ cells (Glass et al., 1989). Innes et al. (1989b) attempted to infect
bovine alloreactive cytotoxic T cell lines with sporozoites of both the parasites. The
lines were very easily infected by T. parva sporozoites, but not by T. annulata
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sporozoites. Another study with T. parva sporozoites showed that the parasite
transformed B cells, CD4+ and CD8+ cells and null cells (75 T cells), but not
monocytes or neutrophils (Baldwin et al., 1988a). Recently, T. annulata sporozoites
were shown to infect mature monocytes more readily than immature monocytes,
although these cells were also easily infectable (Campbell et al., 1994a). It is
interesting to note here that Sergent et al. (1945) demonstrated that T. annulata
infected cells of the reticular endothelial system, reticular cells of the node and the
spleen, Kupffer cells of the liver and hystiocytes.
Most of the these experiments were done in vitro. Further cells infected with
either parasite ceased to express a number of surface markers including those for
monocytes and B cells (Spooner et al., 1988; Baldwin et al., 1988a). Cells positive
for the elastin receptor (a potential ligand for sporozoite entry) or the
lipopolysaccharide (LPS) receptor (CD 14) lost these expressions after transformation
with T. annulata sporozoites (Campbell et al., 1994a). Expression of MHC class II
antigens has been very high on both T. annulata and T. parva infected cells (Spooner
et al., 1988; Glass et al., 1989). The infected cell lines of both parasites express
MHC class I antigens. BoLA specificities of infected cells are unchanged from the
original donor lymphocytes (Spooner & Brown, 1980).
Despite extensive studies on finding target cells for these two parasites in
vitro, little work has been done on identifying the target cells for sporozoite invasion
in vivo. This is probably due to difficulties in simultaneous monitoring of target cell
phenotype and parasitosis, mainly because of changing expression of different cell
surface markers after transformation. Presumably, the same cell subpopulations are
infectable in vivo as well. Some supporting evidence is available in the literature.
Baldwin et al. (1988a) observed that most of in vivo derived T. parva cell lines
expressed T cell markers. Subsequently, T. parva infected cells exiting in the efferent
lymph of animals undergoing clinical infection were shown to co-express both CD4
and CD8 T cell markers (Emery et al., 1988). The authors argued that CD4+ cells
were initially infected and expressed CD8 upon transformation. These observations
have important implications on the pathogenesis and initiation of immunity. The
phenotype of the infected cell would determine the migration patterns through various
body compartments affecting the severity of lesions in different organs or tissues,
secretion and responsiveness to various cytokines and antigen presentation to immuno-
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competant cells. Alterations in the expression of surface markers after transformation
of the infected cells further complicate the situation.
Theileria parasites must undergo a recognition event for entry into target cells
presumably via interaction between ligands on the parasite surface and receptors on
the target cells (Tait & Sacks, 1988). Williamson et al. (1989) identified an antigen
SPAG-1 on the surface of T. annulata sporozoites, which could be involved in this
process. A mAb against SPAG-1 blocked sporozoite penetration into the target cells.
SPAG-1 exhibited a remarkable degree of molecular mimicry to an extracellular
matrix protein, elastin (Hall et al., 1992b). It was, therefore, suggested that receptor
for elastin which is expressed mainly on monocytes and macrophages might be a
ligand for recognition of host cells by the sporozoites. However, T. annulata
sporozoites infected sorted elastin receptor positive and negative cells with equal
efficiency in in vitro experiments (Campbell et al., 1994a). The receptor for entry of
T. parva sporozoites is also not known. It might relate to an epitope on a 67 kd
antigen on the sporozoite surface as entry into the target cells can be blocked by
antibodies raised against this epitope (Musoke et al., 1984; Dobbelaere et al., 1984).
Although, antibodies against MHC class I molecules on the target cells also prevent
entry of T. parva sporozoites in vitro (Shaw et al., 1991), yet MHC class I molecules
are unlikely to be the ligands for sporozoite penetration as these are expressed on all
nucleated cells and the parasite infects only a small cell subpopulation.
2.1.7 Clinical signs
The incubation period of T. annulata or T. parva infection following natural
tick infestation is around two weeks, ranging between 8-25 days (Sergent et al., 1945;
Neitz, 1957). Severity of the disease after T. annulata or T. parva infection in an
animal depends largely upon the dose of initial infection received, the susceptibility
of the host and the parasite strain involved (Jarrett et al., 1969; Gill et al., 1977;
Samantaray et al., 1980; Dolan et al., 1984c; Preston et al., 1992a). Schizonts are
detected in superficial lymph nodes draining the site of tick infection on 5th to 8th
day of infection and piroplasms in red blood cells 2-5 days later. Initial symptoms
include high fever and swelling of superficial draining lymph nodes followed by
symptoms of progressive anaemia (Gill et al., 1980; Samantaray et al., 1980;
Uilenberg, 1981b; Preston et al., 1992a). T. parva infection is followed by a
generalised lymphadenopathy (Morrison et al., 1981a), however, involvement of
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other lymph nodes is not seen in T. annulata infection. Other clinical symptoms
include anorexia, malaise, listlessness, dyspnoea, loss of body weight and digestive
disturbances including a localised ulcerative abomasitis (Preston et al., 1992a).
Terminal cases show hypothermia, recumbency, rapid breathing and pulse rate. Death
can occur between 14-30 days post-infection. Anaemia and jaundice do not normally
develop in East Coast fever, but are common terminal features of tropical theileriosis
(Hooshmand-Rad, 1976; Dhar & Gautam, 1979). The mortality rate in T. annulata
infection is 40-60% (Uilenberg, 1981b; Brown, 1990) and in T. parva infection is 85-
90% (Brocklesby et al., 1961). Animals that survive may undergo a prolonged period
of recovery and become piroplasm carriers. This stage may flare up again to acute
tropical theileriosis at times of stress or intercurrent disease (Sergent et al., 1945).
A cerebral form of theileriosis has been recorded in some animals infected
with T. parva usually several months or even years after the initial disease and is
known as turning sickness (Mettam & Carmichael, 1936; Giles et al., 1978). Affected
animals show ataxia and circling and may die in convulsions. This is associated with
the presence of large numbers of infected cells and free schizonts in brain capillaries,
with congestion and sometimes necrosis of cerebral brain tissue (Moll et al., 1986).
Some animals infected with T. annulata also show nervous symptoms in the form of
ataxia, convulsions, enlargement and bulging of eye balls followed by blindness,
unconsciousness and death (Khanna et al., 1982; Mallick et al., 1986).
2.1.8 Pathogenesis
Pathogenesis of T. parva infection has been studied in depth, but literature on
other Theileria spp. is scanty. Direct extrapolation of findings on T. parva for T.
annulata might not be possible as the two parasites show some striking dissimilarities.
The pathology of T. parva has been extensively reviewed by Neitz (1957), Wilde
(1967), Barnett (1968), Irvin & Morrison (1987) and Norval et al. (1992). Accounts
on the pathogenesis of T. annulata are given in the reviews of Sergent et al. (1945),
Neitz (1957), Gill et al. (1977) and Uilenberg (1981b).
2.1.8.1 Kinetics of parasite dissemination
Following sporozoite inoculation, the parasite has not been followed in great
detail till schizonts appear in the draining lymph node. The mode and place of host
cell invasion by the parasite are not fully understood. Phenotype of target cells during
in vivo infection by both the parasites is also not clearly defined. The infection
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appears to travel through the lymphatic system as the parasite is first seen in the
draining lymph node. Dissemination of the parasite seems to be quite rapid as surgical
removal of the draining lymph node, as early as two days after inoculation of T.
annulata (J.D. Campbell & R.L. Spooner, pers. comm.) or T. parva (Emery, 1981b)
sporozoites or four days after T. annulata infected cell line (P. Goel & R.L. Spooner,
pers. comm.), delayed the initial onset of fever but had no effect on subsequent
course of infection. These results can be expected if parasite dissemination takes place
to more than one lymph node from the site of inoculation. Detection of T. parva
schizonts in the draining lymph node earlier than non-draining lymph nodes (Morrison
et al., 1981a) perhaps reflects a relative enrichment of infection in this location
because of its proximity to the site of inoculation, rather than an initial period of
establishment of infection in the draining node prior to dissemination. The same might
not be true for T. annulata infection where schizonts are not usually detected in the
non-draining nodes. Dissemination of the parasite might occur through blood
circulation to other lymphoid organs.
Schizont parasitosis in T. parva infection shows a logarithmic growth phase
with a 10 fold growth in approximately three days after initial appearance of schizonts
in the lymph node (Jarrett et al., 1969; Radley et al., 1974). There is a dramatic
increase in total cellularity and the size of the draining lymph node corresponding to
the initial appearance of T. parva schizonts (Morrison et al., 1981b). Parasitized cells
are detected in efferent lymph at about the same time as in the draining node and are
associated with an increase in the total and blasting cell output in efferent lymph
(Morrison et al., 1981a; Emery, 1981b). Similar changes are observed in the distant
lymph nodes and spleen 2-3 days later except that these are less pronounced and more
gradual (Morrison et al., 1981a; Shatry et al., 1981). With the increase in parasite
infected cells in the node during later stages of the disease, there is a gradual decrease
in the total cellularity of lymphoid tissues, decrease in output of cells in efferent
lymph and in the cellularity of thoracic duct lymph (Emery, 1981b; DeMartini &
Moulton, 1973b). Enlargement of the draining lymph node is also a common feature
in T. annulata infection, but similar kinetics of infection and the associated cellular
changes in the draining and distant lymph nodes have not been studied. Some of these
studies are reported in this thesis.
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2.1.8.2 Histological studies
Histological examination of the draining lymph node after inoculation of T.
annulata sporozoites in a naive animal revealed areas of blasting cells in the medulla
by day 4 and throughout the tissue by day 8. By day 10, the node was full of infected
cells, normal lymphoid architecture was destroyed with large areas of dead cells,
discrete areas of blasting cells and no germinal centres (Campbell et al., in press).
During the terminal stages of tropical theileriosis, total cell depletion from the
paracortex and medulla with large numbers of infected and blasting cells around
follicles were observed (Eisler, 1988). Other internal organs showed signs of
congestion and haemorrhage (Sergent et al., 1945). An initial phase of blastogenesis
was observed during T. parva infection, followed by the appearance of large numbers
of infected cells (Barnett, 1968). Uninfected blasting cells were more prominent in
the paracortical zone (DeMartini & Moulton, 1973a). Blasting Infected cells were
more numerous in T-dependent areas than in B-dependent areas. Germinal centres
underwent a rapid involution, although some infected cells were observed within
germinal centres (Morrison et al., 1981a). In contrast, inoculation of an allogeneic
T. annulata infected cell line revealed blasting plasma cells and monocytes initially,
followed by appearance of blasting cells in the medullary sisuses. Germinal centre
follicles started to appear by day 9. Sections of lymph node collected on day 16
showed large, hyperplastic germinal centres with clear areas of proliferating dark and
light zones with no signs of nodal dystrophy (P. Goel & R.L. Spooner, pers. comm.).
2.1.8.3 Leucopenia
Infection with both parasites leads to development of severe leucopenia
involving both polymorphonuclear cells and lymphocytes (Wilde, 1967; Sharma &
Gautam, 1971; Laiblin, 1978; Morrison et al., 1981b; Preston et al., 1992a). Some
previous studies reported leucocytosis with T. annulata infection (Sergent et al.,
1945; Barnett, 1977), but the animals were infected by mechanical transmission using
either infected blood or leucocytes and may not present a true picture. Depletion of
lymphocytes is evident from both solid lymphoid tissues and in the recirculating pool
which is associated with marked destruction of cells in the later stages of the disease.
However, mechanisms involved in the destruction of cells are not clearly known.
There is retardation of granulopoeisis in the bone marrow and impairment of
lymphopoiesis in bone marrow and thymus after T. parva infection (Wilde et al.,
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1966). Wilde (1967) suggested involvement of an autoantibody dependent mechanism
which has not been proved. Polyspecific cytotoxic cells were detected from animals
during the terminal phase of East Coast fever which killed a range of different
allogeneic infected cells, but not autologous infected cells in in vitro assays (Emery
et al., 1981a). These cells might be important in causing leucopenia. The parasite
might be inducing some kind of stimulation leading to programmed cell death
(apoptosis). Some T. parva infected cell lines were shown to produce an Interleukin-2
(IL-2) like activity (Brown & Logan, 1986; Dobbelaere et al., 1988). It has been
recently confirmed that T. parva infected cell lines expressed IL-2 mRNA (Heussler
et al., 1992). IL-2 might be responsible for massive proliferation of infected cells and
uninfected host cells. Interferon-7 (IFN-7) is also produced by T. parva infected
lines, whereas T. annulata infected cells probably produce other Interferons (Entrican
et al., 1991; DeMartini & Baldwin, 1991; Ahmed et al., 1993). ILN-7 can activate
macrophages to produce high levels of tumour necrosis factor-a (TNF-a) which
exerts cytostatic and necrotic effects on some target cells (Sugarman et al., 1985).
Similar cells might be activated in infection with these two parasites leading to
destruction of self lymphocytes.
2.1.8.4 Anaemia
Severe anaemia is a common finding during acute T. annulata infection
(Sergent et al., 1945; Neitz, 1957; Hooshmand-Rad, 1976; Dhar & Gautam, 1979),
but anaemia is usually mild during infection with T. parva (Wilde, 1967; Maxie et
al., 1982). Anaemia is not aggravated by splenectomy during T. parva infection
(Barnett, 1968), but parasitaemia flares up even in latent T. annulata infection leading
to anaemia by splenectomy. Strains of T. annulata which had lost the ability to
produce microschizonts and, hence, piroplasms could still induce anaemia
(Hooshmand-Rad, 1976) suggesting that there may be factors other than
intraerythrocytic piroplasms contributing to the cause of anaemia.
Erythrophagocytosis has been suggested as a mechanism of erythrocyte destruction
rather than a direct effect of parasitaemia on the infected animals (Neitz, 1957;
Uilenberg, 1981b). Induction of anaemia by means of autohaemagglutinating
antibodies has been suggested, however the events leading to induction of such
antibodies remain obscure. Peripheral blood mononuclear cells (PBM) from calves
lethally infected with T. annulata spontaneously produced TNF-a and IFN-y (Preston
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et al., 1993). A TNF dependent red cell destruction and dyserythropoiesis has been
shown in mice infected with Plasmodium vinkei (Clark, 1987). It is possible that TNF
might be involved in producing anaemia after infection with T. annulata by activating
macrophages to phagocytose erythrocytes.
2.1.9 Pathological lesions
Pathological lesions are mainly associated with lymphopoietic and vascular
systems. Gross post-mortem findings include emaciated and pale carcass, generalised
enlargement and oedema of lymph nodes and spleen, massive pulmonary oedema,
congestion and consolidation in apical lobes, petechial and ecchymotic haemorrhages
of the serosal surfaces (Barnett, 1968; Uilenberg, 1981b). The most striking and
frequent lesion is haemorrhagic ulceration of the abomasum commonly called punched
necrotic ulcers. The liver is enlarged and haemorrhagic. The gall bladder is often
enlarged with dark green viscous bile. There are generalised symptoms of anaemia
and jaundice (Sergent et al., 1945; Neitz, 1957). Animals with the cerebral form
show congestion of the vessels of the meninges and haemorrhagic necrosis in the
central nervous system (Barnett, 1968). Schizonts can be detected from impression
smears from most of the internal organs.
2.1.10 Diagnosis
Field diagnosis of tropical theileriosis and East Coast fever still depends upon
clinical symptoms, haematological observations, detection of parasite in lymph node
biopsies and blood smears and autopsy lesions in dead animals. The most commonly
used serum antibody assay for serological surveys has been indirect fluorescent
antibody test (IFAT) for T. annulata (Burridge & Kimber, 1972) and T. parva
(Goddeeris et al., 1982). The complement fixation test has also been used in some
places (Dhar & Gautam, 1977). Development of an enzyme linked immunosorbant
assay (ELISA) (Kachani et al., 1992b; Sunder et al., 1993) and DOT-ELISA (Grewal
et al., 1991; Grewal, 1992) has been described for T. annulata. Recently, Campbell
et al. (1994d) developed an immunoperoxidase technique for detection of antibodies
against T. annulata as a replacement for IFAT. Methyl green pyronin staining has
been used to demonstrate infection in the salivary glands of ticks (Walker &
McKellar, 1983; Sangwan et al., 1986; Flach et al., 1993). It is hoped that these tests
would help in conducting serious epidemiological studies in T. annulata endemic
areas.
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T. parva specific repetitive DNA probes were developed and shown to be
useful for the differentiation of the parasite from other Theileria species, and for
discrimination of stocks within T. parva by detection of restriction fragment length
polymorphism (Conrad et al., 1987; Allsopp & Allsopp, 1988; Morzaria et al.,
1990). Recently, oligonucleotide probes detecting small subunit ribosomal RNA
sequences were used to discriminate between six species of Theileria (Allsopp et al.,
1993). Ben Miled et al. (1994) demonstrated considerable diversity amongst various
T. annulata stocks isolated in Tunisia using two genomic DNA probes. Polymorphism
was observed between isolates collected even from the same farm. Similar approaches
have also been used for studying polymorphism in T. sergenti infection (Matsuba et
al., 1993). Currently, these probes only serve as valuable laboratory tools and are not
suitable for routine field application mainly because of the use of radiolabelled probes
to achieve the desired level of sensitivity. However, use of the polymerase chain
reaction (PCR) for in vitro amplification of specific DNA sequences would help in
making these tests more practicable. This technique has been used to detect T.
annulata in infected ticks by amplifying a DNA fragment from small ribosomal RNA
gene of T. annulata using PCR (de Kok et al., 1993). PCR has also been used to
amplify p33/34 genes from the piroplasm DNA to distinguish between T. sergenti,
T. buffeli and T. orientalis (Kawazu et al., 1992).
2.1.11 In vitro cultivation
The methods used for in vitro cultivation of Theileria parasites and their
applications have been extensively reviewed by Brown (1979, 1981, 1983 & 1987).
Cell lines can be established from infected lymphoid tissue or peripheral blood from
a sick animal or infected lymphoid material from a recently dead animal. Cultures can
also be initiated in vitro by incubating suspensions of sporozoites, harvested from
ticks, with uninfected bovine lymphocytes (Brown, 1987). These transformed
parasitised cells can be cultivated in vitro for a seemingly indefinite period without
addition of exogenous growth factors (Hulliger et al., 1964).
The first reported culture of Theileria parasites was achieved by Tsur (1945)
with T. annulata by culturing liver and spleen explants taken from infected cattle, in
plasma clot cultures. This discovery was developed further to cultivate infected cells
established either from infected tissues or blood in monolayers (Tsur and Adler,
1962; 1965) or in suspension cultures (Hooshmand-Rad, 1975) and finally led to the
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development of a cell culture vaccine against T. annulata (Pipano & Tsur, 1966).
However, the same technology did not prove very successful for establishment of T.
parva cell cultures (Brocklesby and Hawking, 1958). The mode of multiplication of
theilerial schizonts was conclusively demonstrated in in vitro cultures by Hulliger et
al. (1964). The first successful establishment of a T. parva infected cell line in vitro
was achieved by Malmquist et al. (1970), using spleen cells from an infected animal
and high concentrations of foetal calf serum. The most important breakthrough came
with the work of Brown et al. (1973), in which normal lymphoid cells were infected
in vitro with sporozoites of T. parva. This technology was extended to culture other
theilerial species (Brown, 1983). This technique has proved to be an invaluable tool
for most of the subsequent studies on T. annulata and T. parva. It created the
possibility of generating infected cell lines in vitro from naive animals without
infecting them. This has been the only stage so far amenable to continuous cultivation
in the laboratory. With further developments in in vitro culture systems, it is now
possible to generate cloned cell lines with one sporozoite infecting one cell (Brown,
1987). The macroschizont infected cell lines of various theilerial species show
unlimited growth potential in vitro (Brown, 1987) which seems to be induced by the
presence of parasite inside the cell. The infected cell stops dividing if the parasite
within the cell is killed (Pinder et al., 1981; Ahmed et al., 1992). Bovine fibroblast
cell lines can be infected with T. annulata or T. parva if co-cultivated with parasite
infected cell cultures in vitro (Brown & Gray, 1981), however the mode of parasite
transfer in such conditions remains obscure. Apart from use as a cell culture vaccine
in T. annulata endemic areas, Theileria culture techniques have helped in elucidating
the life cycle, taxonomy and chemotherapy and has provided material for
immunological, biochemical and molecular studies on these parasites (Brown, 1987).
No other stage of Theileria parasites apart from schizonts has been indefinitely
grown in culture so far. Infected salivary glands and motile kinete stage of the
parasite harvested from backless ticks has been maintained for short periods in culture
(Bell, 1980; Bell, 1984). Some workers have produced merozoites in vitro (Hulliger
et al., 1966; Danskin & Wilde, 1976; Shiels et al., 1992), but no one has been able
to infect erythrocytes with these merozoites in vitro. Pipano & Fish (1982) could
maintain T. annulata piroplasms in vitro for a few weeks, but were not able to grow
these cultures for long periods. Short term cultures of T. annulata piroplasms between
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10-27 days were maintained by Conrad et al. (1985).
2.2 BOVINE LEUCOCYTE MARKERS
With the advent of monoclonal antibody technology, many reagents have been
developed which recognise various leucocyte differentiation antigens in man, mouse
and other species including cattle (Baldwin et al., 1988c). Monoclonal antibodies
generated against human leucocyte differentiation antigens in different laboratories
around the world have been tested on a common platform in international workshops.
Clusters of differentiation (CD) for classifying antigens and mAbs recognising them
have been established on the basis of immunofluorescent cell surface labelling,
immunoprecipitation and immunohistology on tissue sections (Bernard et al., 1984).
This nomenclature has lead to a practical system for identification of cell surface
molecules on the basis of their biochemical structure allowing various cell types to
be defined by the expression of "CD antigens".
A similar approach has also been adopted for identification of bovine leucocyte
differentiation antigens which have been tested and compared in two international
workshops (Howard et al., 1991a; Howard & Naessens, 1993) to date. Clusters of
mAbs directed against bovine antigens that were homologous to a human CD antigen
were assigned the same number with a prefix "Bo" to facilitate comparison of
immunological observations between species. In the case of clusters for which there
was no obvious equivalent human CD antigen, a newWC (workshop cluster) number
was designated (Naessens, 1993). These two workshops have defined many CD and
WC antigens for cattle and other ruminants, some of these relevant to this thesis are
described below.
2.2.1 CD2
This antigen is expressed on T cells, is a receptor for sheep red blood cells
(RBC) and is also known as E-rosette forming receptor. The antigen appears very
early in the ontogeny of T lymphocytes in the thymus and is expressed on both
mature and immature lymphocytes with the all T cell receptor (TCR). The natural
ligand for this molecule is lymphocyte function antigen (LFA)-3, also known as CD58
(Davis et al., 1987). The molecule in humans is a 45-50 kd transmembrane
glycoprotein and is one of the several accessory molecules involved in adhesion and
activation of T cells and transduction of activation signals across the cell membrane
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(Bierer et al., 1989). The mAbs to bovine CD2 precipitate a 50-60 kd molecule and
inhibit rosette formation with sheep RBC (Davis et al., 1988). CD2 is expressed on
the majority of CD4+ and CD8+ cells in PBM and a very small proportion of CD4
/CD8" cells, but not onWC1+ T cells, B cells and monocytes/macrophages. It is also
expressed on some y5TCR+ cells which are not WC1+ (Baldwin et al., 1988b; Davis
& Splitter, 1991). The mAbs to bovine CD2 molecule stain the majority of
thymocytes in both the cortex and medulla of the thymus except some lymphocytes
immediately beneath the thymic capsule, T cell areas in lymph node (LN) paracortex
and a few cells in B cell follicular areas (Davis et al., 1988).
2.2.2 CD4
The CD4 molecule in humans is a single chain glycoprotein of 59 kd and is
expressed on approximately two third of circulating T cells, including most T cells
of helper/inducer type (Terhorst et al., 1980). The mAbs which recognise the bovine
analogue precipitate two polypeptides of approximately 52 and 55 kd. It is expressed
on about 70% bovine thymocytes, 30% PBM and is not expressed by monocytes or
B cells. The expression is restricted to CD2+ and aR TCR+ cells. Cells of this lineage
are found in abundance in T dependent areas of lymph node paracortex, but only a
few are seen in follicular areas (Baldwin et al., 1986; Bensaid & Hadam, 1991).
Cells within this population recognise antigen in an MHC class II restricted manner.
CD4 antigen binds to a non-variable part of the B2 domain of MHC class II molecules
on antigen presenting cells (APC) and stabilises APC/T cell interaction. These cells
usually do not show cytotoxic activity and proliferate in response to mitogenic and
alloantigenic stimulations without addition of exogenous growth factors (Baldwin et
al., 1986; Teale et al., 1986) indicating that these cells are capable of secreting IL-2
on activation.
Two subsets of CD4+ cells have been defined in mouse which are stably
committed to produce distinct cytokines. "Thl" type CD4 cells produce IL-2, IFN-y,
and TNF, whereas "Th2" type CD4 cells secrete IL-4, IL-5 and IL-6. Thl and Th2
cells exclusively utilise IL-2 and IL-4, respectively as their growth factor for
proliferation in response to an antigen (Coffman et al., 1991). Thl cells induce
delayed type hypersensitivity reactions, activate macrophages and induce B cells to
produce IgG2a isotype antibodies. Th2 cells induce B cells to produce IgM and IgGj
antibodies. Repeated IL-4 stimulations secreted by these cells induce production of
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IgE type antibodies by B cells. Th2 cells are usually stimulated in response to
persistent antigenic stimulation eg. parasitic infestations (Abbas et al., 1991).
2.2.3 CD8
The CD8 antigen is expressed on a subpopulation of T lymphocytes which
show MHC class I restricted cytotoxic effector function (Maddox et al., 1985). It has
a molecular weight (Mr) of 34-35 kd and consists of two polypeptide chains a and 8.
The antigen binds to a non-variable portion of the a3 domain of MHC class I
molecules on APC and stabilises the interaction between two cells (MacHugh & Sopp,
1991). CD8 is expressed on the surface of approximately 20% PBM, a subpopulation
of lymphocytes in T dependent areas of LN and spleen and about 70% thymocytes
and is not expressed on B cells, monocytes/macrophages or granulocytes. These cells
are rarely seen in the B dependent zone and follicular areas of LN (Ellis et al., 1986).
The CD8+ cell population is distinct and non-overlapping from CD4 cells in PBM,
but a large population of thymocytes under developmental stages express both the
antigens. In the peripheral blood, most bovine CD8+ cells are CD2+ and all TCR+,
but a few cells also express y5 TCR+ (Howard & Naessens, 1993). Most cattle have
slightly higher levels of CD4+ cells than CD8+ cells in the peripheral blood.
Most CD8+ cells do not produce growth factors like IL-2. Purified CD8+ cells
respond very poorly to mitogens or alloantigens in the absence of exogenous growth
factors (Ellis etal., 1986). Cytotoxic effector function resides intheCD8+ population
in an allogeneic mixed lymphocyte culture (MLC) or in vitro generated cytotoxic T
cell lines against cells infected with various microorganisms (Teale et al., 1986;
Goddeeris et al., 1986b). Small proportions of both CD4+ or CD8+ cells can express
suppressor activities. Some of these cells in man are reported to be CD11 + , a marker
which is more common on monocytes and granulocytes (Yamada et al., 1985).
2.2.4 CD3
This molecule consists of five different polypeptide chains with Mr ranging
from 12-44 kd and is present on all T cells with aB or y5 TCR, but not on B
lymphocytes, monocytes and granulocytes (Davis et al., 1993). The five chains are
closely associated with each other and also with TCR which is essential for T cell
maturation and function. Incubation of T cells with CD3 antibody induces calcium
flux and proliferation. This group of molecules, therefore, may be involved in
transmitting signals to the cell interior following binding of antigen to its receptor
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(Clevers et al., 1988). Binding of an anti CD3 mAb to bovine WC1+ T cells with
natural killer activity augments killing of target cells (Splitter & Choi, 1993),
however the mechanism of augmentation is not clearly understood.
2.2.5 WC1+ y8 T cells
Peripheral blood T cells of man and mouse mainly express differentiation
antigens CD4 or CD8 along with CD3 associated ah TCR. There is another minor
CD3+/CD5+ T cell population in peripheral blood and thymus which does not express
CD2, CD4 or CD8. Immunoprecipitation studies have shown that these cells do not
express ah TCR, but express another form of TCR made up of y and 8 chains
(Brenner et al., 1988) and are called WC1+ cells in cattle and sheep (Mackay et al.,
1989; Clevers et al., 1990; Morrison & Davis, 1991). Northern blot hybridisation
using a, 8, y and 8 probes showed that these cells express y and 8 message (Hein et
al., 1989; Clevers et al., 1990).
These cells also originate in the thymus and hence belong to T cell lineage.
The peripheral blood of young animals exhibit a substantial population ofWC1+ cells
where it may be as high as 25 % in calves of less than three weeks of age. However,
the percentage decreases with age (Clevers et al., 1990). Histological studies show
that the cells are mainly concentrated in the thymic medulla, but a few are observed
scattered through the thymic cortex. In the LN, cells are in the outer areas of the
cortex adjacent to the subcapsular sinuses. A few cells are also present in the sinuses
and in the paracortex but not in B cell follicles. In spleen, they are concentrated in
marginal zones of the spleen (Clevers et al., 1990). The precise function of WC1 +
cells is not properly understood but they may have a role in controlling the
proliferation of other lymphocytes. A potential cytolytic activity for these cells has
been proposed in cattle, but not clearly established (Howard & Morrison, 1994).
2.2.6 IL-2 receptor
Two surface molecules mediate binding of IL-2 to the cells: a 50 kd
glycoprotein CD25 also known as Tac antigen or IL-2Ra which binds IL-2 with low
affinity and a 75 kd antigen IL-2RB which binds IL-2 with slightly higher
(intermediate) affinity (Malek et al., 1983; Robb et al., 1987). The heterodimeric
complex of both surface molecules forms a functionally effective high affinity
molecule which mediates cell proliferation by activating a signal transduction pathway
after binding to IL-2. Binding also leads to internalisation of the IL-2/IL-2R complex
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leading to downregulation of IL-2R expression on the cell surface. Without
continuous stimulation, functional CD25 disappears and the activated cell returns to
a resting stage (Cantrell & Smith, 1983).
Unstimulated T and B cells can express IL-2a (CD25) or IL-2B in very low
quantities, but cells express high quantities of IL-2Ra, and to a lesser extent IL-2R13,
after stimulation on the cell surface. So far only IL-2Rce is characterised in cattle
(Naessens et al., 1992). The antigen is not detected on resting PBM, but is induced
after activation with mitogens. It is also expressed on long-term cultured T cell lines,
on CD2+CD8+ or CD2~CD8+ T cell clones (Naessens et al., 1992), most T. parva
infected lines of T or B cell origin and some T. annulata infected cell lines of non T
cell origin (Dobbelaere et al., 1990; Ahmed et al., 1992). A low level of CD25
expression is seen on resting bovine WC1+ T cells in PBM (Howard & Morrison,
1994). Monocytes and B cells in stimulated bovine PBM cultures also express this
antigen at a lower intensity than T cells (Taylor et al., 1992). The mAb to bovine
CD25 antigen blocks IL-2 driven proliferation even at high concentrations of IL-2,
and is a useful tool for measuring the activation state of particular cells as well as for
studying IL-2 dependent cell proliferation (Naessens et al., 1992).
2.2.7 CD45R
This antigen is reported as leucocyte common antigen (LCA) and consists of
at least five high molecular weight glycoproteins present on the surface of the
majority of leucocytes. Different isoforms arise from a single gene by alternative
mRNA splicing of three individual exons potentially generating eight different
molecules (Thomas, 1989). The larger intracellular portion is identical in all the
isoforms and has tyrosine kinase activity. It can thus potentially interact with
intracellular protein kinases and may be involved in triggering cell activation (Clark
& Ledbetter, 1989).
CD45R is now divided into three isoforms: CD45RO, CD45RA and CD45RB.
The CD45RO isoform is a 180 kd molecule in humans and is expressed on memory
T cells or primed T cells. Cells divided from CD45RO+ cells are also born with the
same protein and are primed against the same antigen as their progenitor. The
CD45RA isoform is a 220 kd molecule expressed on naive or virgin T cells (Akbar
et al., 1988). It is believed that a naive T cell which is CD45RA+/CD45RO" changes
to CD45RA+/CD45RO+ and finally to CD45RAYCD45RO+ after exposure to an
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antigen. Memory T cells have been shown to occasionally revert to naive phenotype
(Bell & Sparshott, 1990). The third isoform CD45RB consists of four molecules with
Mr between 190-220 kd and is expressed on some T cells, and most B cells and
monocytes. Naive cells are CD45RB+ (high) and memory cells are CD45RB" (low)
(Streuli et al., 1988).
In cattle, naive CD4+ cells were shown to be CD45RB+ and memory CD4+
cells were CD45RB, but MHC class I restricted CD8+ cells were heterogeneous with
respect to the LCA isoform they express (Howard et al., 1991b). The CD45RO
antigen was shown to be expressed on the majority of bovine monocytes, granulocytes
and yb T cells, variably expressed on CD2+ T cells and absent from B cells. The
ability to proliferate in response to recall antigens resided in the CD45RO+ cell
population amongst the CD4+ cell population (Bembridge et al., 1993). Sheep B
cells, NK cells and naive T cells expressed CD45RA and proliferative ability to recall
antigens resided within the CD45RA" population (memory) amongst the CD4+ cells
(Mackay et al., 1990). T cells in afferent lymph expressed a memory phenotype, but
most T cells in efferent lymph were naive. The number of naive T cells in the
peripheral blood decreased as the animals aged (Mackay, 1993).
2.2.8 B cells
B cells represent about 5-15% of the circulating lymphoid pool and are
classically defined by the presence of endogenously produced immunoglobulins (Ig)
on the surface. Polyspecific heteroantisera against bovine Ig have been used to
identify B cells for many years (Grewal et al., 1978). Isotype specific heteroantisera
which react with IgM, IgG1? IgG2a or IgA produced in goats have also been used to
identify B cells (Nielsen et al., 1985). Monoclonal antibodies are now available
against most of the bovine Ig isotypes (Naessens et al., 1988; Naessens & Howard,
1991; Mukwedeya et al., 1993). The majority of peripheral blood B cells express
mainly IgM antibodies and only a few express other Ig on their surface, although
these are present in larger numbers under specific locations like IgA bearing cells in
the gut. Subsequently, B cells may change the isotype of antibody produced, but their
antigen specificity remains the same (Baldwin et al., 1988c).
Ig on the surface also acts as an antigen receptor for B cells. B cells are
initially activated in response to an antigen in T cell areas of the lymph node in
association with interdigitating cells and T cell help. On average three activated B
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cells colonise a primary follicle and undergo massive clonal expansion to form
secondary follicles or germinal centres. Germinal centre B cells may take up antigen
held on follicular dendritic cells as an immune complex in unprocessed form, process
this antigen and present it to CD4+ cells (MacLennan, 1994). The majority of B cells
express MHC class II on their surface, complement and Fc receptor (Kunita et al.,
1988). Expression of various antigen markers on maturation stages of B cells viz:
Pro-B cell, Pre-B cell, B cell expressing Ig, activated B cell, B cell blast and plasma
cell are not clearly defined (Mukwedeya et al., 1993).
2.2.9 Mononuclear phagocytic cells
Cells of this lineage comprise a functionally and morphologically heterogenous
population. The two main functions of these cells include phagocytosis of particulate
antigens and act as antigen presenting cells to various subpopulations of lymphocytes.
Different cells within this population occupy distinct locations within the body tissues
or fluids which include blood monocytes/macrophages, Langerhans cells of skin
epidermis, Kupffer cells of liver, pulmonary alveolar macrophages, osteoclasts and
interdigitating or dendritic cells in solid lymphoid tissues (Splitter & Morrison, 1991).
Differentiation of these cells in particular environments may result in the expression
of certain antigens and not others. Further, antigens present on cells of this lineage
may be expressed on other cell types suggesting a common functional importance of
the molecules in myeloid and lymphoid cell differentiation. Monoclonal antibodies
against many molecules expressed on the cell surface at various stages of activation
and differentiation in cattle have been raised and their functions are being investigated
(Baldwin et al., 1988c; Ellis et al., 1988; Splitter & Morrison, 1991; O'Rielly et al.,
1991; Hall et al., 1993; Gupta et al., 1993).
2.2.10 Major histocompatibility antigens
The MHC is a chromosomal region that encodes a group of highly
polymorphic cell surface glycoproteins essential for recognition of foreign antigens
(Klein, 1986). There are two major regions encoding these antigens, namely MHC
class I and MHC class II. Bovine MHC (BoLA) class I molecules consist of an MHC
encoded heavy chain of Mr 44 kd and a non MHC encoded light chain B2-
microglobulin of Mr 12 kd (Hoang-Xuan et al., 1982). These antigens are expressed
on almost every nucleated cell in varying amounts, are involved in the recognition of
self and act as classical alloantigens. MHC class I molecules present endogenously
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processed peptide antigens to cytotoxic T lymphocytes. Identification of
polymorphism of BoLA class I molecules has relied mainly on the use of allo-antisera
produced from calf-dam reciprocal immunisations and used in
microlymphocytotoxicity assays (Spooner et al., 1979a), and isoelectric focusing
(IEF) using mAbs and allo-antisera (Joosten et al., 1988; Al-Murrani et al., 1993).
Sera produced in different laboratories have been evaluated in five international
workshops and used to identify various BoLA specificities using
microlymphocytotoxicity along with IEF using mAbs (Spooner et al., 1979b; Anon.
1982; Bull et al., 1989; Bernoco etal., 1991; Davies et al., 1994b). Some mAbs are
available which identify monomorphic determinants (Bensaid et al., 1989; Kemp et
al., 1990) or polymorphic determinants (Bensaid et al., 1988) on cell surface
associated BoLA class I molecules.
MHC class II gene products or MHC class II antigens are heterodimeric cell
surface glycoproteins consisting of a heavy (a) chain of 33-38 kd and a light (13) chain
of 25-28 kd (Kaufman & Strominger, 1979). MHC class II antigens are mainly
expressed on B cells, dendritic cells, cells of monocyte/macrophage lineage and on
T cells after activation (Hopkins et al., 1993). MHC class II molecules bind to
peptides generated by proteolysis of antigen internalised by the cell and present it to
CD4+ cells (Germain, 1994). BoLA class II genes are located in two regions referred
to as class Ha and class lib regions. The MHC class Ila region is tightly linked to the
class I region and contains bovine DR and DQ genes (Andersson et al., 1986a;
1986b). The class lib region contains DOB, DYA and DIB genes, and probably also
DNA gene (Andersson et al., 1988; Stone & Muggli-Cockett, 1990). MHC class II
polymorphism in cattle has been studied by IEF, serology using allo-antisera, PCR-
RFLP (Bernoco et al., 1991; Davies et al., 1994a) and single-strand conformation
polymorphism (Russell et al., 1994) to characterise class II genes. The mAbs against
monomorphic determinants on MHC class II have been widely used for biochemical
and functional studies (Baldwin et al., 1988c; DeMartini et al., 1993; Hopkins et al.,
1993).
2. 3 BOVINE LYMPHOID SYSTEM
The lymphoid system functions as a single organ despite the fact that it is
dispersed all over the body and composed of numerous distinctly structured lymphoid
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tissues. Its six major compartments viz: blood, lymph nodes, bone marrow, spleen,
gut and thymus, are connected to each other by two vascular networks: the lymphatic
system and the blood vascular system. Lymphocytes are the major cellular constituent
of this system circulating amongst blood, lymph and interstitial tissue (Trnka &
Cahill, 1980). The movement of lymphocytes between these compartments regulates
development and maintenance of immunological functions by the system.
The first phase of lymphocytic development occurs in primary lymphoid
tissues, namely, bone marrow, thymus and possibly Peyer's patches. Undifferentiated
stem cells develop into lymphocytes which mature and proliferate to produce different
populations of immunocompetant lymphocytes, each comprising clones of cells
capable of recognising and responding to individual antigenic determinants by a
process independent of exposure to foreign antigen. The second phase of development
occurs primarily in lymph nodes following exposure to foreign antigen which involves
proliferation and differentiation of specific immunocompetant lymphocytes to produce
antigen specific immune effector cells (MacLennan, 1994).
Events surrounding the initiation of immune responses to antigens in the lymph
node can be analyzed by lymphatic cannulation (Hall & Morris, 1962). Examination
of cells migrating through afferent or efferent lymph has been extensively studied in
sheep, to a lesser extent in cattle, and has provided an understanding of cell kinetics
and development of immune responses to various exogenous protein antigens (Hall
& Smith, 1971; English et al., 1977; McConnell & Hopkins, 1981; Hopkins et al.,
1993) and microorganisms (Hall et al., 1967; Emery, 1981b; Emery et al., 1988;
Entrican et al., 1992; Bird et al., 1993; Buxton et al., 1994; McKeever etal., 1994).
2.3.1 Migration of antigen from site of deposition to the lymph node
After gaining access to the tissue spaces in the body, foreign antigens or
microorganisms rapidly enter the lymph stream through openings in the walls of
adjacent lymphatic capillaries and are transferred via afferent lymphatics to the
regional lymph node (Morris, 1972). Studies on migration of cells from the site of
antigen deposition to the lymph node are facilitated by the technique of pseudoafferent
cannulation where afferent lymphatics are allowed to anastomose with the efferent
lymphatic after surgical removal of the lymph node. Cannulation of efferent lymphatic
at this stage permits collection of afferent lymph (Emery et al., 1987). Bovine
afferent lymph contains around 50% T lymphocytes, 20-25 % B lymphocytes and 23 %
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non-lymphoid cells (Emery et al., 1987). Non-lymphoid cells consist of adherent
cells, "veiled" or "frilly" cells known as dendritic cells and Langerhans cells (Bujdoso
et al., 1989a). T cells in the normal afferent lymph are MHC class II+ (Dutia et al.,
1993) and express a memory phenotype (Mackay et al., 1992b).
Langerhans cells and dendritic cells are believed to carry antigen and migrate
from dermis through afferent lymphatics in the form of veiled cells and enter the
lymph node as interdigitating cells (Bujdoso et al., 1989a; McKeever et al., 1991).
Interdigitating cells present antigen to the helper T cells in the paracortex of the
lymph node (Breel et al., 1988). The origin of interdigitating cells is not clear, but
Langerhans cells, veiled cells and interdigitating cells are phenotypically similar and
have a common lineage (Kraal et al., 1986), indicating that these cell types
presumably represent different migrating stages of the same population (McKeever,
1994). Afferent lymph veiled cells presented soluble antigens to primed T cells in
vitro very efficiently (Bujdoso et al., 1989a; McKeever et al., 1991). These cells
stimulated CD4+ cell responses in vivo, when re-inoculated into a syngeneic animal,
after priming with antigen in vitro (McKeever et al., 1992) indicating that these cells
carry antigen from the site of antigen deposition to the lymph node and process it for
recognition of T cells.
An increase in the output of lymphocytes was observed in the afferent lymph
draining granulomatous and DTH lesions (Smith et al., 1970; Hay et al., 1973).
Following primary inoculation of soluble protein antigens, afferent lymph dendritic
cells transiently expressed increased levels of CD1 (Hopkins et al., 1989). Secondary
antigen challenge in already primed sheep lead to an initial drop in cell output in
afferent lymph for 1-3 days, followed by an approximately five fold increase by day
five. This was associated with an increased output of MHC class II+ T cells in
afferent lymph, probably because of increased recruitment of activated or memory T
cells at the site of antigen challenge. A quantitative increase in expression of MHC
class II on dendritic cells and lymphocytes, and CD1 expression on dendritic cells
was also observed. These changes in dendritic cells were associated with an increased
antigen presenting ability to activated T cells in vitro (Hopkins et al., 1989).
2.3.2 Development of immune responses in the draining lymph node
Lymph nodes are encapsulated fixed structures which act as filters for foreign
antigen material entering the lymphatic system and provide a favourable environment
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for interaction of different cell types in the generation of immune responses. Multiple
afferent lymphatics enter the lymph node capsule and empty into the subcapsular sinus
(Trnka & Cahill, 1980; Morrison et al., 1986a). Naive T cells enter the lymph node
from peripheral blood through specialised endothelial lining of post-capillary venules
also called high endothelial venules (HEV) mainly in the paracortex and come in
contact with antigen presenting cells entering the paracortex through subcapsular
sinuses (Bogen et al., 1991). T cells are stimulated in this perivascular location and
start producing IL-2 or IL-4 and form small clusters (Bogen et al., 1993). Activated
T cells provide help for the growth and differentiation of antigen specific B cells in
the initiation of germinal centre formation in the cortex. With the formation of
secondary follicles, responding T cells migrate to the periphery of the follicles where
they might help in growth and differentiation of follicular B cells by secreting
different cytokines (Bogen et al., 1991; Fuller et al., 1993). Germinal centres mostly
comprise B cells with some follicular dendritic cells and T cells. B cells in a single
germinal centre are the progeny of very few founder B cells and are responsive to the
immunising antigen. T cells within the germinal centre express a memory phenotype,
are antigen specific and provide help for B cell proliferation. A physical link between
T and B cells in the germinal centre is necessary for B cell proliferation (Fuller et al.,
1993). Follicular dendritic cells within the germinal centre contain unprocessed
antigen in the form of antigen-antibody complex for very long periods. Retention of
antigen in this form maintains circulating antibody levels and regulates production of
memory B cells (Klaus et al., 1980).
T cell mediated immune responses are also initiated in the paracortical area
where naive T cells enter lymph node from high endothelial venules and come into
contact with antigen presenting cells. Activated and proliferating T cells travel
through the paracortical sinuses into the medullary sinuses through narrow apertures
at cortico-medullary junctions (Fahy et al., 1980). Proliferation of cells in response
to an antigen leads to expansion of medullary cords (Huang et al., 1990). Medullary
sinuses converge at the hilus where they are continuous with one or more efferent
lymphatic vessel. Immune responsive cells to a particular antigen are disseminated to
the body through efferent lymphatics, entering the circulation through the thoracic
duct (Fahy et al., 1980). If the antigen is inoculated only in one lymph node (through
a cannulated afferent lymphatic) and all the cells exiting in the efferent lymph are
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drained from the challenged node, then the establishment of systemic immunological
memory to that particular antigen is prevented and the animal remains naive as far
as that antigen is concerned (Hall et al., 1967).
2.3.3 Composition of efferent lymph
Lymphocytes are the predominant cellular constituents of efferent lymph which
exit in large numbers from the node. In sheep, efferent lymph contains about 20-30%
B cells, 70-80% T cells and no macrophages or monocytes (Cahill et al., 1978; Trnka
& Cahill, 1980). Resting bovine efferent lymph contained 58.5% CD4+ cells, 21.5%
CD8+ cells, and 17.5% IgM+ B cells (Emery et al., 1988). A single resting lymph
node of approximately lg weight has an average output of 5 ml lymph and 30-50
million lymphocytes per hr in sheep (Trnka & Cahill, 1980).
2.3.4 Cell shutdown after antigen challenge in the draining node
Antigenic stimulation of a lymph node with many antigens results in retention
of lymphocytes in the lymph node transiently. This is evident from decreased cell
output in the efferent lymph within first 24 hrs after administration of antigen. The
mechanism and significance of this phenomenon termed as "cell shutdown" is not
clearly understood. Cell shutdown occurs only on secondary challenge with some
antigens. It probably ensures contact of naive T cells with the antigen, as the number
of naive T cells able to react to a particular antigen is very low. It can be induced by
complement activation leading to retention of B lymphocytes and other cells
expressing C3b receptor within the node (McConnell & Hopkins, 1981). LPS, an
activator of the classical pathway, has also been shown to induce shutdown (Cahill
et al., 1976). Infusion of prostaglandin E2 (PGE2) in the afferent lymphatics leads to
reduced output of cells in the efferent lymph. Increased secretion of PGE2 in the node
might be due to complement activation or by activated macrophages (Hopkins et al.,
1981b). Elevated levels of corticosteroids can also be associated with decreased
lymphocyte traffic through the lymph node (Hall, 1986). Intralymphatic infusion of
products of primed T cells can also induce cell shutdown (Kelly et al., 1972). IFN-
alpha-2a (IFN-o!2a) can directly be involved in the regulation of lymphocyte output
from the lymph nodes (Hein & Supersaxo, 1988). Cell shutdown has been shown to
occur during primary infections with live viruses in sheep (Issekutz, 1985; Smith &
Morris, 1970; Bird et al., 1993) and T. parva infection in cattle (Emery, 1981b).
This phase is specific for the naive population of T cells and the output of memory
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T cells from the node is unaffected (Mackay et al., 1992a). Subcapsular and
paracortical regions were found to be densely packed with lymphocytes during the
period of cell shutdown. Further, there was accumulation of cells around blood
vessels in the medulla also suggesting a continued entrance of lymphocytes into the
node (Hein & Supersaxo, 1988).
2.3.5 Changes in flow and cellularity of efferent lymph after antigen challenge
Cell shutdown is usually followed by a biphasic increase in the lymphocyte
output from the node. The first wave of cells leaving the node is mainly of small
lymphocytes which entered the node during cell shutdown (Cahill et al., 1976;
Hopkins et al., 1993). The second wave of cells consist of blast cells and antibody
producing cells specific for the inoculated antigen generated in the node (Cahill et al.,
1976; Hay & Hobbs, 1977). Resting efferent lymph contains only a few blast cells.
Blast cells formed in the lymph node in response to an antigen first appear in the
efferent lymph during the third day and usually peak between days 4-5 (Trnka &
Cahill, 1980). Appearance of blasting cells in the efferent lymph has been observed
in response T. parva (Emery, 1981b) and Trypanosoma congolense (Akol & Murray,
1986) in cattle, and vaccinia virus (Issekutz, 1985), Toxoplasma gondii (McColgan
et al., 1987), Chlamydia psittaci (Huang et al., 1991) and Maedi-visna virus (Bird
et al., 1993) in sheep.
There is a marked increase in the blood supply to the node after antigen
stimulation leading to increased entry of fluid and lymphocytes to the node (Hay &
Hobbs, 1977). Increased entry of cells and reduced exit from the node were supposed
to be distinct events occurring independently and possibly mediated by different
mechanisms (Cahill et al., 1976). The rate of lymph flow is reported to increase by
2-3 fold around 8-12 days after T. parva infection in cattle (Emery, 1981b). About
two fold increase in the flow of lymph on days 5-6 was also seen in sheep during
Chlamydia psittaci infection which declined to pre-infection levels in the following
days (Huang et al., 1991). A 2-3 fold increase in the volume of lymph and up to a
10 fold increase in lymphocyte output was observed in the efferent lymph of cattle
draining the site of Trypanosoma congolense infection (Akol & Murray, 1986).
Whether the increased blood flow is mediated by the release of cytokines or
vasoactive substances is not clearly known. PGE2 may be involved in the increased
blood flow to the node and enhance vascular permeability to fluid and lymphocytes
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(Hopkins et al., 1981b). Other prostaglandins (Trnka & Cahill, 1980), macrophage
migration inhibitory factors (Hay, 1973), mitogenic factors ( Hay et al., 1973) and
cytokines might be responsible for increased output of fluid in the efferent lymph.
2.3.6 Lymphocyte homing and recirculation
Earlier observations that local irradiation of a single lymph node does not
result in elimination or reduction of cell output in the efferent lymph suggested that
the majority of efferent lymph lymphocytes (ELL) were not generated in the lymph
node (Hall & Morris, 1965a). This was further supported by the experiments of Hall
& Morris (1965b), when they continuously infused 3H-thymidine into lymph node
through a cannulated afferent lymphatic and found only 4% labelled cells in the
efferent lymph. It has been shown that about 90% of ELL come from blood into the
lymph node by passing between specialised HEV in the paracortex (Hall & Morris,
1965b; Schoefl, 1972), 2-3% arise from proliferation within the node and 5-10%
come from afferent lymph in a normal lymph node (Trnka & Cahill, 1980).
Once a primary immune response is initiated in a lymph node to which an
antigen has drained, activated lymphocytes of memory phenotype leave the node via
efferent lymph and eventually drain into the blood stream through the thoracic duct
and are disseminated throughout the body. Memory cells migrate selectively through
peripheral tissues, such as skin, where there are more chances to encounter with the
antigen, and are drained back to the lymph node via afferent lymph (Mackay et al.,
1990). Recent studies have shown that at least a proportion of cells migrate in a tissue
selective manner. Washington et al. (1988) observed that small CD4+ cells were
extracted from a normal lymph node more efficiently than other subsets. Small CD4+
(possibly naive cells) also showed some specificity to recirculate through the same
tissue (Abernethy et al., 1991). Mammary cells exiting the gut lymph nodes
preferentially recirculated through gut and migrated poorly through skin (Mackay et
al., 1992b). Naive lymphocytes recirculate through lymph nodes via paracortical
HEV and leave via efferent lymph. As the frequency of antigen reactive cells within
naive cell population is very low, recirculation through lymph node is an effective
route for naive cells to make contact with new antigens (Mackay et al., 1990).
How naive and memory lymphocytes take different recirculation routes is not
properly understood. This presumably depends upon differential homing receptor
molecules (Mackay et al., 1992b). A three step model of migration has been
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suggested (Mackay, 1993). The first step involves primary interaction between a
selectin on the surface of a cell with HEV, followed by some activation signal
probably by a cytokine or cell surface interactions leading to changes in B1 or B2
integrins. A strong adhesion is formed between the cell and HEV. The final step
involves flattening and transendothelial migration of the cell. Expression of B1
integrin on T cells signifies a differentiation state that correlates either with memory
or recent activation (Mackay, et al., 1992b). L-selectin has been shown to be an
important adhesion molecule on lymphocytes for LN homing (Howard et al., 1992).
CD4+ and CD8+ cells from the gut mucosa were L-selectin negative and only a few
were positive in Peyer's patches. Antigen challenged lymph nodes showed an increase
in the migration of memory type B1 integrin+ T cells, and induction of an
inflammatory adhesion molecule VCAM-1 on the endothelium (Mackay et al.,
1992a). Increase in VCAM-1 on HEV might be one of the molecular mechanisms that
accounts for the transient increase of memory type T cell traffic through the node.
2.3.7 Phenotypic changes in efferent lymph following antigen challenge
Various lymphocyte subsets show marked differences in their distribution
between blood, afferent and efferent lymph (Mackay et al., 1988). The distribution
of CD4, CD8 and y5 T cells is non-random in these three immunological
compartments. Resting efferent lymph had a higher percentage of CD4+ cells and
consequently higher CD4/CD8 ratio than peripheral blood (Bujdoso et al., 1989b).
Following challenge with human BCG, the percentage of CD4+ cells increased
initially, followed by an increase in CD8+ cells (Mackay et al, 1992a). Similar
changes were also observed in the lymph efferent from the node draining local
infection with larvae of blowfly Lucilia cuprina in sheep. Output of CD8+ cells was
more marked after secondary challenge (Bowles et al., 1994). A marked increase in
CD8+ lymphoblasts was observed in the efferent lymph of sheep draining the node
infected with Maedi-Visna virus between day six and 11 after infection (Bird et al.,
1993). In a recent report, a substantial increase in the proportions of CD8+ cells in
efferent lymph was observed between day 8-11 after secondary T. parva infection in
cattle. The frequency of parasite specific cytotoxic T lymphocyte precursors (CTLp)
was as high as 1:32 and confined to the large blasting cell fraction (McKeever et al.,
1994).
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Activated T cells are lymphoblastoid and express MHC class II and CD25
(Greene et al., 1986; Glimcher & Kara, 1992), whereas resting T cells usually do not
express these markers. Primary challenge of the node with ovalbumin was shown to
produce little changes in MHC class II expression on T cells. However, secondary
challenge produced a two fold increase in the proportion of T cells expressing DR and
a 4-5 fold rise in the proportion of DQ+ T cells which involved all T cell
subpopulations (Hopkins et al., 1993). The authors speculated that the increase in
MHC class II expression was probably mediated by the release of cytokines.
The reports mentioned above suggest that studies at the local lymph node level
are very useful in understanding the initiation and development of immune responses
to various antigens. Extensive studies have been done in sheep for understanding
basic immunology and development of immunity to various microorganisms using
lymphatic cannulation. Surprisingly, similar studies on cattle are scanty in the
literature.
2.4 IMMUNITY AGAINST THEILERIOSIS
Immunological studies on T. annulata are limited. Most of the studies have
been conducted on T. parva. Perhaps this is because in vitro propagated T. annulata
infected cell lines were successfully developed as live vaccines in 1966 (Pipano &
Tsur, 1966) and have been extensively used in the field. However, attempts to
immunise cattle against T. parva with infected cell lines have not been very
successful. Most of the field immunisation against T. parva has relied on the infection
and treatment method as discussed below.
2.4.1 Immunisation
Control of theileriosis particularly East Coast fever by immunisation has been
reviewed by Brown (1981), Morrison et al. (1986b), Dolan & McKeever (1992) and
Norval et al. (1992). Attempts were initiated to immunise cattle against theileriosis
soon after the identification of these parasites in the beginning of this century.
Suspensions of lymph nodes and spleen homogenates collected from T. parva infected
animals were used to immunise susceptible cattle (Theiler, 1911; Spreull, 1914). This
approach was soon discontinued because of the erratic availability of immunising
material from sick cattle, development of clinical theileriosis following immunisation
in many animals and risk of transmission of other diseases. The same approach was
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re-investigated several years later by Brocklesby et al. (1965), and Pirie et al. (1970)
without greatly improved results. Sergent et al. (1924) demonstrated that unlike T.
parva, T. annulata could be transmitted to susceptible cattle using infected blood, and
this was developed as a method of immunisation using strains of low virulence.
Continuous mechanical passages of T. annulata in cattle resulted in the loss of ability
of the parasite to produce infection in ticks but retain immunogenicity (Sergent et al.,
1945). This approach was adopted in many countries over the next 40 years, but was
also discontinued because of the risk of transmission of other diseases, failure to
provide a constant infective material and some mortalities in susceptible animals.
With advancements in chemotherapy and in vitro cultivation of theilerial parasites,
attention was focused on the development of prophylactic methods. In particular using
simultaneous infection with sporozoites followed by treatment with a suitable drug
and schizont derived cell culture vaccines, which are discussed below.
2.4.1.1 Immunisation by the infection and treatment method
This method of immunisation has been mainly developed and widely used to
control T. parva infection. It has been known for many years that cattle which
recover from theilerial infections become immune to subsequent challenges (du Toit,
1928; Neitz, 1948). Therefore, one of the first approaches to immunisation was to
produce a mild self limiting disease as severity of infection was shown to depend on
the quantum of initial infection (Barnett, 1957; Wilde, 1967). Further attempts to
induce mild non-lethal T. parva infection by controlled feeding of infected ticks or
titration of GUTS exhibited variable responses in groups of cattle to a given dose of
infection (Cunningham et al., 1974; Radley et al., 1974; Dolan et al., 1984c).
Similar experiments with graded doses of T. annulata infected tick material also
showed a dose dependent response (Gill et al., 1977; Samantaray et al., 1980;
Preston et al., 1992a). Variable infection rates in different batches of ticks and
unpredictable responses in inoculated animals from no reaction to severe disease has
made it impossible to use quantum of infection as a means of immunisation.
The observation of Neitz (1953), that cattle were protected against lethal T.
parva infection by repeated intravenous administration of aureomycin during the
incubation period, laid the foundation for development of the so called "Infection and
treatment method" of immunisation. He observed that treatment resulted in a decrease
and disappearance of schizonts followed by recovery and development of solid
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immunity to reinfection. Similar results were reported while treating the animals with
oxytetracycline after infection (Neitz, 1957). Another breakthrough in further
development of this technique was the production of cryopreserved sporozoite
stabilates which allowed infection of cattle with a particular pre-determined dose
(Cunningham et al., 1973) along with administration of long acting oxytetracyclines
(Radley et al., 1975a; 1975b). Radley (1981) reported further improvements in the
technique by using long acting oxytetracycline. This method has now been greatly
improved and used commonly for the control of T. parva infection. Extensive reviews
on this method by Brocklesby & Bailey (1965), Cunningham (1977), Radley (1981)
and Brown (1985) have explained development and field application of this technique.
Similar techniques have been developed to immunise cattle against tropical
theileriosis using various preparations of tetracyclines with encouraging results (Gill
et al., 1976a; Jagdish et al., 1979; Pipano, 1981; Khanna et al., 1983). However,
neonatal bovine calves inoculated with one tick equivalent (t.e.) (approximately 10
infected acini) or more freshly prepared GUTS along with long acting oxytetracycline
developed clinical theileriosis and died, when immunised with this method. A very
low infective dose of 0.035 t.e. GUTS (approximately 5 infected acini) along with the
drug engendered protection in 80% animals (Mallick etal., 1987). These experiments
suggested that oxytetracycline may not be a drug of choice for immunising very
young calves by this method.
With the development of better theilericidal drugs such as parvaquone
(Clexon, Wellcome) and buparvaquone (Butalex, Mallincrodt Veterinary Ltd.)
(McHardy et al., 1985), successful immunisations have been performed by
inoculation of infective T. parva stabilate along with treatment using parvaquone
(Dolan et al., 1984a) or buparvaquone (Mutugi et al., 1988; Young et al., 1990).
Chemoimmunoprophylactic efficacy of buparvaquone against T. annulata infection
was demonstrated and was found to be better than long acting oxytetracycline (Dhar
et al., 1990). Very young calves below four weeks of age were successfully
immunised using infective tick material from as little as 2 infected acini (Dhar et al.,
1990) to as high as 30 ticks (Kumar etal., 1990) along with buparvaquone treatment.
Calves inoculated only with buparvaquone and left in heavily tick infested paddocks
also became immune indicating that the drug alone can be used to protect calves born
in the disease season for a few days (Kumar et al., 1991). Young calves immunised
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with this regime were immune to subsequent potentially lethal challenge immediately
after immunisation (Rana & Dhar, 1993), and even if they were already in the
incubation period of the disease (Dhar & Rana, 1993). These reports suggest that
immunisation by this method can be undertaken even during the disease season and
also in very young calves. It is important to note here that immunisation against
tropical theileriosis with cell culture vaccine has to be done with caution in very
young calves and cannot be done after the onset of the season. Studies on T. parva
have shown that parvaquone given at early stages of infection could inhibit the
development of immunity (Dolan et al., 1988). Ngumi et al. (1992) have recently
shown that the dose of T. parva sporozoites has to be chosen carefully while using
buparvaquone for simultaneous treatment, since too high a dose can break through the
protection and too low a dose may not produce immunity. However, a wider
sporozoite dose range can be used with buparvaquone than with oxytetracycline.
This method of immunisation has some more limitations as well. Production
of sporozoite material is very labour-intensive and expensive. There is considerable
variation in the infectivity of different batches of ticks. Different vials of the same
cryopreserved stock can also produce variable reactions in inoculated animals.
Another problem with T. parva is heterogenicity amongst various parasite stocks.
Some parasite stocks require higher levels of drug in order to control infection than
others (Radley, 1981). Immunisation against one stock of T. parva did not protect
against all stocks of the parasite (Young et al., 1973; Radley et al., 1975b).
However, T. annulata parasite stocks isolated from different geographical areas show
reasonably good cross-protection (Gill et al., 1980). However in most of the studies,
the parasite stocks were poorly characterised or quantified, making the situation
difficult to interpret. Monoclonal antibodies have been raised against both T. parva
(Pinder & Hewett, 1980; Minami et al., 1983) and T. annulata schizonts (Sheils et
al, 1986b) for identification of parasite strains. Other methods such as isoenzyme
analysis and DNA probes are providing ways of differentiating parasite stocks and
characterising their clones, the results cannot yet be related to cross-immunity.
Although this method of immunisation is cumbersome, expensive and has many
shortcomings, it is the only method available for protection against T. parva. The
technique has also been developed for T. annulata, but only under experimental
conditions. It might be useful in immunising very young calves in T. annulata
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endemic areas which cannot be immunised with the cell culture vaccine.
2.4.1.2 Immunisation with macroschizont infected cells:
Immunisation of susceptible animals with schizont infected cell lines is the
most widely used method of immunoprophylaxis against T. annulata. Development
of cell culture vaccines against tropical theileriosis is mainly attributed to the
pioneering work of Israeli workers. Progress and applications of this vaccine have
been extensively reviewed by Pipano (1977; 1981; 1984; 1992) and Brown (1981;
1989). Virulence of schizonts was attenuated by prolonged cultivation in cell cultures
(Tsur & Adler, 1962) and resulted in milder clinical symptoms and lower
parasitaemia on inoculation into susceptible animals (Pipano & Tsur, 1966; Hashemi-
Fesharki & Shad-del, 1973; Wenshun et al., 1973; Gill et al, 1976b; Stepanova &
Zablotsky, 1989; Singh et al., 1993). With loss of virulence in cultures, the parasite
lost the capacity to produce piroplasms but retained immunological properties (Pipano
& Israel, 1971; Pipano et al., 1973). Cattle vaccinated with completely attenuated
schizonts did not provide a source of infection for ticks (Samish et al., 1984). The
animals immunised with a cell culture vaccine developed mild parasitological
reactions on natural or experimental sporozoite challenge, but were usually protected
(Gill et al., 1976b; Pipano, 1981; Ouhelli et al., 1989; Shukla & Sharma, 1991).
These results encouraged immunisation trials against tropical theileriosis under
field conditions. Satisfactory protection from the disease was induced in young and
adult beef cattle and in female animals up to the age of first pregnancy when
inoculated with l-2xl06 infected cells. This vaccine could be either used fresh or after
cryopreservation, and had four days shelf life at 4°C (Pipano, 1981). Chinese workers
were able to preserve the vaccine at 4-6°C for up to 60 days by addition of gelatin
(Wenshun et al., 1975). Cell culture propagated schizont vaccine has been used
efficiently in many countries where T. annulata is endemic, including Israel (Pipano,
1978; 1992), Turkey (Ozkoc & Pipano, 1981), Iran (Hashemi-Fesharki & Shad-Del,
1973; Hashemi-Fesharki, 1988), Iraq (Hooshmand-Rad, 1973), India (Subramanian
etal., 1986; Shukla & Sharma, 1991; Singh, 1992), Russia (Stepanova et al, 1977),
China (Wenshun et al., 1973; Wenshun et al., 1982) and Morocco (Ouhelli, 1991).
Attenuated cell lines used as a vaccine in different countries have been developed by
continuous passage in culture and tested for immunogenicity by inoculation in
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susceptible calves at different passage levels. Sporozoite challenge of animals
immunised with such schizont infected cell culture vaccines usually results in mild
reactions and protection even against heterologous stocks of the parasite (Pipano,
1981; Brown, 1989; Brown, 1990). Occasionally, highly susceptible adult Friesian
cows were inadequately protected and reinforcement with a second immunisation
using infected tick material was recommended in such animals (Pipano, 1981).
Cattle immunised with a cell culture vaccine were protected on challenge with
sporozoite stocks from remote geographical areas in some experiments (Preston &
Brown, 1988; Innes et al., 1989c), but poorly protected in others (Ozkoc & Pipano,
1981; Subramanian et al., 1987). Various T. annulata stocks have not been fully
characterised and are only known on a geographical basis. Interpretation of cross-
challenge studies after cell line immunisation is, therefore, difficult.
Duration of immunity in absence of reinfection after cell line immunisation has
not been fully investigated. Pipano (1977) reported that cattle immunised with
attenuated schizonts were protected when challenged after 18 months. Animals
vaccinated with cell culture vaccine were protected for more than one year (Singh,
1992). In a more promising report, Zablotsky (1991) found that animals challenged
3.5 years after immunisation were immune. Other evidence in the literature suggests
that immunity to the parasite declines in the absence of re-challenge (Brocklesby,
1978; Pipano, 1981). Recently, Ouhelli et al. (1994) showed that some of the animals
immunised with lxlO4 T. annulata infected cells were not protected when challenged
with sporozoites after seven months.
Little is known about the mechanism by which prolonged culture of cell lines
leads to attenuation of the parasite. It might simply be a clonal selection over a period
of time, in which case selection pressures will be a priority area of study (Brown,
1990). Studies on glucose phosphate isomerase isoenzyme patterns on T. annulata
infected cell lines at very early passages revealed multiple banding patterns, but late
passages and cloned cell lines only revealed a single triplet (Melrose et al., 1980).
Reduction in virulence by prolonged cultivation of T. annulata infected cell lines
seemed to coincide with a gradual decrease in their reactivity to a schizont specific
mAb EU106 and changes in the RFLP patterns leading to selection of a particular
genotype (Sutherland et al., 1993). However, any conclusive evidence of association
between, disappearance of a particular antigen, or alteration of gene expression in
45
infected cells with attenuation has not yet been presented.
Immunisation against T. parva with allogeneic infected cells has not been very
successful as compared to T. annulata. Initial studies indicated that at least 108 T.
parva infected fresh or cultured cells were required to induce reliable immunity (Pirie
et al., 1970; Brown et al., 1971; Brown et al., 1978a; Emery et al., 1982).
However, as few as 102 autologous infected cells resulted in sub-patent infection and
development of immunity to challenge (Morrison et al., 1981a; Buscher et al, 1984).
Further, cattle inoculated with 103 or 105 T. parva infected MHC class I matched
cells produced immunity, but animals inoculated with similar doses of MHC class I
mismatched cells were not protected on subsequent challenge (Teale, 1983 & Dolan
et al., 1984b). On the other hand, cell doses of 102 (Ouhelli et al., 1989) or even 101
(Brown, 1990) allogeneic infected cells would infect and immunise animals against
T. annulata. Cells infected with both parasites express BoLA types identical to those
of the animal from which they were generated (Spooner & Brown, 1980).
During cell line immunisation, the parasite is introduced in the recipient
animal within a foreign cell in the form of a graft. Therefore, histoincompatibility
between cell line and the recipient may influence successful immunisation on
inoculation of a parasite infected cell line. An important feature for the development
of immunity after immunisation with allogeneic infected cells is that infection has to
transfer and establish into the cells of the recipient animal (Wilde 1967; Pipano et al.,
1977; Brown et al., 1978a; Emery etal., 1982; Innes et al., 1989a). However, the
mechanism involved in this transfer is unknown. Using karyotypic analysis, it was
observed that T. annulata would transfer from donor cells and infect cells of the
recipient animal within hrs of inoculation {Hulliger et al., 1965 (unpublished)
reported in Wilde, 1967}, whereas, parasite transfer was very inefficient with T.
parva infected cells and could take many days (Brown et al., 1971; Brown, 1981).
Innes et al. (1989a) elegantly demonstrated the phenomenon of parasite transfer by
immunising animals with BoLA mismatched T. annulata infected cells and re-isolating
parasite infected cells from the recipients. The in vivo isolated cell lines expressed the
BoLA type of the recipient. It is not clearly known whether transfer of parasite from
donor cells to the cells of the recipient takes place before the development of an
allogeneic response to MHC antigens of the immunising cell line or thereafter, giving
inoculated allogeneic cells some time to proliferate in the recipient. This has
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important implications for T. annulata cell line immunisation as immunity wanes and
reimmunisation is recommended to ensure protection. Histoincompatibility between
the donor cell line and the recipient animal might pose similar problems during
secondary cell line immunisation against T. annulata, as it does during primary
immunisation against T. parva.
Some attempts have been made to immunise cattle with killed T. annulata
schizont material. Animals developed high antibody titres after inoculation, but were
not immune to sporozoite challenge (Pipano et al., 1977). In a more recent study, two
calves inoculated with purified plasma membranes from a T. annulata infected cell
line were protected on sporozoite challenge with the same parasite stock, but the other
two calves immunised with the same material were fully susceptible to challenge with
a slightly different stock of the sporozoites (Chaudhri & Subramanian, 1991). In a
similar study, Emery et al. (1986) showed that 3 out of 4 calves inoculated with
purified plasma membranes from autologous T. parva infected cell lines were
protected on sporozoite challenge, whereas calves inoculated with purified plasma
membranes from an allogeneic cell line were not protected. The mechanism of
development of immunity against both parasites to such immunising regimes is not
understood. It is not clear whether these findings are repeatable as further work in
this field is lacking. However, it has been shown that purified plasma membranes can
stimulate cytotoxic T lymphocyte responses in vitro but only after priming with viable
material in vivo (Lemonnier et al., 1978; Loh et al., 1979).
2.4.2 Immune responses
Cattle recovered from T. annulata or T. parva infection are immune to
subsequent challenge, indicating that generation of immunity against theileriosis is a
possibility (Neitz, 1957). Extensive studies have been conducted over the past few
years to understand the development of immunity against these two parasites. Several
recent reviews provide a comprehensive cover of present knowledge on immunology
of these two parasites (Morrison et al., 1986b; Hall, 1988; Morrison et al., 1989;
McKeever & Morrison, 1990; Tait & Hall, 1990; Dolan & McKeever, 1992; Norval
et al., 1992; Goddeeris et al., 1994). Studies concentrated on elucidating immune
responses to different stages of the parasites during the last few years as discussed
below.
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2.4.2.1 Immune responses to sporozoites
The current state of recombinant sporozoite vaccines has been briefly reviewed
by Musoke & Nene (1990). Although the sporozoite stage of the parasite is exposed
to the host immune system for a very short time (Brown et al., 1978b; Jura et al.,
1983), the immune serum produced in vivo has been able to inhibit entry of
sporozoites into uninfected leucocytes in vitro (Gray & Brown, 1981; Preston &
Brown, 1985; Ahmed et al., 1988). Sera raised in T. parva infected animals did not
neutralise infectivity of T. annulata sporozoites in vitro indicating that the immune
serum is species specific (Gray & Brown, 1981). Williamson et al. (1989) raised
mAb against T. annulata sporozoites which neutralised sporozoite infectivity in vitro.
One of these mAb (1A7) recognised a sporozoite surface antigen (SPAG-1) on
geographically distinct stocks of the parasite. The gene coding for this protein was
expressed only in sporoblasts and sporozoites to a significant degree and not in
schizonts or piroplasms. Further characterisation and sequencing of the gene showed
regions homologous to repetitive structures present in bovine elastin (Hall et al.,
1992a; 1992b; Hall & Baylis, 1993). Neutralising B-cell epitopes recognised by both
immune sera and mAb 1A7 were located in the C terminus of this gene (Boulter et
al., 1994). The epitope recognised by mAb 1A7 mapped to a 16 amino acid linear
sequence and immune bovine sera recognised distinct but adjacent epitopes in the
same region (SRI). Immunisation experiments with recombinant protein derived from
the cloned gene were carried out to test the level of engendered protection, but the
initial results were not very encouraging as all the immunised animals suffered from
acute disease on sporozoite challenge (Boulter & Hall, 1994). Meanwhile another T.
annulata sporozoite surface antigen (SPAG-2) recognised by a mAb 4B11 has also
been described. The gene coding for this protein was cloned and expressed as a fusion
protein. Hyperimmune serum against this protein raised in rabbits neutralised
sporozoite invasion in vitro and recognised an antigen on sporozoites and schizont
infected cells (Knight et al., 1994).
Antibodies capable of neutralising infectivity of T. parva sporozoites were
demonstrated in cattle immunised against East Coast fever by the infection and
treatment method and subsequently challenged with infective ticks several times
(Musoke et al., 1982). Immune sera from such cattle neutralised infectivity of
sporozoites of various T. parva stocks which were otherwise not cross-protective
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(Musoke et al., 1984). A mAb generated against sporozoites of T. parva also
neutralised invasion of host cells in vitro (Dobbelaere et al., 1984; Musoke et al.,
1984; Dobbelaere et al., 1985). Immune sera and mAb recognised an antigen (p67)
of relative Mr of 67 kd on the surface of sporozoites only (Musoke & Nene, 1990;
lams et al., 1990). The gene coding for p67 protein was cloned and expressed in a
plasmid vector (Nene et al., 1992). Partially purified recombinant antigen (NSI-p67)
induced sporozoite neutralising antibodies when inoculated into susceptible animals
and protected six out of nine cattle on homologous challenge (Musoke et al., 1992).
In another experiment, 11 animals immunised with NSI-p67 were challenged with a
heterologous Marikebuni stock of T. parva, but only six were protected (Musoke et
al., 1993). The challenge dose in these experiments was very low (0.1 t.e.), lower
than one might get from a single tick. Thus its efficiency in protecting against a field
challenge needs testing. Another problem is that an immune response against
sporozoites alone might not be adequate to prevent infection of host cells as a few
sporozoites might escape neutralisation. Sequence analysis of PCR amplified p67 gene
product from six different stocks of the parasite show no variation making it
theoretically possible to cross-protect amongst various T. parva stocks (Musoke et al.,
1993). Use of better adjuvants or live delivery systems might improve the immunising
efficacy of these recombinant proteins. This may help in reducing the infective dose
to allow the development of a protective immune response to the macroschizont stage
or recombinant sporozoite surface antigen could be used as a part of a cocktail
vaccine along with antigens from other stages.
As the schizont culture vaccine does not work, there has been a tremendous
pressure to develop alternative molecular vaccines against T. parva. However, the
case for a recombinant vaccine against T. annulata is very weak as it has to compete
with a highly effective cell culture vaccine.
2.4.2.2 Immune response to macroschizont infected cells
This stage of the parasite seems to be most pathogenic in T. annulata as well
as T. parva infection (Morrison et al., 1981b; Preston et al., 1992a). The parasite
lives inside the host cells and divides in synchrony with division of the infected cell.




Animals undergoing immunisation against T. annulata or recovering from the
infection develop circulating antibodies to all stages of the parasite (Kachani et al.,
1992a; 1992b). High antibody titres were detected in cattle after exposure to the
parasite (Pipano & Cahana, 1969) and after vaccination with attenuated cell lines
(Shukla & Sharma, 1991). Kachani et al., (1992a) demonstrated three antigens
between 71 and 73 kd by Western blot analysis which were common to sporozoite,
schizont and piroplasm stages of T. annulata. Another 32 kd antigen was found to be
specific to the piroplasm stage. Several observations suggested that humoral responses
may not have any protective role particularly against the schizont stage of the
parasite. Immune sera recognised the parasite inside host cells as shown on IFAT
slides, but were shown not to recognise parasite associated antigens on the cell
surface (Creemers, 1982; Shiels et al., 1989; Glascodine et al., 1990). Passive
transfer of immune serum from immunised to susceptible animals did not prevent
development of either T. annulata (Sergent et al., 1945; Dhar & Gautam, 1978;
Samad et al., 1984a) or T. parva infection (Muhammed et al., 1975), although sera
from immune cattle exhibited antibodies against all stages of the parasite (Burridge
& Kimber, 1972). Experiments using lysates or inactivated schizont material to
immunise animals have not induced a protective response in either T. annulata
(Pipano et al., 1977) or T. parva (Wilde, 1967; Emery et al, 1981b) infection,
despite generation of antibodies. Similar attempts to immunise animals against T.
parva using extracts of piroplasms were unsuccessful (Wagner et al., 1974). Serum
from T. annulata immune cattle was not opsonic for parasite infected cells and did
not lyse these cells in the presence of complement (Ahmed et al., 1988). Similarly,
Duffus et al. (1978) demonstrated that serum from T. parva immune cattle did not
lyse infected cells. However, generation of antibodies against schizonts and
piroplasms is a useful diagnostic aid for conducting serological surveys and assessing
the response of animals after immunisation.
Monoclonal antibodies against T. annulata schizonts were raised (Shiels etal.,
1986a) which identified three sets of antigens on the surface of infected cells (Shiels
et al., 1986b). Two glycoproteins of Mr 100-125 kd and 80 kd were identified on the
surface of infected cells. The 100-125 kd molecule was recognised by a mAb 4H5
which was shown to vary in size between various parasite infected lines (Shiels et al.,
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1989). This mAb induced complement mediated lysis of infected cells (Preston et al.,
1986) indicating induction of a cell surface molecule by the parasite which is
important immunologically but is not immunodominant for cattle. The role of
infection specific antigens in generating immune responses is not very clear. It is not
known whether these molecules are parasite gene products or induced by host cells.
2.4.2.2b Cell mediated responses generated in vivo
Because of lack of correlation between the presence of antibodies and
immunity to the parasite, it was suggested that immunity is mediated by cellular
mechanisms. Earlier observations of Singh et al. (1977), Ahmed et al. (1981) and
Samad et al. (1983; 1984b) also supported involvement of cell mediated responses in
protection. Cattle undergoing lethal T. parva infection exhibited increased cellularity
and lymphoblasts in lymph efferent from the node draining the site of infection
(Emery, 1981b). Protection against concurrent challenge with T. parva sporozoites
by adoptive transfer of thoracic duct lymphocytes from immune to naive chimeric
twin calves (Emery, 1981a) confirmed the role of cellular responses in protection.
A series of further in vivo experiments with T. parva demonstrated
involvement of cytotoxic T lymphocytes in protection. Cattle undergoing
immunisation or challenge with T. parva transiently expressed cytotoxic cells in
efferent lymph and PBM at the time of remission of infection which killed autologous
parasite infected cells but did not kill infected cells from unrelated animals (Eugui &
Emery, 1981). These effector cells seemed to be T lymphocytes recognising cell
surface antigens in the context of MHC molecules. In another experiment, cattle
undergoing lethal T. parva infection exhibited cytotoxic cells in PBM which killed
allogeneic infected cells and xenogeneic murine cells but not autologous infected
cells, whereas animals immunised by infection and treatment generated genetically
restricted cytotoxic cells which killed autologous infected cells (Emery et al., 1981a).
The appearance of cytotoxic cells was transient and coincided with recovery from
mild infection. Fractionation and depletion of effector PBM into different cell
populations revealed that cytotoxic activity was mediated by T cells (Emery et al.,
1981b). Cattle immunised by inoculation of approximately 107 allogeneic T. parva
infected cells generated cytotoxic cells specific for killing the donor cell line and
autologous infected cells. Cytotoxicity against autologous infected cells correlated
with the subsequent infection and protection on challenge. Cattle inoculated with 102-
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105 autologous T. parva infected cells developed cytotoxic responses directed against
autologous parasitized cells (Emery et al., 1982). These cytotoxic cells were
presumed to be genetically restricted. Cytotoxic cells against autologous T. parva
infected cells were a feature in immune animals or in animals undergoing
immunisation and directly correlated to protection from lethal sporozoite challenge.
This mechanism was not stimulated in animals undergoing acute T. parva infection.
Studies on T. annulata showed that calves recovering from infection produced
cytotoxic cells which recognised infected cells in conjunction with self MHC class I
molecules (Preston et al., 1983). This was the first evidence of generation of MHC
class I restricted cytotoxic cells during Theileria infections. Two peaks of cytotoxicity
were observed during recovery from T. annulata infection. The first peak was BoLA
restricted and probably analogous to cytotoxic T lymphocytes, while the second peak
was not MHC restricted and probably analogous to natural killer cells. Further
evidence of genetically restricted cytotoxic cells came from the experiments of
Morrison et al. (1987b). They showed that cytotoxic cells generated in East Coast
fever immune cattle following sporozoite challenge killed only autologous infected
cells or infected cells from other animals expressing matched or half matched BoLA
types. The response was found to be biased towards one or the other BoLA type. A
mAb specific for bovine CD8 cells partially blocked cytotoxic activity. Cytotoxic
activity was also blocked by an MHC class I specific mAb but not by MHC class II
mAb indicating that the response was produced by MHC class I restricted cytotoxic
T lymphocytes (CTL) of CD8 lineage (Morrison et al., 1987b).
A direct analysis of cell mediated cytotoxic activity against T. annulata
infected cells was demonstrated by inoculating animals with autologous or allogeneic
T. annulata infected cell lines by Innes et al. (1989a). Animals inoculated with an
allogeneic cell line developed a strong cytotoxic response directed against MHC
antigens of the immunising cell line followed by development of MHC class I
restricted cytotoxic cells against autologous infected cells. Animals inoculated with
autologous infected cells developed severe clinical reactions and a low level of
cytotoxic activity against parasite infected cells, which was not MHC restricted up to
day 20. Sera specific for bovine MHC class I antigens blocked the cytotoxic activity
further confirming that the response was MHC class I restricted (Innes, 1988).
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A limiting dilution micro-culture system to quantify the frequency of T. parva
specific CTLp in PBM of immune cattle was standardised (Taracha et al., 1992a).
The technique displayed specificity for infected cells, genetic restriction and in some
cases strain specificity. Using this technique, a correlation between parasite strain
specificity of CTL and in vivo cross-protection was confirmed (Taracha et al.,
1992b). The most direct evidence that immunity to T. parva is mediated by CTL was
recently provided by McKeever et al. (1994). They showed that frequency of CTLp
significantly increased, in lymph efferent from the node draining the site of T. parva
sporozoite challenge of an immune animal, which mainly resided in the CD8+ cell
population. Adoptive transfer of purified CD8+ cells at this stage, from an immune
animal to its naive monozygotic twin undergoing lethal T. parva infection, protected
the recipient calf showing that lethal infection can be controlled by responding CD8+
cells alone. These observations highlight the potential of exploiting parasite antigens
recognised by CTL for vaccination (McKeever & Morrison, 1994). However,
stimulation of such a mechanism of immunity would require recognition of parasite
antigen(s) by the host in the context of self MHC.
Preston (1981) showed a cytostatic effect of adherent cells on T. annulata
infected cell lines. Adherent cells isolated from peripheral blood of calves immunised
using schizont infected cells or sporozoites, exhibited a strong cytostatic effect via a
soluble factor on schizont infected autologous as well as allogeneic cell lines (Preston
& Brown, 1988). Several studies have reported the presence of a lymphocyte
migration inhibition factor in immune animals undergoing challenge with T. annulata
(Singh et al., 1977; Ahmed et al., 1981; Chaudhri & Subramanian, 1992). Further,
certain cytokines have been reported to significantly inhibit in vitro development of
trophozoite infected cells of T. annulata as well as T. parva. However, these
cytokines had no effect on already established cell lines of both species (Preston et
al., 1992b). PBM, pulmonary macrophages and lymph node cells from a calf lethally
infected with T. annulata spontaneously produced IFN-7 in vitro (Preston et al.,
1993). Large numbers of CD25+ cells appeared transiently in the draining lymph
node after T. annulata sporozoite infection. The loss of CD25+ cells from the node
coincided with the loss of germinal centres indicating a T cell dysregulation during
infection (Campbell et al., 1994b). Immunisation of animals with an allogeneic T.
annulata infected cell line lead to activation of T cells near HEV and formation of
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germinal centres with many blasting cells in the draining lymph node indicating that
animals mounted a protective response (P. Goel & R.L. Spooner, pers. comm.).
Activation of T cells, secretion of cytokines and their role in immunity and
pathogenesis during T. annulata and T. parva infection has not been extensively
studied. Understanding the activation of immunocompetant cells by the parasite and
parasite antigens could help in manipulating the immune response in the favour of
host during lethal challenge.
2.4.2.2c Generation of T cells in vitro
Cellular responses against the parasites were only observed for a short period
during in vivo studies. In order to expand these responses for identification of
antigens recognised by the immune system, it is necessary to generate T cell lines and
clones in vitro. Early observations demonstrated that irradiated T. parva infected cells
induced proliferative responses in autologous PBM which killed autologous infected
cells as well as uninfected blast cells (Pearson et al., 1979; 1982). In further studies
by Eugui & Emery (1981), cytotoxic cells generated by incubation of PBM (collected
immediately following challenge) with irradiated autologous T. parva infected cells
showed low levels of killing of autologous infected cells. Cytotoxic cells generated
in vitro, by incubation of PBM separated from defibrinated blood of immune or naive
cattle with irradiated autologous T. parva infected cells, showed no genetic
restriction. However, cytotoxic cells generated in vivo after challenge of immune
animals only lysed autologous infected cells (Emery & Kar, 1983).
The discrepancies in the above results from in vitro generated cytotoxic cells
related to a number of factors concerning the source of responder and stimulator
populations. The infected cell lines used as stimulators were not cloned cell
populations. It has been shown that T. parva transforms a variety of target cells in
vitro (Baldwin et al., 1988a). There is a variation in the ability of different cell lines
to stimulate proliferation and induce cytotoxic responses in autologous PBM
(Goddeeris et al., 1986a). Depletion of monocytes from the responder population
tends to give non-specific proliferative responses known as autologous Theileria MLR
(Goddeeris & Morrison, 1987; Goddeeris et al., 1987). The role of monocytes in
generation of a genetically restricted response is not clear. It is possible that initial
antigen presentation by monocytes in an MHC class II restricted pathway to CD4+
cells is necessary to stimulate MHC class I restricted CD8+ cells.
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Cytotoxic cells specific for autologous T. parva infected cells were generated
in vitro by stimulation of PBM from immune animals with irradiated autologous
infected cells but not from PBM of naive animals. Further weekly stimulations of
cells from these cultures with irradiated autologous T. parva infected cells resulted
in enrichment for specific cytotoxic cells. The cultures consisted of mainly CD4+ and
CD8+ T cells, but cytotoxic activity was contained in the CD8 fraction only
(Goddeeris et al., 1986a). Cytotoxic cells generated in vitro seemed to be analogous
to in vivo generated cytotoxic cells in T. parva immune cattle. Cloned T cell
populations specific for T. parva infected cells were derived from these lines
(Goddeeris & Morrison, 1988a). Two types of clones were generated: CD8+
cytotoxic cell clones (Goddeeris et al., 1986b) and CD4+ non-cytotoxic cell clones
(Baldwin et al., 1987).
Cytotoxic T cell clones derived from an animal immunised with T. parva
(Marikebuni) killed infected cells of Marikebuni as well as Muguga stocks. Clones
obtained from an animal immunised with T. parva (Muguga) only killed parasite
infected cells of this stock (Morrison et al., 1987a). This animal was not protected
on challenge with sporozoites of Marikebuni stock. On the other hand, two types of
cytotoxic T cell clones were generated from another animal immunised with the
Muguga stock, which showed a cross-protective response in vivo. Some clones were
specific for Muguga stock only, whereas others were cross-reactive (Goddeeris &
Morrison, 1988b). T cell clones seemed to recognise two antigenic epitopes, one of
which was common to both the stocks and the other was specific to Muguga stock
only. These studies raised a question as to why some animals immunised with T.
parva (Muguga) responded to one epitope only, while others responded to both
epitopes. Goddeeris et al. (1990) showed that selection of the T cell epitope for
immune responsiveness was governed by MHC phenotype of the animal. Cytotoxic
T cell responses to viral antigens have shown that mice of different MHC phenotypes
respond to different epitopes on immunogenic molecules (Vitiello & Sherman, 1983;
Townsend & McMichael, 1985). Recently, foot and mouth disease (FMD) peptides
recognised by T cells were shown to be influenced by MHC class II types of the
recipient animal (Van-Leirop et al., in press).
Further investigations with T. parva specific T helper cell (CD4+) clones
revealed that these clones identified two sets of antigens on infected cells (Brown et
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al., 1989b). One antigen was schizont membrane associated and appeared to be
expressed on the infected cell surface (Brown et al., 1989c). This antigen could be
derived from different parasite stocks and purified schizonts, and was only seen by
primed CD4+ cells (Baldwin et al., 1992). The second antigen was a soluble antigenic
fraction prepared by high speed centrifugation and seemed to be expressed on the
surface of infected cells (Brown et al., 1990). Elimination of schizonts from infected
cells by in vitro treatment with parvaquone also removed this antigen indicating that
the antigen was parasite associated (Brown et al., 1989c). Crude fractionation of this
soluble antigen by gel filtration and high performance liquid chromatography
demonstrated that the antigen is a 24 kd protein and is recognised by CD4+ cells from
immune cattle (Grab et al., 1992).
The main importance of generating CD4+ and CD8+ parasite specific lines and
clones is to identify relevant parasite antigens, apart from identification of different
parasite stocks. CD8+ cells recognise antigens in association with MHC class I
molecules which requires active synthesis and processing. Therefore, the CD8+ cell
response to a particular epitope cannot be generated in vivo by using killed parasite
material or purified antigens. However, it might be possible to introduce candidate
antigens into target cells by transfecting parasite gene(s) into a mammalian cell
expressing the appropriate bovine MHC molecule(s), or by inserting genes into
recombinant virus vectors which could be used to infect bovine cells. Mouse L
fibroblast cells have been transfected with a bovine MHC class I gene and expression
of MHC class I on the transfected cells has been stable (Toye et al., 1990; Hasima
et al., 1992; Sawhney et al., in press). Extensive information on the T. parva genome
is available (Morzaria & Young, 1993), but initial co-transfection studies of the
parasite DNA into bovine MHC class I transfected L cells were not rewarding (Toye
etal., 1991).
Another approach of identifying parasite specific epitopes on the cell surface
for recognition by CD8+ cells could be by elution of peptides from infected cells and
identifying the ones recognised by cytotoxic T lymphocytes. Conze et al. (1994)
eluted peptides from T. annulata infected cells and fractionated them on high
performance liquid chromatography. One of these fractions fed to syngeneic cells was
recognised by parasite specific cytotoxic cells generated in an immune animal
undergoing sporozoite challenge. Further characterisation of this peptide fraction
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would help in finding relevant antigenic epitope(s) for CD8+ cells.
There have been fewer studies on in vitro T cell responses on T. annulata than
T. parva. Initial observations showed that PBM from immune or naive calves
proliferated in the presence of irradiated autologous T. annulata infected cells
(Preston, 1981), but these findings were never followed. Some success in generating
T. annulata specific T cell lines from an immune animal which could be maintained
for a short period was demonstrated by Innes (1991). The line showed specific
cytotoxic activity against autologous and BoLA matched T. annulata infected target
cells which could be inhibited by addition of immune allo-antisera against MHC class
I types but not by anti MHC class II antisera. Cytotoxic effector function resided in
the CD8+ cells. Although T cells from immune and naive cattle proliferated in
response to irradiated autologous T. annulata infected cells in vitro, stable T cell lines
could not be generated by repeated in vitro stimulations of PBM from immune
animals with autologous infected cells (Campbell et al., 1994b; A.K. Nichani & R.L.
Spooner, unpublished observations). Both CD4+ and CD8+ cells from naive animals
proliferated and expressed CD25 and MHC class II when cultured with irradiated
autologous T. annulata infected cells. Proliferating cells also expressed mRNA for
various cytokines viz: IL-2, IL-2R, IL-4 and IFN-7, suggesting induction of a non¬
specific polyclonal T cell activation in response to the parasite (Campbell et al.,
1994c).
Most lymphocyte effector responses depend on activation of CD4+ cells to
secrete cytokines and transmit signals to other cell populations. The fact that animals
can be immunised against T. annulata emphasize that these responses are generated
in vivo in immune animals. Inability to generate T. annulata specific T cell lines was
surprising and unexpected, in contrast to the observations on T. parva as discussed
above. There could be several reasons for this failure. Both parasites infect and
transform different cell subpopulations (Spooner et al., 1989) and, therefore, deliver
different signals to T cells. Infected cells of both parasites secrete different cytokines
in vitro. T. parva infected cells produce IL-2 (Dobbelaere et al., 1988; Brown et al.,
1989a; Heussler et al., 1992) and IFN-7 (DeMartini & Baldwin, 1991; Entrican et
al., 1991; Ahmed et al., 1993) which may at least partially be responsible for
stimulating proliferation in culture of PBM with autologous irradiated T. parva
infected cells. T. annulata infected cells produce type 1 IFN (a/B) (Entrican et al.,
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1991) which might have some suppressive effect on T cells. T. annulata infected cell
lines generated in vitro and in vivo have been shown to express different cell surface
antigens (Howard et al., 1993). It is possible but unlikely that the parasite infects
different cell populations in vivo and in vitro, and if they do, T cell activation by
parasite infected cells in vivo and in vitro will be different.
2.4.2.3 Immune responses against merozoites and piroplasms
Immune responses against erythrocytic stages are not considered very
important since these occur very late in the course of the disease and damage has
already been done by that time. Generation of immunity against this stage might be
important when sub-unit vaccines containing antigenic determinants from all stages
of the parasite are used to block the parasite at all levels. Secondly, it might be
important in blocking transmission of parasite to tick vector. Antibody responses to
piroplasms have been observed in cattle recovering from infection or undergoing
immunisation with either T. annulata (Kachani et al., 1992b) or T. parva (Burridge
& Kimber, 1973). Immune serum from T. annulata infected animals has been shown
to react with free merozoites produced by lysis of erythrocytes (Ahmed et al., 1988).
Monoclonal antibodies generated against T. annulata merozoites cross-react with
piroplasms (Glascodine et al., 1990).
Extensive research on immunity against theileriosis over the past few years has
provided a good understanding on cellular immune effector mechanisms involved in
protection against both parasites. Cell culture vaccines have been extensively used to
control tropical theileriosis. Reimmunisation is recommended in some endemic areas,
but no information on feasibility of reimmunisation is available. Little is known about
the cellular interactions involved in activation of immune effector cells leading to the
development of immunity. An attempt has been made to address some of these
questions in this thesis, particularly elucidating the role of allograft response on cell
line immunisation against T. annulata and investigating T cell activation responses
after immunisation and challenge.
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CHAPTER 3
GENERAL MATERIALS AND METHODS
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The various materials and techniques used during the persuit of this study are
describeded in this chapter. Preparation of common laboratory solutions and media
is given in the appendix with a reference in the relevant sections.
3.1 Experimental animals
The animals used in this study were male or female Friesian, Hereford or
Charolais calves or their crosses aged between 2-8 months. They were maintained at
Dryden Mountmarle farm and fed with a regulated supply of concentrate ration and
ad libitum hay and water. All the animals were housed together in an animal shed
during reimmunisation experiments, however they were housed individually in calf
pens during lymphatic cannulation studies where they could easily move around.
3.2 MHC class I (BoLA) typing of animals
MHC class I types of all the animals used in this study were detected by
micro lymphocy totoxicity as described by Spooner et al. (1979a). BoLA types of T.
annulata infected cell lines isolated from animals after cell line immunisation were
also determined by microlymphocytotoxicity as described previously (Spooner &
Brown, 1980).
3.2.1 Alloantisera for BoLA Typing
A panel of alloantisera was used to define the BoLA specificities of the
animals and T. annulata infected cell lines used in this study. These alloantisera were
produced in Edinburgh from cattle by reciprocal skin grafting between dam and
offspring (Spooner et al., 1979a). These operationally monospecific sera have been
tested and compared with sera developed in other laboratories in the five international
comparison workshops carried out to date (Spooner et al., 1979b; Anon., 1982; Bull
et al., 1989; Bernoco, et al., 1991; Davies et al., 1994b), and have been assigned the
workshop specificities. The Edinburgh alloantisera typing panel is listed in appendix
(no. 10) and includes sera defining the presently agreed workshop specificities
(Davies et al., 1994b).
These typing sera were stored neat in small aliquots at -70°C. Control serum,
which was selected for non-reactivity with any of the test cells, was included in the
lymphocytoxicity test to estimate baseline test cell viability. Appropriate dilutions of
both the control and typing sera were prepared in Hank's balanced salt solution
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(HBSS) (appendix, no. 1) and dispersed (1 ^ 1 per well) in Terasaki 60 well plastic
typing plates (Intermed, Nunc) in a known order under liquid paraffin using a
multidispenser Hamilton syringe. Batches of typing plates were also stored at -70°C.
3.2.2 Preparation of test cells for BoLA typing
Preparation of lymphocytes for use in the microlymphocytotoxicity test was
carried out essentially as described by Spooner et al., (1979a). Three ml of venous
blood, collected in sterile vacutainers containing lithium heparin (Becton Dickinson),
was layered onto 2.5 ml Ficoll-hypaque solution of specific gravity (S.G.) 1.077
(Lymphoprep, Nycomed Pharma As, Oslo, Norway) and centrifuged for 15 minutes
(min.) at 1500g. The lymphocyte layer at the plasma/Ficoll-hypaque interface was
removed and washed in HBSS by centrifugation at 400g for 5 min. The resultant cell
pellet was resuspended in a small volume of HBSS and lysis of any contaminating
erythrocytes was achieved by the addition of 2 ml of deionised distilled water to the
cell sample with constant mixing, followed rapidly by 2 ml of double strength (2x)
HBSS. The cell suspension was then washed twice by centrifugation at lOOg for 5
min. (to remove platelets) and resuspended in HBSS. Cells were counted in a
haemocytometer (Neubauer chamber) using a phase contrast microscope (Diavert,
Leitz) and adjusted in HBSS to give a final concentration of 2.5xl06 cells per ml.
T. annulata infected cells were washed twice in HBSS by centrifugation at
400g for 5 min. The cells were resuspended in HBSS and adjusted to a final
concentration of 2xl06 cells per ml in HBSS for testing.
3.2.3 Microlymphocytotoxicity test
The microlymphocytotoxicity test was conducted as described by Spooner et
al. (1979a). The Terasaki typing plates were thawed to room temperature (temp.)
before use. All the following incubations were performed at room temp. Details for
preparation of complement, eosin dye and fixing solution used for this test are given
in appendix (no. 2, 3 and 4). The test cell suspension (1 jul) was added to each well
and plates incubated for 30 min. Complement (5 yul) was added to each well of the
plate and further incubated for one hour (hr). Following incubation, 2 yu.1 of 5 % eosin
solution was added to each well and incubated for 5 min. Finally, 5 fA of fixing
solution was added. The plates were then read immediately using an inverted phase
contrast microscope (Nikon) at lOOx magnification or stored at 4°C and read within
a week. Test plates were scored as shown in table 3.1 using the system described in
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3.3 Generation of allogeneic immune responses
Immune responses against allogeneic MHC antigens in calves were produced
either by repeated inoculation of uninfected leucocytes or by repeated skin
implantation essentially as described by Pringnitz et al. (1982). For preparation of
uninfected leucocytes, venous blood was collected in acid citrate dextrose (ACD,
appendix, no. 5) and centrifuged at 800g for 15 min. Plasma was discarded and RBC
from the pellet were lysed by addition of ammonium chloride lysis solution
(appendix, no. 6). Cells were pelleted by centrifuging at 300g for 10 min. and
washed twice with phosphate buffer saline (PBS) pH 7.2 (appendix, no. 7) by
centrifugation at 100g for lOmin. The cells were finally resuspended in PBS at lxlO8
per ml and inoculated subcutaneously (s/c) in the neck.
For skin implantation, skin from the donor was removed from the dorsal side
of the base of the ear. The site was scrubbed with a disinfectant soap and shaved.
About 3 ml of local anaesthetic (Lignavet, C. VET Ltd.) was injected s/c at the site
which was then disinfected by spraying with 5 % Hibitane (ICI). Skin was lifted with
toothed forceps and cut with a scalpel to obtain a piece of tissue approximately one
cm in diameter. Pressure was applied to the donor site to stop bleeding. The wound
was sprayed with an antibiotic spray (Polybactrin powder spray, The Wellcome
Foundation Ltd.) and usually healed without any complications within 2 weeks. The
piece of donor skin was immediately transferred into a sterile universal tube
containing PBS for transport to the recipient calves.
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The recipient calves were implanted with the piece of donor skin in the middle
of the neck. The implant site was prepared as described above for collection of skin
from the donor. A subcutaneous pocket was created by a single stab with a scalpel.
The donor skin was inserted into this pocket and the incision closed with a single
suture and sprayed with an antibiotic spray. The incision healed within 2 weeks
without complications. This was repeated usually after 4 weeks or later to boost the
titre of anti MHC antibodies.
3.4 Generation and maintenance of cell lines and sporozoites
Techniques used for initiation and maintenance of T. annulata schizont
infected cell lines, uninfected lymphoblastoid lines and T. annulata sporozoites are
described in this section.
3.4.1 Theileria annulata isolates
The species and stocks of T. annulata used in this study are detailed in the
relevant chapters. Three isolates of T. annulata; Gharb (Ouhelli, 1985), Hissar (Gill
etal., 1980) and Ankara (Schein, 1975) were used in this work. The parasite material
used included cell lines, GUTS and cryopreserved tick stabilates.
3.4.2 Establishment of T. annulata cell lines
T. annulata infected cell lines were established in vitro as described by Brown
(1983). The technique is briefly outlined here.
3.4.2.1 Isolation of peripheral blood mononuclear cells (PBM)
Venous blood was collected in vacutainers containing ACD and centrifuged
over Ficoll-hypaque S.G. 1.077 (Lymphoprep) at 1500g for 25 min. at room temp.
PBM were removed from the interface of plasma and Ficoll-hypaque, and washed in
PBS by centrifugation at 300g for 10 min. The cells were further washed twice in
PBS and once in RPMI-1640 by centrifugation at lOOg for 10 min. Finally, the cells
were resuspended in complete tissue culture (TC) medium (appendix, no. 8), counted
and adjusted to the required cell concentration.
3.4.2.2 Ground up tick supernatant (GUTS)
The tick material was prepared and stored by staff at the Centre for Tropical
Veterinary Medicine, Edinburgh and kindly provided as and when required. The
procedure for obtaining a sterile preparation of GUTS as a source of sporozoite
material (Brown, 1983) is briefly described below.
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Adult Hyalomma anatolicum anatolicum ticks infected with T. annulata
(Walker et al., 1985) were fed for 3 days on rabbits' ears to stimulate maturation of
sporozoites. Partially engorged ticks were removed and washed, once in 1%
benzalkonium chloride (Roccal, Winthrop) and a further three times in 70% ethanol.
They were then transferred to a sterile container and washed three times in warm
Eagle's minimum essential medium (MEM) with Hanks salts, double strength
antibiotics i.e. pencillin, 200 i.u. per ml and streptomycin 200 ug per ml (Gibco
BRL), and 0.1 mg per ml nystatin (Gibco BRL). They were left for 10 min. in the
fourth wash. The medium was discarded, and 2-5 ml of cold MEM with 3.5 % bovine
plasma albumin (BPA) (Fraction V, Sigma) containing antibiotics as described above
was added to the ticks. Ticks were transferred to a sterile mortar and ground with a
sterile pestle, with an aliquot of supernatant being removed, and measured quantities
ofMEM and 3.5 % BPA solution (as described above) added. This was repeated until
the required concentration of supernatant material (usually 4 t.e. per ml) was reached.
The supernatant was centrifuged for 5 min. at lOOg. The supernatant
(containing the sporozoites) was removed and filtered through a sterile 25mm or
47mm Millipore Swinnex filter with an AP prefilter and 8g MF filter (Millipore
Corporation). The sporozoite strength of the material was expressed as t.e. per ml.
The quality of the preparation was assessed using Giemsa (Sigma) stained
cytocentrifuge smears prepared to one t.e. per ml.
3.4.2.3 In vitro infection of bovine PBM with T. annulata sporozoites
This technique is described in detail by Brown (1983) and Brown (1987). PBM
at 2xl07 cells in one ml TC medium were usually mixed with one ml of the
sporozoite suspension (GUTS filtrate) at 1.0 t.e. per ml in a 25 cm2 tissue culture
flask (Intermed, Nunc). The flask was kept in a standing position in a C02 incubator
at 37°C for two hrs. A further 8 ml of TC medium was added in the flask after two
hrs and the flask was placed in the normal horizontal position in the incubator.
For establishing infected cell lines from cryopreserved GUTS, the sporozoite
material was rapidly thawed from liquid nitrogen, kept at room temp, to equilibrate
for 20 to 30 min. and serially diluted slowly with TC medium containing 20% foetal
calf serum (FCS) by three doubling dilutions at 20 min. intervals. Diluted tick
material (8 ml) was mixed with 2 ml of PBM at a cell concentration of lxlO7 per ml
in a 25 cm2 flask. The flask was kept in an upright position overnight in a C02
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incubator at 37°C. The next morning, 7 ml of supernate were removed very slowly
from the flask and replaced with 7 ml of fresh TC medium. The flask was then
placed horizontally in the incubator. Depending upon the amount of tick material
available and purpose for which cultures are intended, T. annulata cell lines can be
generated with varying numbers of PBM and volumes of GUTS in different types of
smaller well plates.
The cultures were incubated at 37°C in a 5% C02 humidified incubator
(Scotlab VSL). The TC medium was subsequently changed at least twice a week
according to the metabolic demands of the culture. Aliquots were removed at intervals
for cytocentrifuge preparations to monitor infection and transformation rates. Once
30% or more of the cells were infected, the cultures were transferred to a larger
culture flask (Intermed, Nunc). After transformation, cells were usually maintained
at a concentration between 106 and 2xl06 per ml.
3.4.2.4 Establishment of parasite infected in vivo cell lines
Attempts were made to generate T. annulata infected cell lines from animals
after cell line immunisation and sporozoite inoculation as described by Brown (1987).
For establishing cell lines from lymph node biopsy material, a needle biopsy was
collected from the lymph node in RPMI-1640 containing antibiotics (200 i.u./ml
penicillin and 200 jug/ml streptomycin) and 10 i.u./ml heparin (Leo laboratories Ltd.).
The material was transferred to a universal tube, pipetted vigorously and washed once
in TC medium. The cell concentration was adjusted to 2xl06 per ml, layered in a 25
cm2 flask and incubated in a C02 incubator at 37°C. For isolating parasite infected
lines from blood and/or efferent lymph, PBM (3.4.2.1) and ELL (3.4.5), adjusted to
2xl06 cells per ml and seeded at 2 ml per well in 24 well plates. Cultures were
monitored for the growth of infected cells as described above for in vitro lines.
3.4.3 Establishment of uninfected lymphoblastoid lines
Uninfected lymphoblasts were established by stimulating normal bovine PBM
once with 2 /ug/ml of concanavalin A (Con. A, Sigma type IV-S) in mixed
lymphocyte culture (MLC) medium (appendix, no. 9), as described by Innes et al.
(1989a). PBM were prepared as described above (3.4.2.1) and incubated with Con.
A for 72 hrs in a 5% C02 incubator at 37°C. After three days, blast cells were
separated by centrifugation over Ficoll-Hypaque solution S.G. 1.077 (Lymphoprep)
for 25 min. at 1500g. Viable cells were gently pipetted from the interface,
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resuspended in RPMI-1640 and centrifuged again at 300g for lOmin. followed by
another wash for 10 min. at lOOg. The resultant blast cells were cultured at a
concentration of 2.5 x 106/ml in MLC medium containing a supplement of 20% T-cell
growth factor (TCGF). TCGF was prepared by collecting supernatant from a
continuously growing gibbon lymphoid cell line, MLA 144 (Rabin et al., 1981;
Henderson et al., 1983) which releases a factor biologically and chemically similar to
human TCGF. The line was grown in 75 cm2 culture flasks (Intermed, Nunc) using
MLC medium. After 48 hrs, when the cells were in exponential growth phase,
supernate was collected by centrifuging the cells at 1500g for 15 min., filtered
through a 0.22/x filter and stored at -20°C in 20 ml aliquots. These cells were used
as target cells in the cytotoxicity assays.
3.4.4 Cryopreservation of cell lines and sporozoites
Parasite infected lines, uninfected Con. A blast lines and GUTS were
cryopreserved using the methods described by Brown (1983). The infected lines and
Con. A uninfected lines were cryopreserved in 10% dimethyl sulphoxide (DMSO)
(BDH biochemical). The cells were resuspended in RPMI-1640 supplemented with
50% FCS at a cell concentration of 2xl07 per ml and mixed with equal volumes of
20% DMSO in FCS. The final mixture was distributed in 1 ml aliquots and stored
at -70°C for 24 hrs and then in liquid nitrogen until required. The GUTS were
cryopreserved as a tick stabilate using 7.5% glycerol (BDH biochemicals) as the
cryoprotectant in MEM supplemented with 3.5% BPA and stored in liquid nitrogen.
For the resuscitation of infected lines, the method described by Brown (1987)
was followed. Vials containing frozen cell lines were thawed rapidly at 37°C and the
DMSO was diluted by adding warm (37°C) medium and removed by centrifugation
at 200g for 10 min. The cells were resuspended in fresh TC medium and incubated
at 37°C. Sporozoite stabilates were also thawed rapidly in a 37°C water bath, and left
at room temp, to allow equilibration over 30 min. At this stage they were used either
undiluted or diluted slowly with MEM containing 3.5% BPA as described above
(3.4.2.3) for challenge of animals or generation of in vitro parasite infected cell lines.
3.4.5 Preparation of efferent lymph lymphocytes (ELL)
ELL were collected from an indwelling cannula draining the efferent
prescapular lymphatic duct. The technique of lymphatic cannulation is described
below (3.5). Cells in efferent lymph were usually lymphocytes with less than 1%
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contamination of neutrophils and eosinophils. However, at times the lymph contained
varying numbers of RBC depending upon damage during surgery and haemorrhages
in the lymph node at the later stages of infection with GUTS or T. annulata infected
cell lines. Freshly collected ELL were washed twice with RPMI-1640 by
centrifugation at 300g for 10 min. for preparation of cytospin smears. Lor all other
techniques, ELL were purified on ficoll-hypaque as described for PBM above.
3.4.6 Preparation of cytocentrifuge smears
The morphology of ELL, uninfected Con. A blasts, T. annulata infected cells
and sporozoites in GUTS were examined using Giemsa stained smears of
cytocentrifuge preparations. These were prepared by spinning 100 gl aliquots of the
material onto a clean glass microscope slides at llOg for 7 min. in a cytocentrifuge
(Cytospin II, Shandon, Southern Instruments). The slides were first "primed" by 100
jx\ of RPMI-1640 (Gibco BRL) and centrifugation at llOg for 5 min. Cytocentrifuge
smears were air dried, fixed for 5 min. in methanol (BDH) and stained for 40 min.
with 1:10 dilution of Giemsa stain (Sigma) in Gurr buffer (BDH, one tablet dissolved
in 1 litre of distilled water and pH adjusted to 7.2). The stained slides were rinsed in
Gurr buffer, air dried and examined under an Ortholux II microscope (Leitz).
3.5 Surgical cannulation of the efferent prescapular lymphatic duct
Efferent lymphatic vessel of the prescapular lymph node (also known as the
superficial cervical lymph node) of calves was cannulated to study development of
immune responses in the lymph node draining the site of sporozoite infection or cell
line immunisation. All the surgical operations were carried out by Dr. Roger
Spooner.
3.5.1 Anatomy of the prescapular lymph node
The anatomical position of the lymph node is shown in fig. 3.1 & 3.2, which
have been adapted from, "Sisson and Grossman's the anatomy of the domestic
animals" by Getty (1975). The lymph node is located laterally at the cranial border
of the supraspinatus muscle on the scalenus muscle. The dorsal two thirds of the
lymph node is covered by the omotransversarius and the ventral third by the
bracheocephalicus muscle. The efferent lymphatic descends from the node over the
scalenus muscle and opens on the right side into the right tracheal trunk. On the left
side, it terminates in the thoracic duct or the left tracheal trunk (Saar & Getty, 1975)
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1. Mandibular In.; 2, parotid In.; 3, lateral retropharyngeal In.; 4, superficial cervical In.; 5. subiliac In.; 5 . Inn. of para-
lumbar fossa; 6, gluteal In.; 7, popliteal In.; 8, tuberal In.
Figure 3.1: Diagram showing the areas drained by afferent lymphatics to various
superficial lymph nodes in cattle.
(Figure adapted from "Sisson and Grossman's The Anatomy of domestic Animals"
Vol, 1, editor R. Getty, W,B Saunders Co., 1975).
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Lymph flow of the head, neck and
shoulder region of the ox.
1. Pterygoid In.; 2, mandibular In.; 3, rostral hyoid In.; 4, medial
retropharyngeal In.; 5, parotid In.; 6, caudal hyoid In.; 7, lateral re¬
tropharyngeal In.; 8. cranial deep cervical In.; 8', middle deep
cervical In.; 8". caudal deep cervical Inn.; 9, superficial cervical
In.; 10, accessory superficial cervical In.; 11, costocervical In.;
11. subrhomboid In.; 12, axillary Inn. of first rib; 13, proper axil¬
lary In.: 14. infraspinous In.; 15, cranial mediastinal In.; 16,
cranial sternal In
Figure 3.2: Schematic diagram showing lymph flow in head, neck and shoulder
region of cattle.
(Figure adapted from "Sisson and Grossman's The Anatomy of domestic Animals"
Vol. 1, editor R. Getty, W B. Saunders Co., 1975).
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as shown in fig. 3.3 & 3.4. The prescapular efferent lymphatic was cannulated with
some modifications to the technique described originally by Lascelles & Morris
(1961), Hall & Morris (1962) and Hall (1967) for sheep and later by Emery (1981b)
and Emery et al. (1987) for cattle.
3.5.2 Preparation of cannulae for lymphatic cannulation
Apolvinyl tube (Critchley Electrical Products Pty. Ltd., Australia) of 1.5 mm
outer diameter and 1.0 mm internal diameter was used for the efferent cannulation.
The cannula was impregnated with heparin before use to reduce clotting and allow
better flow of lymph (Hopkins et al., 1993). The tubing was thoroughly rinsed with
acetone (BDH), filled with a 2% solution of 3-aminopropyltriethoxy silane (Sigma)
in acetone and left for 5 min. It was then rinsed through again with acetone, drained
and finally filled with heparin (5,000 i.u. per ml, Leo Laboratories Ltd.). Knots were
tied at both ends of the tubing. It was wrapped in aluminium foil and stored at 4°C.
3.5.3 Presurgical procedures and anaesthesia
Animals were starved 24 hrs before surgery. Anaesthesia was induced by
intravenous (i/v) injection of 10% thiopentone sodium (RMB Animal Health Ltd) at
one ml per 10 Kg. body weight. The animals were intubated immediately using a
cuffed endotracheal tube. Anaesthesia was maintained by a mixture of halothane,
nitrous oxide and oxygen using a closed circuit anaesthetic machine (BOC Boyle
International) fitted with a C02 absorber and rebreathing bag. The area around the
prescapular lymph node was clipped and scrubbed. Two ml of a blue dye (Bleu patent
V, Laboratoire Guerbet, Cedex) was injected s/c at a few different sites in the
shoulder area drained by the prescapular lymph node (over the shoulder, above the
node and just above and in front of the node) for easy identification of the efferent
lymphatic. The operation site was disinfected with 5% Hibitane (ICI).
3.5.4 Surgical procedure
An incision was made parallel to and about 2.5 cm above the jugular vein,
directly below the node. The thin layer of the bracheocephalicus muscle was divided
by blunt dissection and held open with retractors. Only by digital dissection, the area
under the muscle was exposed towards the rear area of fat. The efferent lymphatic
follows the anterior surface of fat surrounding the artery and vein which serves the
node and skin above it. The duct shows up as blue 10-30 min. after the dye has been
injected. The blue dye aids in identification of the duct but is not essential (fig. 3.5).
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Termination of thoracic duct of ox
and left tracheal trunk, left view.
a, Thoracic duct; a', termination of a; b, left tracheal
trunk; c, efferents from superficial cervical In.; e, com¬
municating branch from right tracheal trunk; f, efferents
from cranial mediastinal In.; 1, 2, 2', caudal deep cervical
Inn.; 3, 3', axillary Inn. of first rib; 4, proper axillary In.; 5,
costocervical In.; 6, superficial cervical In.; 7, cranial ster¬
nal In.; I, common jugular v.; II, left external jugular v.;
Ill, left internal jugular v.; V, left brachial v.; VI, left
brachial a.; VII, ventral, and VII', scalenus dorsalis; VIII,
rectus thoracis; IX, sternocephalicus; I.R., 2.R., 3.R. = 1st,
2nd. 3rd ribs.
Figure 3.3: Route of efferent lymphatic from prescapular lymph node of cattle
(left side).
(Figures adapted from "Sisson and Grossman's The Anatomy of domestic Animals"
Vol. 1, editor R, Getty, W B. Saunders Co., 1975).
7 I
Termination of right tracheal trunk of ox, right
view.
a, Right tracheal trunk; c, efferents from superficial cervical In.; 1, 1',
caudal deep cervical Inn.; 3,3', axillary Inn. of first rib; 4, proper axillary
In.; 5, costocervical In.; 6, superficial cervical In.; I, common jugular v.;
Ill, right internal jugular v.; IV right external jugular v.; V, right
brachial v.; VI, right brachial a. II, ventral and, VII', scalenus dor-
salis; VIII, rectus thoracis; IX, sternocephalicus; l.R , 2.R., 3.R., = 1st,
2nd, 3rd ribs.
Figure 3.4: Route of efferent lymphatic from prescapular lymph node of cattle on the
right side.
(Figures adapted from "Sisson and Grossman's The Anatomy of domestic Animals"
Vol. 1, editor R. Getty, W.B. Saunders Co., 1975).
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Figure 3.5: Cannulation of efferent lymphatic of prescapular lymph node.
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About 2 cm of the duct was exposed but not separated from the fat on which
it rests. A braided silk tie was made at the lower end of the exposed vessel, pulled
tight and anchored with a haemostat. The vessel then filled up and was easier to see.
A further tie was positioned about 1.5 cm nearer the node and the first throw was
made but was not pulled tight. The heparin impregnated tubing immersed in alcohol
was rinsed with sterile PBS and passed s/c under the skin from the incision site to
approximately middle of the neck using a disposable catheter passer (Codman) by
making an incision to exteriorise the catheter. The cannula at the lymphatic end was
cut at 45° and positioned for introduction into the vessel. The lymphatic duct was then
nicked using spring scissors (size 15 cm, Interfocus Ltd.) and a lachrymal probe
(Arnolds Vet Products) of appropriate size inserted into the duct towards the node.
If valves were encountered, attempts were made to break these down with the probe
for providing at least 1 cm of free vessel above the top tie. The cannula was inserted
into the vessel gently up to the valve and then withdrawn slightly to keep it clear of
the valve and the top knot tied tight. The flow of lymph through the cannula was
checked. Fluid level should fall by lifting the free end of the cannula as the fluid
presses back against the valve. When the cannula is dropped below the incision site
lymph should flow. The cannula was slightly repositioned if it was not flowing well.
It was further secured using the original occluding tie. In addition a half hitch of
braided silk was tied round the cannula as it emerged from the muscle and attached
to the subcutaneous fascia.
The wound was repaired by using continuous sutures (mersilk 2/0 size, W193,
Ethicon) for the muscle layer and mattress sutures (Supramid, 4 metric, B. Braun
Melsungen AG) for the skin. The point where the cannula exited the skin, was
secured with a purse string suture. A small piece of adhesive insulation tape (about
5 cm) was stuck to the cannula at the point where it came out of the skin and stuck
back on itself to provide a tag which was sutured to the skin and served as an anchor
to the cannula.
3.5.5 Post-operative procedures
An indwelling jugular cannula was inserted and secured for infusion of lymph
back into the animal to avoid loss of fluid, electrolytes and proteins, so as not to
interfere in the development of immune responses and for simplifying blood sampling
during the course of experiments. A plastic collar was placed around the animals neck
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onto which a plastic bottle for collection of the lymph was tied. The collar, bottle and
the cannulae were covered with an expanding netting (No. 6, Surgifix, manufactured
by FRA, Italy; supplied by Vet Drug Co.) anchored distally to a surcingle. The
animal was moved to the recovery area and allowed to recover. An injection of long
acting penicillin (Duphapen LA, Solvey duphar Veterinary) was given via a deep
intramuscular (i/m) route to avoid any secondary infection. Once the animal regained
consiousness, a sterile bottle was attached to the collar for collection of lymph as
shown in fig 3.6. Heparin (Leo laboratories ltd.) to provide 10 i.u. per ml and
antibiotics (Gibco BRL) to provide penicillin 20 i.u. and streptomycin 20 /xg per ml
based on filled volume were added in the bottle before use.
3.5.6 Monitoring of animals after cannulation
The bottle for lymph collection was changed 2-4 times a day depending upon
the rate of flow of lymph. The size of the bottle to be attached was decided based on
the rate of lymph flow and size of the animal. The volume of lymph collected was
measured with every bottle change and used to calculate the hourly flow rate. A small
sample was taken for cell count using trypan blue exclusion and a Neubauer
haemocytometer. The lymph was collected for one hr every morning for use in
various studies. Remaining lymph was pooled aseptically in 500 ml bottles and
infused back slowly into the animal through the jugular cannula. The jugular cannula
was flushed at least twice a day with heparinised saline (500 ml pack of sterile 0.9%
Sodium Chloride intravenous infusion BP (Baxter Health Care Ltd.) containing
10,000 i.u. of heparin} to prevent clotting. The same cannula was used for collecting
blood samples as and when required.
3.6 Clinical observations on infected cattle
Animal experimentation included skin grafting, efferent lymph cannulation,
infection by subcutaneous inoculation in the prescapular area with either T. annulata
macroschizont infected cells or cryopreserved sporozoites. Details of these
experiments are given in the appropriate chapters. Observations on clinical,
parasitological and haematological parameters were undertaken throughout the
experiments.
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Figure 3.6: Position of cannula and collecting bottle on the animal.
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3.6.1 Clinical parameters
Rectal temp, was recorded daily after efferent cannulation and cell line or
sporozoite inoculation, and >39.5°C was considered a febrile response. The general
state of the animals, enlargement of the lymph nodes and colour of mucous
membranes were also recorded.
3.6.2 Haematological parameters
Venous blood was collected in 2 ml vacutainers containing disodium EDTA
(Becton Dickinson) for haematological examinations. Packed cell volumes (PCV),
total erythrocyte counts (TEC) and total leucocyte counts (TLC) were routinely
measured usually twice a week after cell line immunisation and sporozoite
inoculation. PCV was estimated by a microhaematocrit technique. Blood was drawn
in microcapillary tubes, one end was sealed with plasticine and the capillaries were
centrifuged at 12,000 rpm for 15 min. in a microhaemotocrit centrifuge (Biofuge,
Heraeus Sepatech). PCV was determined using a microhaematocrit reader. TEC and
TLC were measured using a coulter counter (Coulter ZBI electronic particle counter,
Coulter Electronics Ltd). Blood smears were prepared on glass slides, fixed with
methanol and stained with Giemsa stain. These smears were used for differential
leucocyte counting (DLC). A total of 200 cells were counted to calculate percent
neutrophils, eosinophils, basophils, lymphocytes and monocytes in the blood.
3.6.3 Parasitological parameters
Both blood and lymph node smears were examined for evidence of the parasite
in experimentally infected cattle after cell line immunisation and sporozoite
inoculation. Thin blood smears were prepared by spreading a small drop of freshly
obtained venous blood onto a clear glass slide, using the edge of a second slide,
followed by rapid air drying. Lymph node smears were prepared from needle biopsies
of infected nodes. This involved insertion of a 20G sterile disposable needle into the
lymph nodes where it was rotated several times and withdrawn following closure of
the syringe attachment part of the needle with a finger or thumb. The material within
the needle was then transferred onto a clean glass slide and was spread and dried as
described above for the blood smear. The smears were fixed in methanol for 5 min.
and stained with Giemsa stain (1:10 dilution in Gurr buffer) for 40 min. The slides
were then rinsed in Gurr buffer and dried prior to microscopic examination.
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3.7 Serological observations
Sera samples were collected at weekly intervals from animals after inoculation
of uninfected leucocytes, skin grafting, cell line immunisation and sporozoite
inoculation and were used to determine humoral antibody responses. Antibody titres
against allogeneic MHC antigens after inoculation of uninfected leucocytes, skin
grafting and cell line immunisation were measured by microlymphocytotoxicity as
described above for BoLA typing (3.2.3) except that serial dilutions of unknown sera
were added in Terasaki plates and tested against PBM of known BoLA types (Kachani
& Spooner, 1992). Antibody titres against T. annulata were measured by an indirect
fluorescent antibody test as described below.
3.7.1 The indirect fluorescent antibody test (IFAT)
IFAT was carried out to detect levels of anti-macroschizont or anti-piroplasm
antibodies in sera taken from cattle before and after inoculation of T. annulata
infected cell lines and sporozoite challenge using the method described by Burridge
and Kimber (1972). Macroschizont antigens were prepared from a T. annulata (Gharb)
cell line propagated in vitro as described by Burridge and Kimber (1972). Briefly, the
cells were washed twice in sterile PBS and once in PBS supplemented with 1 % BPA.
The cell pellet was resuspended in three times its volume of PBS/BPA. Multiwell
glass slides (Flow Laboratories) were coated with this cell suspension by applying 20
111 to each well and then immediately removing it, leaving a thin film of cells on the
slide. The slides were quickly dried and fixed in acetone (BDFI) for 15 min., air dried
and stored at -20°C until used.
Piroplasm antigen was prepared according to the method of Burridge (1971).
Briefly, 5 ml venous blood was collected from a calf infected with T. annulata
(Ankara) showing 20% parasitaemia into a bottle already containing 150-200 ml
sterile chilled PBS. It was centrifuged at 400g for 10 min. at 4°C. The supernatant
and buffy coat were discarded, the erythrocyte pellet was resuspended again in 100
ml PBS and centrifuged as above. The supernate was discarded, pellet was
resuspended in 5 ml of 1 % BPA in PBS and spun again as above. Finally the pellet
was resuspended in 2 volumes of 1 % BPA in PBS to 1 volume of erythrocytes. Thin
blood smear slides were prepared, air dried and fixed in acetone (BDH). The antigen
slides were stored at -20°C until used.
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For the test, antigen slides were removed from -20°C and held at 4°C for 30
min. and then at room temp, for a further 30 min. The requisite number of wells
were drawn on the piroplasm antigen slides with a diamond pencil. Schizont antigen
slides were rinsed three times and piroplasm antigen slides four times in PBS and air
dried. Meanwhile four fold dilutions of the sera to be tested were prepared in PBS.
The antigen slides were placed in a humidity chamber. Samples (5/xl) were pipetted
onto designated wells on the antigen slides and incubated for 30 min. at room temp.
The slides were washed three times in PBS and dried. A drop of fluorescein
isothiocynate (FITC) labelled rabbit anti-bovine (RAB) IgG (whole molecule)
conjugate (Nordic) at 1:80 dilution was applied to each well on the slides and
incubated for a further 30 min. in the dark. These were washed x3 with PBS and
dried. The slides were mounted using a 66% solution of glycerol (BDH) in Tris
(BDH) buffer and examined under an ultraviolet epi-illuminated fluorescent
microscope (Ortholux II, Leitz) using a 64x oil immersion objective. The highest
dilution of the test sera producing a positive fluorescence was recorded.
3.8 Phenotypic analysis of PBM and ELL using flow cytometry
Flow cytometry is an analytical technique which permits accurate quantitation
of various parameters of individual cells (size, complexity and fluorescence) in a
population of continuously flowing fluorochrome labelled cells. In this work, flow
cytometric analysis was performed with a FACScan (Becton Dickinson, Mountain
View, CA, U.S.A.). The equipment has a single argon laser which produces a beam
of 488 nm wavelength. As the cell passes through the focussed laser beam, it scatters
laser light and the fluorescent molecules on its surface are excited to fluoresce. A
forward light scatter (FSC) detector collects light at relatively small angles and
converts it to an electronic signal which is directly proportional to size of the cell.
Signals collected at large angles (90°) gives information on fine internal structure and
granularity and termed as side scatter (SSC). Fluorochrome bound to the cell surface
absorbs the laser light and emits a light of longer wavelenght. FITC emits light at 530
nm and phycoerythrin (PE) at 580 nm. Fluorescent light is collected by a lens and the
different colours produced by different dyes are directed to separate photomultiplier
(PMT) detectors. Data on these parameters can be stored and analysed in a computer.
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3.8.1 Bovine leucocyte specific monoclonal antibodies
Monoclonal antibodies which react with distinct bovine leucocyte sub-
populations were used in this study. The putative specificities of these antibodies,
characterised by their cellular distribution and function within the bovine immune
system have been tested in two international bovine leucocyte antigen workshops
(Howard et al., 1991a; Howard and Naessens, 1993). A summary of the mAbs and
the cell surface markers they detect is given in table 3.2.
Table 3.2: List of monoclonal antibodies used in this study.
mAb Isotype Specificity Working dilution
IL-A19 IgG2a MHC class I 1:1000
IL-A12 IgG2a CD4 1:1000
IL-A51 IgG> CD8 1:500
SBU-T8 IgG2a CD8 1:1000
IL-A26 IgM CD2 1:1000
MM1A IgGj CD3 1:100
IL-A29 IgGi y<5 T cells 1:1000
CC 15 IgG, 76 T cells 1:1000
IL-A111 IgGi CD25 1:1000
CC 76 IgGi CD 45RB 1:2000
VPM-30 IgM Pan B cells 1:1000
IL-A30 IgGi Surface IgM 1:1000
IL-A24 IgGi Macrophages 1:1000
IL-A109 IgM Monocytes 1:1500
Jll IgGi MHC class II 1:1000
IL-A21 IgG2a MHC class II 1:1500
The mAb IL-A19 is specific for MHC class I antigens on cell surface (Bensaid
et al., 1989), therefore this mAb was used as a positive control in all tests because
all viable cells should express MHC I on the cell surface. The mAb IL-A12 identifies
a distinct subpopulation ofT lymphocytes, bearing the bovine CD4 molecule (Baldwin
et al., 1986; Teale et al., 1986). The mabs IL-A51 (Ellis et al., 1986) and SBU-T8
(Maddox et al., 1985) recognise bovine CD8. The mAb IL-A26 is specific for bovine
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CD2 (Baldwin et al., 1988b) and mAb MM1A recognises bovine CD3 (Davis et al.,
1993). WC1+ 76 T cells are recognised by mAbs IL-A29 (Morrison et al., 1988) and
CC 15 (Clevers et al., 1990). The mAb IL-A111 is a marker for the a chain of the
interleukin-2 receptor (IL-2Ra) also known as bovine CD 25 (Tac antigen) on the cell
surface (Naessens et al., 1992). The mAb CC 76 binds to the CD45RB molecule on
the cell surface (Howard et al., 1991b). Bovine B cells expressing IgM on the surface
are recognised by mAb IL-A30 (Naessens etal., 1988). The mAb VPM 30 is specific
for B cells (J. Hopkins, pers. comm.; Naessens & Howard, 1991). The mAb IL-A24
recognises a molecule present on bovine monocytes/macrophages associated with
antigen presentation (Ellis et al., 1988). The mAb IL-A109 is thought to recognise
an antigen analogous to CD64 (FcRl) on monocytes and macrophages (MacHugh et
al., 1990). The mAb Jll and IL-A21 recognise a monomorphic determinant on
bovine MHC class II molecules (Baldwin et al., 1988c). All mAbs were titrated for
optimal working dilutions before use.
3.8.2 Immunoconjugates
A list of various immunoconjugates used as secondary antibodies is given in
table 3.3. All conjugates were titrated before use to assess their optimal working
dilution.
Table 3.3: Secondary immunoconjugates.
Antibody Conjugated dye Specificity Working dilution
Rabbit anti-mouse Ig (Nordic) FITC Polyvalent 1:100
Goat anti-mouse Ig (Sigma) FITC IgM 1:100
Goat anti-mouse Ig (Sigma) PE IgG 1:100
Goat anti-mouse Ig (Seralab) FITC IgGi 1:200
Goat anti-mouse Ig (Seralab) PE IgG2a 1:250
3.8.3 Protocols for Indirect immunofluorescence staining
An indirect immunofluorescence test was used to stain cells for analysis on the
FACScan essentially as described by Spooner et al. (1988) and Glass & Spooner
(1989). For single colour analysis, 5xl05 cells in 50 /jl\ of FACS medium (RPMI
1640 with 25 mM Hepes and 5% 7 globulin-free horse serum, (Gibco BRL) and
0.1% sodium azide (Sigma)} were mixed with 50 yu.1 of the mAb at a predetermined
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optimal dilution and incubated for 30 min. at 4°C on ice in a 96 well round-bottomed
culture plate (Nunc). The cells were washed twice in cell wash (Becton Dickinson)
by repeated suspension and centrifugation for three min. at lOOg at 4°C. Supernatant
was removed, 25 /d of FITC conjugated rabbit anti-mouse (RAM) Ig (whole
molecule, Nordic) at a dilution of 1:100 in FACS medium was added to each well,
and the test plate was incubated for 30 min. on ice at 4°C. Plates were covered with
tin foil to keep the cells in dark. The cells were washed three times in cell wash as
described above and finally resuspended in 100 /d cell wash and either analysed
within 3 hrs or stored in the dark at 4°C. The cells were preserved by addition of 100
;ul of 1 % paraformaldehyde (Sigma) solution in cell wash to each well. The stored
cells were analysed within 2 weeks. A negative control sample was included which
comprised either cells in medium with no mAb or 50 /d of normal mouse serum
(NMS, Seralab) at 1:500 dilution in place ofmAb for the first incubation. The second
incubation was with the same fluorochrome as used for staining positive cells.
For two colour flow cytometry, cells were dispensed as above and incubated
simultaneously with 25 /d each of two mAbs of different isotypes at half of their
working dilution. Incubation and washings were done as explained above for single
colour staining. This was followed by simultaneous incubation with 25 /d of two
appropriate secondary fluorescent reagents, at working dilutions, depending upon the
isotypes of primary antibodies. These were two of: l.Goat anti-mouse (GAM) IgM-
FITC (Sigma); 2.GAM IgG-PE (Sigma); 3.GAM IgGrFITC (Seralab); 4.GAM IgG2a-
PE (Seralab). One conjugate was FITC for green fluorescence and the second was PE
for red fluorescence.
3.8.4 Flow cytometry acquisition and analysis
The "lysys II" programme (Becton Dickinson) was used in the acquisition and
storage of both the single and two colour flow cytometric parameters of the labelled
cells. The "lysys II" and "PC lysys" programmes (Becton Dickinson) were used for
analysis of the data.
For single colour parameters, the cytometer configurations were calibrated and
set using negative control cells stained with NMS and the appropriate
immunoconjugates. FITC fluorescence (530 nm) emission was detected with the PMT
voltage set at 600-620 mV (FL1, 1024 channels) as logarithmic (log) amplification
scale. FSC and SSC (90°) amplifications were linear and set at EOO (unamplified)
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and 400mV, respectively. Using a FSC versus SSC dot plot, lymphocytes were live
gated for acquisition and analysis while cell debris, dead cells and RBC were
excluded (fig. 3.7a & 3.7b). There were no granulocytes in these cell preparations
as the cells were separated on a density gradient (lymphoprep, S.G. 1077) before
staining. For acquisition, cell samples were run at approximately 500 cells per second
(sec.) and normally data on 5,000 or 10,000 cells were recorded. Data was plotted
either as frequency histograms with log fluorescent intensity presented on the x-axis
and frequency of cell numbers presented on the y-axis (fig. 3.7c) or as dot plots with
log fluorescent intensity presented on the x-axis and FSC on the y-axis (fig. 3.7d).
For two colour parameters, the cytometer configurations were calibrated and
set as described above using the negative control cells stained with NMS and
appropriate secondary conjugates. The cells were live gated by using a dot plot of
FSC verses SSC. The optimum FITC (FL1) and PE (FL2) levels were adjusted to
bring the cells to the lower left corner of the box (fig. 3.8a). These optimal PMT
voltages were found to be 600-620 mV and 520-540 mV for FL1 and FL2,
respectively and both were in the log amplification using 1024 channels.
To compensate for the unwanted spectral overlap of emitted light from the
FITC and PE dyes used (fig. 3.8b), the FLl-% FL2 PMT voltage was set between
0.5-1.5% to remove PE signal from FL1 region, and the FL2-% FL1 PMT voltage
was set between 30-50% to remove FITC signal from the FL2 region. These settings
were done for every test with cells stained with only one primary mAb but both
secondary conjugates. Sometimes these settings were slightly different for different
mAbs and, therefore, changed accordingly between samples. The data was analysed
using dot plots with log FL1 (FITC) intensity on the x-axis and log FL2 (PE)
intensity on the y-axis. For statistical analysis, the dot plots were set into 4
calculation regions by setting quadrant markers (fig. 3.8c). Figure 3.8c represents a
B cells FITC (FL1) versus CD4 PE (FL2) plot in which quadrant 1 represents CD4
positive cells only, quadrant 2 represents CD4/B cells dual positives, quadrant 3 is
the negative population for both primary antibodies while quadrant 4 is the B cells.
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Figure 3.7: Flow cytometry display of cells for live gating during acquisition using
forward and side scatter (FSC vs SSC).
a: Dot plot display (ungated) of a negative control sample showing the distribution
of various cellular components of blood based on their physical characteristics,
b: Exclusion of dead cells and RBC by live gating during acquisition,
c: Frequency histogram of live gated cells.
d: Dot plot display of live gated cells with log fluorescence on x- axis and FSC on
y-axis.
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Figure 3.8: Flow cytometry display of cells for two colour analysis,
a: Dot plot display of the negative control sample adjusted for optimal FITC and PE
voltage levels
b: Figure showing spectral overlap from emmision of FITC and PE. (Adapted from
the working manual of the FACScan, Becton Dickinson),
c: Two colour immunofluorescence dot plot display of cells stained for B cell
antibody (FL1) and CD4 antibody (FL2). quadrant 1: CD4+ cells, 2: CD4+ B
cells (double positive), 3: double negative (CD4- Bcells), 4: B cells.
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3.9 Cytotoxicity Assay:
A standard 4 hr chromium release assay was used to assess cytotoxic activity
of effector cells using the technique previously described in detail by Teale et al.
(1985); Spooner et al., 1987 and Innes et al.(1989a).
3.9.1 Effector cells
Cytotoxic activity of ELL and PBM from the animals was assayed at regular
intervals after cell line immunisation and sporozoite inoculation. The cells were
prepared by centrifugation of blood or efferent lymph on ficoll-hypaque as described
above. ELL and PBM stimulated for 5 days with irradiated autologous T. annulata
infected cells or infected donor immunising cells were also used as effector cells in
some experiments. The effector cells were finally resuspended in TC medium. The
FCS used in the medium was from a batch that had previously been screened to give
low levels of spontaneous 51Cr release from the target cells.
3.9.2 Target cells
Both T. annulata infected target cells and uninfected blasts in exponential
growth phase were chosen for use as target cells. The cells were washed once in TC
medium by centrifugation at 300g for 10 min. and resuspended in the same medium
at a concentration of 2xl07 cells per ml. An equal volume of 51Cr at a concentration
of 1 mCi per ml in TC medium (as sodium chromate, Amersham International Ltd.)
was added to each target cell suspension. The cells were incubated for 60 min. at
37°C and mixed gently a few times during incubation. Following incubation the
labelled cells were washed three times in TC medium (300g for 5 min.), after which
they were resuspended to give a final cell concentration (based on prelabelling counts)
of 1x10® cells per ml. The cytotoxicity assay was performed by adding 25/j.l (2.5 x
104 cells) of the labelled target cell suspension to 100 pi of effector cell suspension
in 96-well round-bottomed tissue culture plates (Intermed, Nunc) in duplicate. The
concentration of effector cells was varied to give different effector:target ratios i.e 1
xlO7 cells per ml for a 40:1 ratio, 5 x 106 cells per ml for 20:1 ratio, 2.5 x 106 cells
per ml for 10:1 ratio and so on. The test plates were incubated for 4 hrs in a 5 % C02
incubator at 37°C. The contents of each well were individually mixed followed by
centrifugation at 170g for 5 min. A 25 p\ of the supernatant from each well was
removed and placed in a disposable 96 well assay plate (Falcon). 100 p 1 of scintillant
(Optiphase safe, LKB Scintillation products) was added to each well. The plates were
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sealed with a plate seal (Wallac) and counted in a scintilation counter (Microbeta,
Wallac). The percentage cytotoxicity was calculated as:
Test release-Spontaneous release
Specific cell lysis (%) = x 100.
Maximum release-Spontaneous release
Spontaneous release of 51Cr from the target cells was measured by incubating
25 fx 1 of target cells with 100 of assay medium alone and maximum release was
evaluated by mixing 25 j«l of target cells with 100 /xl of 1 % sodium dodecyl sulphate
(SDS, Sigma) solution for lysis of all the cells. The spontaneous and maximum
release controls were carried out in triplicate wells.
3.10 Proliferation assays
These were performed essentially as described by Glass and Spooner (1990a).
Briefly, ELL or PBM (1 x 105/well in 50 p\) were used as responders and stimulated
by the following (100 /xl) in quadriplicate wells: a. Con. A at 4 /xg/ml; b. Human
recombinant IL-2 (Boehringer Manheim) at 40 i.u./ ml; c. irradiated autologous T.
annulata infected cells (lxl04/well); d. irradiated T. annulata infected immunising
cells (lxl04/well). Irradiated autologous PBM (1x10s /well in 50 /jl\) were added to
provide the antigen presenting cells. PBM were irradiated at 5000 rads, whereas T.
annulata infected cells were irradiated at 7500 rads. The responder cells with
irradiated PBM alone were used as negative control to see baseline proliferation
without any stimuli. The test was performed in 96 well flat bottom plates (Inter med,
Nunc) in a final volume of 200 /xl per well. Cell proliferation was measured after 72
hr of incubation at 37°C in a C02 incubator. The cells were labelled with [3H]
thymidine (Amersham International, Amersham) for 6 hr and harvested onto a glass
fibre filter paper (Wallac) using a cell harvester (Inotech AG). The filters were dried,
sealed in plastic bags with 3 ml of scintillant (Optiphase safe, LKB Scintillation
products) and counted using a liquid scintillation counter (Microbeta, Wallac).
3.11 Interferon-y assay
For estimation of IFN-y in the efferent lymph, an aliquot of fresh lymph
collected in the morning was centrifuged at 800g for 15 min., cell-free supernate was
decanted and stored at -20°C. A solid phase sandwich ELISA using mAbs specific for
bovine IFN-y was used (Wood et al., 1990; Rothel et al., 1990) to measure levels
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of IFN-7 in the lymph plasma using a ready made test kit (CSIRO, Australia). The
frozen lymph supernates were thawed and brought to room temperature. All the
necessary reagents and procedures were provided with the kit. A known positive and
negative sample was included in each plate. The plates were read in an ELISA reader
(MR 700 Microplate reader, Dynatech) at 450 nm within 20 min. after adding the
final solution to stop the enzyme substrate reaction. Serial two fold dilutions of
recombinant bovine IFN-7 (Ciba Giegy; a gift from Dr. R.A. Collins, Institute of
Animal Health, Compton) were used to plot a standard curve for estimating the
biologically active IFN-7 in the lymph samples. Each sample was tested in duplicate
and the mean O.D. was used to calculate the ammount of IFN-7. The samples
showing very high levels of IFN-7 were diluted with PBS to get an O.D. within the
range of the standard curve.
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CHAPTER 4
The effect of anti MHC immune responses on cell line
immunisation against Theileria annulata
Objectives:
1. To study the feasibility of reimmunisation against T. annulata with the cell
line used for primary immunisation.
2. To investigate the effect of a previously generated allogeneic immune
response on immunisation against T. annulata with schizont infected cell lines.
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4.1 INTRODUCTION
Theileria annulata or T. parva infected cells can be cultured in vitro either
from the tissues of infected animals (Tsur, 1945; Tsur & Adler, 1962) or by in vitro
infection of bovine lymphocytes with sporozoites (Brown etal., 1973; Brown, 1983).
Continuously growing T. annulata infected cell lines have been successfully used as
live vaccines in endemic areas of various countries (Hashemi-Fesharki & Shad-Del,
1973; Wenshun et al., 1975; Pipano, 1977; Ozkoc & Pipano, 1981; Stepanova &
Zablotsky, 1989; Singh, 1992). A cell line vaccine introduces parasites to the
recipient animal in the context of a foreign graft. Therefore, histoincompatibility
between the cell line and the recipient may influence successful establishment of the
parasite within the recipient, which is important for the development of protective
immunity (Brown et al., 1978a; Emery et al., 1982; Innes et al., 1989a). One of the
major differences between T. annulata and the closely related parasite T. parva, is
that it is easier to infect and immunise animals with T. annulata than with T. parva
infected cell lines.
Initial attempts to immunise cattle with T. parva infected cell lines produced
varying results [Brown et al., 1964 (unpublished) reported in Wilde, 1967], It was
later found that 108 cells were needed to immunise cattle reproducibly. However,
some animals suffered from the disease after cell line immunisation and some others
were not protected on sporozoite challenge (Brown et al., 1971; Cunningham, 1977;
Wilde, 1977; Brown et al., 1978a). The cell lines infected with both parasites express
BoLA phenotypes identical to those of the animal from whose lymphocytes they are
derived (Spooner & Brown, 1980). It was proposed that different pathogenic
responses observed in animals after inoculation of T. parva infected cell lines were
caused by a graft rejection phenomenon (Spooner, 1979). This hypothesis was tested
by Teale (1983) in Kenya. Cattle inoculated with 103 or 105 T. parva infected MHC
class I matched cells were successfully immunised against subsequent challenge.
However, animals inoculated with similar doses of MHC class I mismatched T. parva
infected cells were not protected against challenge (Teale, 1983; Dolan et al., 1984b).
About 107-108 T. parva infected cells were needed if they were allogeneic (Brown et
al., 1978a; Brown, 1981; Emery etal., 1982).
On the other hand, animals were successfully immunised against T. annulata
by inoculation of 104 to 10s allogeneic infected cells (Pipano & Tsur, 1966; Ozkoc
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& Pipano, 1981; Hashemi-Fesharki, 1988; Sharma, 1989) and later with as few as
102 (Ouhelli et al., 1989) or even 10' (Brown, 1990) cells. Extensive field uses of T.
annulata cell line vaccines in different countries also suggested that graft rejection
was not a problem with T. annulata and was formally demonstrated by Innes et al.
(1989c). Inoculation of cattle with an allogeneic T. annulata cell line produces a
strong cytotoxic T cell response (Innes et al., 1989a) and complement fixing
antibodies (Kachani and Spooner, 1992) against the MHC antigens of the immunising
cell line, followed by the development of an antiparasite immune response (Innes et
al., 1989a; Kachani etal., 1992b). The histocompatibility barrier does not jeopardise
infection and primary immunisation against T. annulata as it does with T. parva.
The duration of immunity after cell line immunisation is poorly defined. There
is evidence that immunity wanes (Pipano, 1977; Brocklesby, 1978; Ouhelli et al.,
1994), particularly in the absence of natural tick challenge in the field. Thus there
may be a need to boost immunity. In Turkey, routine reimmunisation with the same
cell line used for the initial immunisation is being done (M. Gunay, pers. comm.).
However, there is no information on whether it is necessary or effective. Some
evidence from Morocco and Israel suggests that reimmunisation with the same cell
line may not be effective (Pipano, 1978; Ouhelli et al., 1994). In an experiment in
Morocco, animals inoculated with lxlO4 allogeneic T. annulata infected cells were
immune on challenge one month after the immunisation, but some animals challenged
six months after immunisation were not immune. Another group of animals
immunised with lxlO4 cells, reimmunised with lxlO6 cells from the same cell line
after seven months and challenged one month later showed mixed reactions from
complete susceptibility to mild disease (Ouhelli et al., 1994). This experiment
indicated that an anti MHC immune response, generated after first vaccination, might
be interfering in the development of immunity at the time of second vaccination with
the same cell line. However, another factor influencing this particular experiment was
that animals were poorly fed during the trial. It is not known whether a pre-existing
allogeneic immune response, produced after first cell line immunisation, would
interfere in the parasite transfer and development of immunity against the parasite,
if the animal is reimmunised with the same cell line vaccine.
Setting up an experiment where animals are immunised with a cell line vaccine
and then left in a T. annulata free area for many months or several years until
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immunity wanes is clearly very costly, time consuming and logistically difficult. We,
therefore, tried to devise a model to address this question over a shorter period of
time scale. An allograft response was generated by leucocyte inoculation or skin
grafting. It has been shown previously that cell line inoculation produces a similar
allogeneic response to that produced by inoculation of uninfected leucocytes or skin
implantation (Kachani & Spooner, 1992). We then asked the question whether this
interfered with the generation of immunity to T. annulata, following primary cell line
vaccination, assuming that the first cell line has behaved as a first graft and the cell
line gives the second set response.
4.2 MATERIALS AND METHODS
4.2.1 BoLA typing
All animals and T. annulata infected cell lines isolated from animals after cell
line immunisation were BoLA typed using the microlymphocytotoxicity test described
in chapter 3.2 as per the method of Spooner et al. (1979a).
4.2.2 Cell lines
Theileria annulata cell lines were established in vitro by infection of bovine
PBM with sporozoites and maintained in culture as described in chapter 3.4 using the
method of Brown (1983). Parasite material used was from the Ankara (Schein, 1975)
and the Hissar (Gill et al., 1980) stocks. The cell lines at passage 3 were inoculated
s/c above the left prescapular lymph node in one ml volume at varying cell
concentrations as shown in table 4.1.
4.2.3 Stabilate challenge
The sporozoites used to provide the lethal challenge were prepared as a
stabilate (Cunningham et al., 1973) of H. a. anatolicum ticks, infected with the
Gharb stock of T. annulata (Ouhelli, 1985), as described in chapter 3 (3.4.2.2).
Stabilate material (2 t.e. per ml) equivalent to 1 tick (0.5 ml) was inoculated s/c
above the right prescapular lymph node.
4.2.4 Animals and experimental design
The animals used in this study were Friesians or Friesian x Brown Swiss or
Friesian x Charollais calves aged 3-8 months. The experimental design is shown in
table 4.1 and described below.
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4.2.4.1 Experiment 1
Five susceptible MHC mismatched calves (group 1) were used in this
experiment (Table 4.1a). Two animals (200 & 215) were immunised against MHC
antigens by three s/c inoculations of uninfected BoLA mismatched leucocytes from
a BoLA A10/A11 animal on day 0, 14 and 28. Seven days after the last priming with
uninfected leucocytes, one of the animals was inoculated with a T. annulata (Ankara)
infected cell line derived from the uninfected leucocyte donor animal. The second
animal was inoculated with a T. annulata (Ankara) cell line from another animal with
a different MHC phenotype (A19/A20). Two other animals not primed with
leucocytes were inoculated one with each cell line as immunised controls. The T.
annulata infected cells were injected s/c at lxlO6 per animal. All four animals along
with one control were challenged with T. annulata (Gharb) sporozoites 26 days later.
4.2.4.2 Experiment 2
Six animals were used in this experiment (group 2) and divided into two
subgroups: 2a and 2b (table 4.1b). Animals in group 2a were implanted with skin (x3)
from an MHC mismatched animal (BoLA type, A10/A11), as described by Pringnitz
et al. (1982), to produce an allogeneic immune response. Animals in group 2b were
not skin grafted. All animals in group 2 were immunised with lxlO6 cells from a T.
annulata (Hissar) infected cell line derived from the skin donor animal (BoLA type,
A10/A11). Animal 838 was implanted with skin on day 0, 28 and 49 and immunised
with the cell line 7 days later. Animal 841 was given the skin implants on days 0, 28
and 74 and was immunised 9 days after the last implant. Skin implantations were
done on day 0, 28 and 127 in animal 845 which was immunised 11 days after the last
implant. All six animals were challenged with 1 t.e. T. annulata (Gharb) sporozoites.
The period between the day of immunisation to the day of challenge varied from 28
days to 6 months in these animals because they were also used in efferent lymph
cannulation experiments described in chapter 7.
4.2.4.3 Experiment 3
Six animals (group 3) were divided into two subgroup: 3a and 3b (table 4.1c).
Animals in group 3a were implanted with skin (x3) from the same MHC mismatched
animal (BoLA type, A10/A11) as used in experiment 2 on days 0, 27 and 55.
Animals in group 3b were not skin grafted. All animals were immunised with lxlO4
cells from a T. annulata (Hissar) infected cell line derived from the skin donor
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Tabic 4.1: EXPERIMENTAL DESIGN
a. Experiment 1
Animal no. Priming Immunisation Challenge
Group 1
200 Immunisation with leucocytes TaA (A10/A11), IxlO6 Stabilate (TaG)
from a A10/A11 animal cells per animal, (cell 1.0 t.e./animal
(repeated x3) line from WBC donor)
223 —do— —do—
215 Immunisation with leucocytes TaH (A19/A20), lxlO6 -—do-—
from a A10/A11 animal cells per animal, (cell line





838 Skin grafting from TaH (A10/A11). 1 x 10r> Stabilate (TaG)
a A10/A11 animal cells per animal, (cell 1.0 t.e./animal
(repeated x3) line from skin donor)
841 -—do-— -—do— —do—-







245 Skin grafting from TaH (A10/A11), IxlO4 Stab ilate (TaG)
a A10/A11 animal cells per animal, (cell 1.0 t.e./animal
(repeated x3) line from skin donor)
246 —do— —do— —do—





- No action taken —do— As above
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animal. The immunisation in skin grafted (group 3a) animals was done 5 days after
the last implant. All animals were challenged with T. annulata (Gharb) sporozoites
32 days after cell line immunisation.
4.2.5 Monitoring of animals
The clinical condition of the animals was assessed by observation of their
general condition eg. feeding and by rectal temperature (a febrile response being
>39.5°C). PCV was measured twice a week by micro-haematocrit. Schizonts in
biopsy smears from the draining lymph node and piroplasm in blood smears were
assessed, three times a week by Giemsa stained slides, during the period when
parasitological reactions were expected. Attempts were made to re-isolate parasite
infected cell lines in vitro from lymph node biopsies and PBM after cell line
immunisation at regular intervals.
4.2.6 Serology
Sera were collected weekly from all the animals after generation of allogeneic
responses, cell line immunisation and sporozoite challenge. The level of anti MHC
antibodies was measured as described previously by Kachani & Spooner, (1992) using
microlymphocytotoxicity. Anti-macroschizont and anti-piroplasm antibodies were
determined by IFAT as described by Burridge & Kimber (1972).
Techniques used for clinical monitoring, serology, haematology and re-
isolation of parasite infected cell lines from animals after cell line immunisation and
sporozoite challenge are described in detail in chapter 3.
4.3 RESULTS
4.3.1 Experiment 1
Two animals inoculated with uninfected leucocytes (200 & 215) developed anti
MHC antibodies but exhibited very low titres at the time of cell line immunisation
(table 4.2).
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Table 4.2: Anti MHC antibody titres (reciprocal) after inoculation of leucocytes




7 14** 21 28** 35
200* - - 32 16 8 2
215* - - 16 32 32 8
* Titres of sera against PBM of A10/A11 BoLA type.
** Day of inoculation of uninfected leucocytes.
Clinical reactions of calves after cell line immunisation are shown in fig. 4.1
& 4.2. Animal 200 inoculated with a cell line bearing the same MHC antigens against
which it had already been preimmunised (A10/A11) showed mild fever for a day on
day 7 (fig. 4. la). Very low levels of schizoids in lymph node biopsies and piroplasms
in blood smears could be seen on and after day 17 of cell line immunisation which
always remained less than 1% (fig. 4.1c & 4. Id). Its counterpart animal 223 which
was inoculated with the cell line only also exhibited similar reactions with the only
difference being that fever was seen one day later on day 8 and schizonts were
detected in biopsy smears from day 12 and piroplasms in blood smears from day 14
onwards.
Animal 215 was primed against A10/A11 BoLA types followed by
immunisation with a T. annulata infected cell line of BoLA A19/A20. This animal
also showed similar reactions i.e. fever for a day on day 8, a few schizonts (day 14
onwards) in biopsies and very mild parasitaemia in blood smears which was always
less than 1%. However animal 221 which was inoculated with the cell line only,
suffered from fever for two days initially which reappeared later for three days (fig.
4.1a). The animal exhibited 6% piroplasms in blood and a decrease in haematocrit
from 29 to 20% (fig. 4.1b).
The titre of anti MHC antibodies rose sharply in animal 200 after cell line
immunisation as this animal already had antibodies to MHC antigens of the
immunising cell line. The levels of anti MHC antibodies were similar in all these
animals except animal 221 which had a slightly lower titre (table 4.3).
Cultures of T. annulata infected cells were re-isolated from all the four
animals between day 12-26 after cell line immunisation (table 4.3). BoLA typing of
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a: Rectal temperature (group 1)
DAYS
—■ 200 ♦ 223 6 215 X 221
b: Haematocrit (group 1)
DAYS
Figure 4.1: Clinical reactions in animals of experiment 1 after immunisation,
(a) Rectal temperature. (b) Haematocrit.
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0 4 8 12 16 20 24
DAYS
■ 200 ♦ 223 A 215 X 221
d: Piroplasms (group 1)
10
8
0 4 8 12 16 20 24
DAYS
Figure 4.1: Clinical reactions in animals of experiment 1 after immunisation,
(c) Schizonts in lymph node biopsy. (d) Piroplasms in blood smears.
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these cultures showed that the parasite had transferred from the inoculated donor cell
lines to the cells of the recipients. No cell line of donor origin could be isolated either
from lymph node biopsies or peripheral blood at any stage after cell line
immunisation. The pre-existing anti MHC immune response in animals 200 and 215
seemed to have no effect on parasite transfer which is presumed to be a prerequisite
for the development of immunity following cell line immunisation.
Table 4.3: Anti MHC antibody titres (reciprocal) and re-isolation of parasite
infected cell lines after immunisation in animals of experiment 1.
Animal
no.
Day after cell line immunisation First day of
re-isolation
of cell line1 7 14 21 28 56
200* 2 64 128 32 32 8 17
223* - - 32 128 64 32 12
215** - 2 32 128 128 32 14
221** - - 2 128 64 32 12
209* - - - - - - -
* Titre of sera against PBM of an animal having BoLA type A10/A11.
** Titre of sera against PBM of an animal having BoLA type A19/A20.
When these animals were challenged with sporozoites, the reactions were
again similar in all the four animals (Fig. 4.2a to 4.2d). The animals reacted mildly
and recovered. Maximum piroplasms were always less than 2.5%. However, the
challenge control animal (209) suffered from acute clinical theileriosis. This animal
developed fever for five days, a sharp drop in haematocrit, 23% schizonts in biopsy
smear, 29% piroplasms in blood smear and began to go off its feed by day 12 when
it was treated with buparvaquone (Butalex, Mallincrodt Veterinary Ltd.) as described
by McHardy et al. (1985).
The animals with anti MHC antibodies specific for the vaccine cell line at the
time of immunisation had slightly higher anti parasite antibody titres on cell line
inoculation, but these were similar in all the animals after challenge (table 4.4).
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a: Rectal temperature (group 1)
12 16
DAYS
■ 200 ♦ 223 ^ 215 X 221 O 209
b: Haematocrit (group 1)
DAYS
Figure 4.2: Clinical reactions in animals of experiment 1 after challenge,
(a) Rectal temperature. (b) Haematocrit.
O) Animal no. 209 was treated with buparvaquone on day 12.
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■ 200 ♦ 223 & 215 X 221 -O 209
d: Piroplasms (group 1)
DAYS
Figure 4.2: Clinical reactions in animals of experiment 1 after challenge,
(c) Schizonts in lymph node biopsy. (d) Piroplasms in blood smears.
O) Animal no. 209 was treated with buparvaquone on day 12.
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1 14 26* 40 47 54
200 10 40 640 2560 2560 2560
223 - 40 160 2560 2560 2560
215 10 10 640 640 2560 2560
221 - 10 160 2560 2560 2560





1 14 26* 40 47 54
200 10 40 640 2560 2560 2560
223 10 40 640 2560 2560 2560
215 - 10 640 2560 2560 2560
221 - 640 2560 2560 2560 2560
209** - - - - 40 2560
* Day of sporozoite challenge.
** Treated on day 38.
4.3.2 Experiment 2
The animals in group 2a developed a strong allogeneic immune response after
skin grafting. The anti MHC antibody titres are shown in table 4.5. The response
generated after skin grafting was stronger than the response generated by inoculation
of uninfected leucocytes.
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Day after skin grafting
0 7 14 21 28 35 42 49 56 74 83 127 138
838* _ _ 2 32 128 256 512 1024 512
*
Hoo - - 16 16 32 128 256 512 256 256 512
845* - - 4 16 32 32 64 128 64 32 16 16 64
* Titres of sera against PBM of A10/A11 BoLA type
The skin grafting was done on day 0, 28 & 49 in 838; 0, 28 & 74 in 841 and 0, 28 & 127 in 845.
After cell line immunisation, the animals in group 2a (skin grafted) exhibited
mild fever for a day (fig. 4.3a). Haematocrit values dropped slightly in two animals
(fig. 4.3c). Schizonts were seen in one animal (838) and piroplasms in two animals
(838 & 845). No parasitological reactions were observed in animal 841 (fig. 4.4a &
4.4c). All three animals in group 2b, which were not skin grafted, exhibited very
mild parasitological reactions (fig. 4.4b & 4.4d) after inoculation of lxlO6 T.
annulata infected cells. Haematocrit values dropped in all the three animals. Schizonts
and piroplasms were also seen in all the three animals (fig. 4.4b & 4.4d). The skin
grafted animals had a strong pre-existing allogeneic response at the time of cell line
immunisation. Anti MHC antibody titres increased 2 fold in animal 838, 8 fold in
845, but the titres in 841 decreased (table 4.6). The non skin grafted animals
developed allogeneic antibodies after cell line immunisation.
Parasite infected cell lines were re-isolated easily from all the three non skin
grafted animals of group 2b between day 12-28 after cell line immunisation.
However, cell lines could only be isolated from two of the skin grafted animals (838
& 845) in group 2a between day 17-28. No parasite infected cell line could be
isolated from animal 841 (table 4.6) and it did not show any parasitological reactions.
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Figure4.4:Clinicalrea tionsianim lofxper ment2f erimmu satio .GroupSkingraft dbtskir fted,
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Table 4.6: Anti MHC antibody titres (reciprocal) and re-isolation of parasite




Day after cell line immunisation First day of
re-isolation
of cell line0 7 14 21 28
2a
838* 256 512 256 128 64 17
841* 512 256 256 128 128 none
OO -P-
*
64 256 512 256 256 21
2b
933* _ 4 32 256 128 12
937* _ 8 32 128 128 15
OO - 4 8 128 256 12
* Titre of sera against PBM of an animal having BoLA type A10/A11.
On challenge with sporozoites, all the animals in group 2a (skin grafted)
exhibited fever (fig. 4.5a). Animal 838 suffered from fever for 5 days and 845 for
only 2 days, but both recovered spontaneously. Whereas, animal 841 expressed very
high fever for 6 days, started to go off its feed and was treated with buparvaquone
on day 10. Fever continued for another 7 days after treatment, therefore, a second
dose of buparvaquone was given to this animal on day 17. The animal exhibited 42%
schizonts in the biopsy smear and 10% piroplasms in the blood smear on day 10
before treatment (fig. 4.6a & 4.6c). The other two animals in this group (838 & 845)
only showed very mild parasitaemia and were immune to challenge, which could have
been lethal in animal 841 had it not been treated. The animals in group 2b also
showed only mild reactions on sporozoite challenge and were immune. Only animal
937 expressed fever for 4 days, but recovered spontaneously (fig. 4.5b). This animal
was challenged with sporozoites six months after cell line immunisation. The other
two animals in this group (933 & 859) exhibited no rise in rectal temperature. The
level of parasitaemia was always less than 1% in these animals (fig. 4.6b & 4.6d).
There was a mild drop in haematocrit values in all the animals on challenge except
animal 841 where the drop was very severe (fig. 4.5c & 4.5d).
IFAT for anti parasite antibodies indicated that the animal 841 did not develop
any antibodies after cell line immunisation, whereas all other animals did. The titres








































Figure4.6:Cl nicalreactionsia m lofexperiment2fterch llenge.GroupSkraft d.r2b tskigra t ,
(a&b)Schizontsinlymphodeiopsy.cdP r lasmlo dsmear . O)Animalo.841wastreatedithbuparv quoneond y10f rch lleng .





Day after immunisation Day after challenge
0 14 28 0 13 28
2a
838 - 10 160 160 640 640
841* - 10 10 10 40 2560
845 - - 160 160 640 2560
2b
933 - 10 160 40 640 2560
937 - 10 160 40 160 640




Day after immunisation Day after challenge
1 14 28 0 13 28
2a
838 - - 640 640 640 2560
*
OO - - 10 10 10 2560
845 - - 640 40 640 640
2b
933 - - 160 160 640 640
937 - 10 640 160 160 640
859 - - 2560 640 2560 2560
* Treated on day 10 after challenge.
4.3.2 Experiment 3
Animals in group 3a (skin grafted) developed a strong anti MHC immune
response after skin grafting (table 4.8) similar to those developed in the animals of
group 2a. The allogeneic antibody titres were very high at the time of cell line
immunisation in these animals, whereas there were no antibodies in the animals of
group 3b. The anti MHC antibody titres in these animals at the time of and after cell
line immunisation are shown in table 4.9.
On inoculation of cell line, the skin grafted animals (group 3a) exhibited mild
fever for one day on day 7 or 8 (fig. 4.7a). Haematocrit values dropped very
marginally around day 10 (fig. 4.7c). Naive animals in group 3b (not skin grafted)
also exhibited fever for a day or two and slight drop in haematocrit (fig. 4.7d).
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Schizonts and piroplasms could be detected only in one animal (264). Schizonts were
seen in this animal between day 14-18 (max. 0.5%) and piroplasms from day 15
onwards (max. 0.4%). None of the other animals in this experiment (3 skin grafted
& 2 non skin grafted) exhibited any parasitological reactions.





7 14 21 34 41 48 55** 60
245* - - - 16 128 256 128 512 512 512
246* - - 2 2 16 32 32 128 64 32
249* - - - - 32 64 64 64 32 64
* Titres of sera against PBM of A10/A11 BoLA type
** Day of skin grafting.
Attempts were made to re-isolate parasite infected cell lines from lymph node
biopsies and blood after cell line immunisation of these animals. It was not possible
to isolate any T. annulata infected cell lines from the skin grafted animals in group
3a, whereas, parasite infected cell lines were isolated from all three animals in group
3b (table 4.9). Many cell lines were isolated from animal 264 between day 14-28
after cell line immunisation. Two lines were isolated from animal 250 from PBM
only, on day 14 and 22 after immunisation. Only one line was isolated from animal
273 also from blood on day 20 after immunisation. BoLA typing of these cell lines
revealed that the cell lines originated from the cells of the recipient animal. Titre of
anti MHC antibodies started to rise immediately after cell line immunisation in skin
grafted animals (group 3a). These antibodies began to appear in animals of group 3b
on day 7 and peak titres were seen between day 22-32 (table 4.9).
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Figure4.7:Clinicalrea tionsi anima sofxperiment3f rimmu s tio .Group:Skgraft dbtskir f e ,
(a&b)Rectaltemperature.(dH em ocrit.
d:Haematocrit(Group3b)
Table 4.9: Anti MHC antibody titres (reciprocal) and re-isolation of parasite




Day after cell line immunisation Day# of
re-isolation of
cell line0 7 14 22 28 32 38 59
3a
245* 512 256 512 128 32 32 64 none
246* 32 256 128 512 256 256 128 32 none
249* 64 128 512 128 256 64 64 16 none
3b
250* - 8 64 32 64 64 64 4 18 & 22
(two lines)
264* - 4 16 64 32 128 64 4 14 (many lines)
273* - 4 16 64 64 32 32 20 (one line)
* Titre of sera against PBM of an animal having BoLA type A10/A11.
The IFA titres for anti schizont antibodies were very low in animals of group
3a and one animal in group 3b (maximum 1:40, four weeks after immunisation). The
only animal (264) which showed some parasitological reactions after immunisation
also showed a titre of 1:640 and the other animal in this group 273 showed a titre of
1:160 four weeks after immunisation. The titres of anti-piroplasm antibodies were
very low in all six animals after cell line immunisation (table 4.10).
The three animals in group 3a suffered from acute theileriosis on challenge
(fig. 4.8 & 4.9). Rectal temperatures started to rise from day 6 and were more than
41°C on day 10 in all three animals (fig. 4.8a). Schizonts were seen in lymph node
biopsies from day 5 onwards and ranged from 33-60% on day 10 (fig. 4.9a).
Piroplasms in blood smears were 8-16% on that day (fig. 4.9c). Animal 245 was
humanely killed and animal 246 & 249 were treated with buparvaquone (McHardy
et al., 1985) on day 10.
The animals in group 3b showed mixed clinical reactions on sporozoite
challenge (fig. 4.8 & 4.9). Animal 264 which showed very mild clinical and
parasitological reactions on immunisation was immune to sporozoite challenge. It
suffered from very mild theileriosis and recovered quickly. Animal 250 exhibited high
fever starting from day 6 which continued to rise for 5 days. It then started declining
and returned to normal after three more days (fig. 4.8b). Schizonts were detectable
from day 5 onwards in lymph node biopsy smears and were 16% on day 12, followed





























Figure4.8:Cl nicalreactionsia imalsofexperime t3ftechallenge.G oup:Skgr f ed.boskr ft ,





































Figure4.9:Clinicalreactionsian m lofexper ment3af rchallenge.Gr up2 :Skigrafted.upb:notskingraf ed,
(a&b)Schizontsinlymphodeiopsy,cdP r lasmsibl odsmears.(►)Anim ls246nd9w retr tedith buparvaquoneond y10fterch lleng .(-*•)Animals245a d73w reuth nasedod y10aft rc al nge.
up to 23% on day 20 and then started to decline (fig. 4.9d). The haematocrit fell to
14% by day 25 but then started to rise (fig. 4.8d) indicating that the animal was
partially immune. The third animal in this group 273 suffered from acute disease. The
animal had very high fever which started from day 6. Schizonts were 52% and
piroplasms were 12% on day 10 when it was humanely killed. The symptoms of the
disease in this animal were similar to those in animals of group 3a (skin grafted).






1 14 28 37 44 58
3a
245** 10 10 10 40
246*** - 10 40 160 640 2560
249*** 10 10 40 160 640 2560
3b
250 10 10 40 40 160 2560
264 - 40 640 640 2560 2560





1 14 28 37 44 58
3a 245** 10 - - 10
246*** - - - 160 160 2560
249*** - - - 10 40 640
3b
250 - - 10 10 40 2560
264 - - 10 10 40 640
273** - - 10 40
* The animals were challenged on day 32. ** Euthanased on day 10 after challenge.
*** Treated on day 10 after challenge.
4.4 DISCUSSION
These experiments provided a model where questions about reimmunisation
with allogeneic T. annulata infected cell lines could be addressed in a logistically
possible manner within a short time period. Strong allogeneic antibody responses can
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be generated by skin grafting between BoLA mismatched animals (Spooner et al.,
1978; Spooner et al., 1979a). Inoculation of allogeneic T. annulata infected cell lines
also produces a strong response to MHC antigens of the immunising cell line
comparable to those produced by skin grafting (Kachani & Spooner, 1992). This was
further confirmed in these experiments where non skin grafted animals developed
strong immune responses against allogeneic antigens of the inoculated cell line after
immunisation. Inoculation of T. parva infected allogeneic cell lines also gave rise to
anti-lymphocyte antibodies in inoculated animals (Cowan et al., 1984). However,
precise specificity of these antibodies was not determined. Strong allogeneic immune
responses were produced in animals of group 2a and 3a after skin grafting which
mimicked the response produced after cell line immunisation. Although, inoculation
of uninfected leucocytes only produced mild responses.
No challenge control animals were used in experiments 2 and 3 to test the
potency of stabilate used for challenge. However, very high potency of this batch was
confirmed by severe disease symptoms in some of the animals (animal 841 in group
2a & all in group 3a), which were not protected and had to be treated or killed. Naive
animals in other experiments (chapter 6) inoculated with 0.1 t.e. GUTS (i.e. 1/10th
of the sporozoite concentration used in this experiment) also developed acute disease
and had to be treated with buparvaquone (McHardy et al., 1985) on day 10 or 11
after infection in order to save their lives. The dose of challenge was 1.0 t.e. in these
experiments which was undoubtedly capable of producing potentially lethal infection
in naive animals.
In the first experiment, animals were primed against MHC antigens by
inoculation of allogeneic uninfected leucocytes. Immunisation of these animals with
lxlO6 T. annulata infected cells, of the same or different MHC phenotype, lead to the
development of immunity against potentially lethal sporozoite challenge. The pre¬
existing anti MHC immune response seemed to have no effect on the development of
immunity against the parasite after cell line immunisation, although the day of first
isolation of schizonts was delayed. Cell lines were inoculated immediately after
priming the animal. In the field situations where animals may be reimmunised with
the same cell line vaccine, revaccination would not be carried out for at least one year
in the light of the seasonal occurrence of the disease in endemic areas. The level of
an allogeneic immune response one year after first cell line vaccination may be low
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and comparable to the level of response generated in this experiment.
Keeping in view a weak allogeneic response produced by inoculation of
uninfected leucocytes to cell line immunisation, anti MHC responses were produced
by repeated skin grafting in animals of group 2a and 3a in further experiments
(Spooner et al., 1979a). The animals exhibited a strong response which mimicked the
allograft response produced by inoculation of the cell line. Immunisation of animals
with lxlO6 cells (group 2a), despite the presence of a strong allogeneic response,
produced immunity in 2 out of 3 animals but the third animal suffered from acute
clinical theileriosis on challenge. This animal appeared fully susceptible to challenge
and thus not protected by cell line immunisation. On the other hand, all 3 naive
animals (not skin grafted, group 2b) immunised with the same dose of cells were
immune to challenge. In the third experiment, using T. annulata infected cells at
lxlO4 per animal, the skin grafted animals (group 3a) were not protected from
sporozoite challenge. The animals in group 3b (non-skin grafted) also showed some
reactions on challenge. Two of the three animals were immune. Animal 264
withstood challenge very well, 250 suffered moderately and recovered but animal 273
suffered from acute disease. Animal 273 was not protected by immunisation with 104
infected cells and was killed on day 10. However, there was a clear difference in the
severity of reactions between the two groups. These two experiments clearly indicated
that pre-existing allogeneic response inhibited the development of immunity against
the parasite.
Sporozoite challenge of immunised animals with T. annulata infected cell lines
usually results in mild clinical symptoms and recovery (Pipano, 1981). Animals have
been successfully immunised with as few as 102 infected cells (Ouhelli et al., 1989;
Brown, 1990). Development of clinical disease on sporozoite challenge in animal 273
(group 3a; immunised with 104 cells) was unusual. Although similar reactions were
observed on severe sporozoite challenge in some of the animals inoculated with low
cell doses (Shukla & Sharma, 1991). At least with unattenuated cell lines, most other
reports in the literature suggest that 104 cells engender enough protection against
sporozoite challenge (Ouhelli et al., 1989; Innes et al., 1989c; Brown, 1990; Ouhelli
etal., 1994).
Critical analysis of parasitological reactions showed that appearance of
schizonts and piroplasms was delayed after cell line immunisation in animals with a
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pre-existing allogeneic response in all three groups of animals as compared to their
non skin grafted immunised counterparts. However, all these animals were immune
on sporozoite challenge. In animals where the appearance of schizonts and piroplasms
was totally prevented after cell line immunisation (841 in group 2a & all animals in
group 3a), severe disease ensued after challenge.
All animals showing parasitological reactions after cell line immunisation
irrespective of their group, developed parasite specific antibodies to schizonts.
However, animals in which parasitological reactions were totally prevented after cell
line immunisation (841 in group 2a & all in 3a), showed no increase in IFA titres to
parasite antigens. Parasite specific serological responses after cell line immunisation
may not have any protective value, as passive transfer of immune serum (Sergent et
al., 1945; Dhar & Gautam, 1978; Samad et al., 1984a) or generation of anti-parasite
antibodies by inoculation of killed schizonts (Pipano et al., 1977; Wilde, 1967;
Cunningham, 1977), does not protect against sporozoite challenge. However, parasite
specific antibodies are a good indicator that the animal is recognising the parasite in
the inoculated cell line. Serology has been used to predict whether the animal would
be immune on challenge or not (Pipano & Cahana, 1969; Shukla & Sharma, 1989).
Parasite infected cell lines were re-isolated from all animals in groups 1, 2b
and 3b and only from 2 animals in group 2a (skin grafted) and these animals
exhibited higher anti-macroschizont antibody titres after cell line immunisation.
However, isolation of parasite infected cell lines was delayed in animals with a pre¬
existing allogeneic response as compared to their counterparts. The parasite transfers
from donor cells to the cells of the recipient animal during an effective cell line
immunisation (Pipano, 1977; Brown et al., 1978a; Innes et al., 1989a). All cell lines
isolated were of recipient origin indicating that parasite transferred to the recipient's
cells. No cell line of donor origin was isolated at any stage. No cell line was isolated
from animal 841 or any animal in group 3a (skin grafted) after immunisation. These
animals neither developed anti parasite antibodies nor exhibited any piroplasms in
blood smears. The allogeneic response in the animals of group 3a and one animal in
2a prevented the establishment of the parasite in the recipient's cells on cell line
immunisation and, as a consequence, the animals were fully susceptible on challenge.
The ability to isolate parasite infected cell lines correlated with protection from
sporozoite challenge. Even in the non-skin grafted group 3b where one animal was
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not protected by 104 cells against a very potent sporozoite challenge, only one cell
line was isolated with great difficulty, the number and timing of cell line isolation
correlated with protection.
There is a strong MHC barrier to immunisation against T. parva where
animals can only be immunised with lxlO8 or more allogeneic schizont infected cells
(Pirie et al., 1970; Brown et al., 1971; 1978a). Animals inoculated with lxlO6 T.
parva infected allogeneic cells are infrequently immunised or protected against lethal
sporozoite challenge (Brown, 1981). However, 103-105 T. parva infected cells which
were MHC class I matched with respect to the recipient did immunise animals against
subsequent sporozoite challenge (Teale, 1983; Dolan et al., 1984b). This sort of
barrier does not exist against T. annulata at the time of primary cell line
immunisation, where as little as lxlO2 allogeneic infected cells can immunise an
animal (Ouhelli et al., 1989). The experiments reported in this chapter indicate that
a histoincompatibility barrier boosted artificially, can jeopardise cell line
immunisation against T. annulata as it does with primary T. parva cell line
vaccination. Inoculation of higher cell doses during a second immunisation might be
able to overcome this situation if anti MHC response is not very strong, as indicated
from the experiment 1. Preliminary experiments from Morocco refutes this (Ouhelli
et al., 1994). They used 106 T. annulata infected cells on second inoculation which
did not reimmunise. It is possible that cells in the range of 107-108 would be required
for reimmunisation as are needed for primary immunisation against T. parva.
The relative ease of immunisation using allogeneic cell lines in the case of T.
annulata compared to the difficulties with T. parva is unlikely to be solely as a result
of histoincompatibility, a common element in both cases. It might be because of the
ability of the parasite to transfer and infect recipient's cells subsequent to cell line
immunisation. It is not known how the parasite transfers from an allogeneic cell line
to the recipient's cells. We also do not know the precise mechanism of development
of immunity after primary cell line immunisation. An attempt has been made to study
the kinetics of cellular changes during development of immunity to T. annulata
infection in the following chapters. Kinetics of the parasite dissemination in the
draining efferent lymph has been studied. Further experiments are needed to explain
this. It was demonstrated by karyotypic analysis of infected cells that T. annulata
would transfer from donor cells to the cells of the recipient within hrs of inoculation
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[Hulliger et al., 1965 (unpublished) reported in Wilde, 1967], whereas parasite
transfer with T. parva was very inefficient and could take many days (Brown et al.,
1978a). It is not known whether parasite transfer involves active invasion of host cells
by the schizonts or some form of passive transfer (Innes et al., 1992a). The initial
immune response induced after the inoculation of an allogeneic infected cell line
involves generation of alloreactive cytotoxic T lymphocytes (Innes et al., 1989a) and
anti MHC antibodies (Kachani & Spooner, 1992). Innes et al. (1992a) proposed that
the parasite infected cells are destroyed by these two arms of the immune response
and the debris phagocytosed by macrophages. In vitro infection studies on various
lymphocyte subpopulations suggest that T. annulata preferentially infects and
transforms macrophages/monocytes and B cells but not T cells, whereas T. parva
preferentially transforms T cells and not macrophages (Baldwin et al., 1988a;
Spooner et al., 1989; Innes et al., 1989b; Glass et al., 1989). However, it is not
known which cells are infected in vivo during T. annulata infection or primary cell
line immunisation. Assuming the same cells are infected in vivo as in vitro, one could
postulate that parasite might be phagocytosed by macrophages and infect the
recipient's cells by passive transfer. This type of parasite transfer does not take place
with T. parva as it mainly infects T cells. Therefore, a very high number of
allogeneic infected cells is needed to establish infection and immunise against T.
parva. A precise knowledge of the cells infected after allogeneic cell line
immunisation, with both the parasites, could be very useful in designing future
immunisation regimes.
In the primary immune response to cell line immunisation, the development
of an allogeneic response takes some time and inoculated cells keep on dividing in the
recipient's body. The chances of parasite transfer are consequently high. If the animal
already has experienced an allogeneic response, the infected cells may be destroyed
immediately. The chances of parasite transfer may be reduced because of no time for
the multiplication of infected cells. This hypothesis of parasite transfer needs testing.
Fibroblasts have been infected in vitro by overlaying T. annulata infected cells
(Brown & Gray, 1981), but purified T. annulata or T. parva schizont particles would
not infect other cells in vitro (Innes et al., 1992a) or animals inoculated in vivo
(Pipano et al., 1977; Wilde et al., 1966). The mechanisms of parasite transfer after
cell line immunisation are a topic for future studies.
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From these experiments, it seems that an anti MHC immune response can
interfere with parasite transfer and the development of an anti parasite immune
response following cell line immunisation. If the allogeneic response is strong, it can
block the development of immunity. These observations are of immediate importance
in endemic areas where cell lines of T. annulata schizonts are being used or are
planned to be used as vaccines to control the disease. The anti MHC immune
response, generated in the animals after first immunisation with a cell line, might
interfere with the development of immunity against the parasite if the animals are
reimmunised with the same cell line used for first immunisation. Consequently, it is
not recommended to use the same cell line for repeated reimmunisation to boost the
immunity. Producing a panel of cell lines with different BoLA phenotypes and using
one cell line every year might help in overcoming this problem. Although the effect
of allogeneic response against one BoLA type against the other needs to be studied
in detail before making a firm recommendation.
Similar levels of allograft response prevented parasite transfer and
development of immunity in some animals but not in others. The mechanism of this
interference cannot be interpreted because of lack of knowledge on the cellular
interactions between the parasite and various lymphocyte subpopulations. Little is
known about the mechanism of development of immunity after cell line immunisation
and sporozoite challenge. Further studies in this thesis are concentrated on
understanding the dynamics and activation of various lymphocyte subpopulations and
parasite dissemination in the peripheral blood and efferent lymph, both after cell line
immunisation and sporozoite challenge, in skin grafted and non-skin grafted animals.
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CHAPTER 5
Phenotypic changes in the peripheral blood leucocytes of animals
after T. annulata cell line immunisation and sporozoite challenge
in relation to pre-existing allogeneic responses.
Objectives:
1. To study the effect of cell line immunisation and sporozoite challenge on the
kinetics of various lymphocyte subpopulations of peripheral blood in animals
with or without a pre-existing allogeneic response.
2. To monitor changes in the peripheral blood leucocytes induced by the parasite
leading to leucopenia manifested in the pathogenesis of tropical theileriosis.
122
5.1 INTRODUCTION
Theileria annulata infection causes a serious lymphoproliferative disease in
cattle leading, amongst other things, to severe leucopenia (Sharma & Gautam, 1971;
Laiblin, 1978; Preston et al., 1992a). Previous studies have shown the involvement
of various subpopulations of leucocytes in the pathogenesis and development of
immunity. The parasite preferentially infects and transforms MHC class II+
monocytes and B cells (Spooner et al., 1989; Glass et al., 1989; Campbell et al.,
1994a). Animals, recovering from sporozoite infection or immunised with parasite
infected cell lines, generate a strong cytotoxic T lymphocyte response in the
peripheral blood which is effective in killing autologous schizont infected cells
(Preston et al., 1983; Innes et al., 1989a). Adherent cells isolated from the peripheral
blood exhibit a strong cytostatic effect on macroschizont infected cells via a soluble
factor (Preston & Brown, 1988). All these observations suggest that considerable
alterations of circulating lymphocytes in the peripheral blood are associated with T.
annulata infection. However, the cause of leucopenia and involvement of various
lymphocyte subpopulations are not clearly understood.
Large numbers of lymphocytes continuously enter and exit lymphoid and non-
lymphoid tissues using blood as a traffic route with a mean transit time of
approximately 30 hrs (Westermann & Pabst, 1990). Therefore, analysis of the cell
dynamics and alterations in the various circulating lymphocyte subpopulations could
provide useful information on the involvement of various lymphocyte subsets in the
development of immunity against the parasite.
In the previous chapter (chapter 4), a pre-existing anti MHC response was
shown to prevent development of parasite specific immune responses in some of the
animals after immunisation with a T. annulata infected cell line. Variable
parasitological reactions ranging from acute to subacute and mild forms of the disease
were observed in the animals after sporozoite challenge. We decided to investigate
phenotypic changes in the peripheral blood lymphocytes of these animals to
understand the pathogenesis of T. annulata infection and involvement of various
lymphocyte subsets in the development of immunity. We hoped to find differences
in the response of animals, which became immune after cell line immunisation in the
presence of an existing allogeneic response and those which did not respond to
immunisation, to further elucidate the effect of allogeneic responses on cell line
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immunisation. As T. annulata infection leads to severe leucopenia, an attempt was
made to define the involvement of various leucocyte subpopulations.
5.2 MATERIALS AND METHODS
5.2.1 Animals and experimental design
Peripheral blood leucocytes were monitored from the animals used in the
previous chapter (chapter 4). Two other animals used for lymphatic cannulation
studies and inoculated with T. annulata sporozoites (details in chapter 6) were also
used for these experiments. The different procedures used on these animals are briefly
illustrated in table 5.1, with detail in the relevant chapters.
Table 5.1: EXPERIMENTAL DESIGN
Animal no. Priming Immunisation Challenge
Group la
200 Uninfected leucocytes TaA (lxlO6 cells) Sporozoites
223 —do— —do—-







838 Skin grafted TaH (lxlO6 cells) Sporozoites
841 —do— —do— —do—
845 —do— —do— —do-—
Group 2b




245 Skin grafted TaH (lxlO4 cells) Sporozoites
246 —do— —do— —do—





- No action taken
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5.2.2 Monitoring of animals
The clinical, parasitological and haematological reactions of these animals
were monitored after primary immunisation with a T. annulata infected cell line and
after challenge with sporozoites. The detailed clinical, parasitological and
haematological observations are illustrated in the relevant chapters.
5.2.3 Leucocyte counts
TLC were monitored in all animals at regular intervals. Blood was collected
from the jugular vein in 2 ml vacutainers containing disodium EDTA (Becton
Dickinson) for haematological examinations. Leucocytes were counted using a Coulter
Counter (Coulter ZBI electronic particle counter, Coulter Electronics Ltd.). Thin
blood smears were prepared for differential leucocyte counting on clean glass slides,
fixed with methanol and stained with Giemsa stain. A total of 200 leucocytes were
counted to calculate percent polymorphonuclear cells (neutrophils, eosinophils and
basophils) and mononuclear cells (lymphocytes and monocytes) in the blood. These
figures were used to calculate total circulating polymorphonuclear cells and
mononuclear cells in the periphery.
5.2.4 Peripheral blood mononuclear cells (PBM)
Collection and separation of PBM has been described in detail in chapter 3
(3.4.2.1). Briefly, PBM were separated by centrifugation of blood collected in ACD
on ficoll-hypaque (Lymphoprep). The cells were resuspended in FACS medium for
immunostaining and flow cytometry. Cytospin smears were occasionally prepared
from these cells to check for polymorphonuclear cell contamination which was usually
less than 1 % in the purified population.
5.2.5 Monoclonal antibodies
Various mAbs and immunoconjugates have been described in detail in chapter
3 (3.8.1). The following mAbs were used for analysis of various lymphocyte
subpopulations in this chapter. The mAb IL-A26 for CD2+ cells, IL-A12 for CD4+
cells, IL-A51 or SBU-T8 for CD8+ cells, IL-A29 for WC1+ yd T cells. B cells were
identified by mAb VPM 30, monocytes and macrophages by IL-A24. This mAb
reacts with monocytes, macrophages and granulocytes. Since granulocytes were
removed from peripheral blood by centrifuging on ficoll-hypaque, only monocytes
and macrophages were identified with this mAb. MHC class II molecules were
identified by J 11 or IL-A21, CD25 by IL-A111 and CD45RB molecules by CC 76.
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5.2.6 Immunofluorescent Staining
The technique used for indirect immunofluorescent staining and flow
cytometry has been explained in chapter 3 (3.8). This technique was used to analyze
phenotypic changes in the PBM following primary cell line immunisation and
secondary sporozoite infection.
The results were processed to calculate the percentage of various lymphocyte
subpopulations in the peripheral blood. These, along with total mononuclear cell
counts, were used to calculate the absolute number of various lymphocyte
subpopulations in the peripheral blood.
5.3 RESULTS
5.3.1 Parasitological reactions
The detailed parasitological reactions in the animals used in these experiments
have been described in the relevant chapters (chapter 4 & 6). The brief parasitological
reactions are shown in table 5.2 for reference. All animals in group la exhibited mild
parasitological reactions after cell line immunisation and were immune on sporozoite
challenge. The naive animals in group lb were not immunised with a cell line but
were inoculated only with sporozoites and acted as challenge controls. All these
animals suffered severely from acute theileriosis on sporozoite challenge.
The animals in group 2a were skin grafted to produce an allogeneic response
before immunisation with the cell line. Two animals in this group (838 & 845)
showed mild parasitological reactions after immunisation and were immune on
sporozoite challenge. The third animal (841) did not show any parasitological
reactions on immunisation and suffered from an acute disease after challenge with
sporozoites. All the animals in group 2b reacted mildly after immunisation and were
immune on sporozoite challenge.
The animals in group 3a were also skin grafted. None of these animals showed
any parasitological reactions after immunisation with the cell line and suffered from
acute clinical theileriosis after challenge with sporozoites. In group 3b, only animal
264 exhibited mild reactions after immunisation. No piroplasms were seen in the
smears from the other two animals (250 & 273) in this group after immunisation.
However, a parasite infected cell line of recipient origin was isolated from both the
animals indicating a very mild response to the cell line. Animal 264 was found to be
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immune after sporozoite challenge, animal 250 suffered moderately and recovered but
273 suffered severely. All the animals showing severe disease symptoms were either
treated with buparvaquone (Butalex, Mallinkrodt Veterinary Ltd.) or euthanased as
shown in table 5.2.
























200° 0.5 0.5 mild 0.5 1 mild
223 0 0.8 mild 0.8 1.5 mild
215° 0.5 0.5 mild 0.5 3 mild
221 0.5 6 mild 0 2 mild
lb 209* - - - 25 28 severe
903** - - - 36 10 severe




838 0.3 0.8 mild 0.1 0.3 mild
***
00 0 0 none 43 13 severe
845 0 0.5 very mild 0.3 0.3 mild
2b 859 2.5 1.2 mild 0.2 0.5 mild
933 0.2 0.5 mild 0.5 0.3 mild




245° 0 0 none 31 10 severe
246*** 0 0 none 60 8 severe
249*" 0 0 none 36 12 severe
3b 250 0 0 very mlid 15 23 moderate
264 0.3 0.2 mild 0.6 1 mild
273° 0 0 none 52 12 severe
No action taken. * Treated on day 12.
o Primed with uninfected leucocytes ** Treated on day 11.
n Euthanised on day 10 *** Treated on day 10.
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5.3.2 Total leucocyte counts in the peripheral blood
TLC decreased slightly in most of the animals immediately after cell line
immunisation but returned to normal levels by day 10 (appendix, no. 11). The initial
mild leucopenia was neither related to the dose of cells used for immunisation nor to
the following parasitological reactions in these animals (fig. 5.1). All the skin grafted
animals in group 3a which showed no piroplasms or schizonts after immunisation also
exhibited a mild drop in TLC which quickly returned to normal levels (fig. 5.1e).
However, the drop was less marked and shorter lived in these animals than the ones
showing mild parasitological reactions after immunisation (fig. 5.1a, 5.Id and animal
838 & 845 in fig. 5.1c).
Animals showing severe parasitological reactions after sporozoite challenge [all
animals in group lb (fig. 5.1b), animal 841 in group 2a (fig. 5.1c), all animals in
group 3a (fig. 5.1e) and 273 in group 3b (fig. 5. If)] also exhibited severe leucopenia
(appendix, no. 12). Whereas, the fall in TLC was less severe in other animals which
were immune to sporozoite challenge (group la in fig. 5.1a and group 2b in fig.
5.Id). TLC values started to increase in very sick animals after treatment with
buparvaquone. Leucopenia would have been very severe had these animals not been
treated. The leucopenia corresponded to a decrease in total polymorphonuclear cells
(fig. 5.2) as well as total mononuclear cells (fig. 5.3) in the peripheral blood. The
drop in total mononuclear cells was due to lymphocytopenia and usually not due to
decrease in the number of monocytes.
5.3.3 Changes in the T cell subsets
Initial leucopenia was accompanied by a drop in total CD2+ cells in peripheral
blood of most of the animals after cell line immunisation which quickly returned to
normal. A slight decrease in total circulating CD2+ cells was also seen in the skin
grafted animals which did not show any parasitological reactions after immunisation.
The decline in CD2+ cells in animals showing mild parasitological reactions was
because of a fall in the total circulating CD4+ cells (fig. 5.4) and CD8+ cells (fig.
5.6). Levels of total CD4+ cells returned to normal by day 10 after immunisation in
most of the animals. Animals not showing any parasitological reactions after cell line
immunisation also showed a mild transient drop in circulating CD4 cells (fig. 5.4d
& animal 841 in fig. 5.4b). An increase in total circulating CD8+ cells was seen
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Figure5.3:Dropintotalmononuclearce lountstha imalsft rc llim u is tionndsporozoitech lleng .
after immunisation (all animals in fig. 5.6a & 5.6c, animals 838 & 845 in fig. 5.6b).
The skin grafted animals not showing any parasitological reactions either exhibited
no change or a mild early increase in the total CD8+ cells which returned to normal
levels soon afterwards (animal 841 in fig. 5.6b and all animals in fig. 5.6d). A slight
increase in total circulating y8 T cells was seen in some animals after immunisation
while in others it remained unchanged (data not shown). The levels of circulating y8
T cells were around lxlO3 per cmm in most of the animals.
On challenge with sporozoites, the drop in the circulating CD2+ cells was more
pronounced in animals showing severe parasitological reactions than in animals
immune to challenge. Levels of total CD2+ cells started to return to normal in
animals showing severe disease only after treatment. An initial drop in CD2+ cells
after challenge corresponded to a fall in circulating CD4+ and CD8+ cells. It was
more severe in animals showing acute disease symptoms {all animals in group lb
(fig. 5.5b) & 3a (fig. 5.5e), animal 841 (fig. 5.5c)}. CD4+ cells returned to normal
values very slowly in these animals after treatment. Total circulating CD4+ cells also
dropped slightly in immune animals on sporozoite challenge but soon returned to
normal or near normal levels (fig. 5.5a, 5.5d & animals 838 & 845 in fig. 5.5c). The
number of circulating CD8+ cells initially remained unchanged in immune animals
after sporozoite challenge. This was followed by a profound increase between days
8-18 (fig. 5.7a, 5.7d, animals 838 & 845 in fig. 5.7c and animals 250 & 264 in fig.
5.7f). On the other hand, animals showing acute disease symptoms on sporozoite
challenge exhibited a gradual reduction in circulating CD8+ cells which became more
severe with progression of the disease (fig. 5.7b, animal 841 in fig. 5.7c and animal
273 in fig. 5.7f). These animals later exhibited an increase in total circulating CD8+
cells corresponding to recovery after treatment. There was a slight drop in total
circulating y5 T cells in most of the animals after sporozoite challenge which was
more pronounced in the naive animals undergoing acute disease than in the immune
animals (data not shown).
5.3.4 CD4:CD8 ratios
The ratio of CD4+ vs CD8+ cells was in favour of CD4+ cells in most of the
animals at the time of immunisation with the cell line. It increased in favour of CD4+
cells initially, but fell to unity after day 10 and later below in favour of CD8 cells in





































Figure5.6:TotalCD8+cellsintheperipheralbl odfa imalsft rc llinimmunisation.
Figure5.7:TotalCD8+cellsintheperipherabl odfanim lfts orozoitcch ll ng .
5.8a, fig. 5.8c, animal 838 & 845 in fig. 5.8b and animal 264 in fig. 5.8e). The skin
grafted animals not showing any parasitological reactions after cell line immunisation
always expressed CD4:CD8 ratios above unity in favour of CD4 cells (fig. 5.8d &
animal 841 in fig. 5.8b). After challenge with sporozoites, all immune animals
showed a shift in the ratio in favour of CD8 cells after day 9 indicating an increase
in circulating CD8 cells as compared to CD4 cells (fig. 5.9a, 5.9d, animal 838 & 845
in fig. 5.9c and animal 250 & 264 in fig. 5.91). The ratio usually remained higher in
favour of CD4+ cells in the animals undergoing acute theileriosis after sporozoite
challenge. However, it quickly fell below unity in favour of CD8+ cells in all these
animals after treatment (fig. 5.9b, 5.9e, animal 841 in fig. 5.9c).
5.3.5 Changes in B cells
A slight drop in total circulating B cells was observed in most of the animals
immediately after immunisation (fig. 5.10). Total B cells began to rise after day 12
in most of the animals reacting mildly after cell line immunisation and becoming
carriers (fig. 5.10a, 5.10c, animals 838 & 845 in fig. 5.10b). B cell levels usually
remained low and did not show any increase in other skin grafted animals which did
not show any parasitological reactions after immunisation (fig. 5.10d & animal 841
in fig. 5.10b). Sporozoite challenge produced a sharp decrease in total B cells
corresponding to leucopenia in the naive animals and other skin grafted animals
showing clinical disease which stopped falling further in some animals after treatment
or started to increase slowly mothers (fig. 5.11b, 5.11e& animal 841 in fig. 5.11c).
Variable B cell kinetics were seen in the immune animals after challenge. Total
circulating B cells either slightly decreased or showed no change in immune animals
after sporozoite challenge. This was followed by an increase in their number in some
animals usually after day 15 (fig. 5.11a, 5.lid, animals 838 & 845 in fig. 5.11c and
animals 250 & 264 in fig. 5.1 If).
5.3.6 Monocytes or macrophages
Circulating monocytes/macrophages usually seemed not to be involved in
leucopenia. Levels of these cells did not change very much for the first few days after
immunisation. Most of the animals reacting mildly to the cell line expressed elevated
levels of total circulating monocytes in the peripheral blood usually after day 10 of
immunisation (fig. 5.12a, 5.12c, animals 838 & 845 in fig. 5.12b and animal 264 in
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skin grafted animals not showing any parasitological reactions after immunisation (fig.
5.12d). The sporozoite challenge revealed an early monocytosis in some of the
immune animals (fig. 5.13a, 5.13d, animal 845 in fig. 5.13c & animal 264 in fig.
5.13f) following an increase in total CD8+ cells. Naive animals, undergoing
sporozoite challenge, and other skin grafted animals exhibiting acute theileriosis
showed no change in the total circulating monocytes initially during acute clinical
reactions. However, some animals expressed monocytosis during the recovery phase
after treatment (fig. 5.13b & 5.13e).
5.3.7 Expression of IL-2Ra (CD25) on PBM
Only a few cells expressing CD25 were seen in the peripheral blood before cell
line immunisation or sporozoite challenge in all the animals. The number of CD25 +
cells increased in the periphery between days 7-10 after cell line immunisation. Data
from a representative animal (845) is shown in fig. 5.14a. Immune animals also
exhibited some CD25+ cells after sporozoite challenge transiently around day 6 (fig.
5.14b shows data from immune animal 859 after sporozoite challenge), although the
parasitological reactions were very mild in these animals. Naive animals undergoing
an acute infection after sporozoite challenge expressed CD25+ cells in the periphery
from day 6 to 13 (fig. 5.14c shows data from animal 841 undergoing acute
theileriosis). The skin grafted animals which did not show any parasitological
reactions after cell line immunisation exhibited no increase in CD25+ cells in the
periphery at any stage.
5.3.8 Expression of CD45RB molecule on PBM
Expression of CD45RB+ (naive phenotype) and CD45RB (memory/activated
phenotype) cells in the resting peripheral blood is almost equal. The level of
CD45RB cells initially decreased up to day 10 in the animals undergoing mild
parasitological reactions after cell line immunisation. However, the balance turned in
the favour of CD45RB cells from day 13 onwards indicating the presence of more
circulating effector/memory cells which returned to normal levels by day 21 (a
representative figure 5.15a from animal 845 after cell line immunisation). Animals
which did not show any parasitological reactions after cell line immunisation also did
not express any changes in the kinetics of CD45RB positive and negative cells. The
immune animals after sporozoite challenge expressed an increase in the CD45RB"

























Figure5.13:Totalmonocytes/macrophagesithperiphe alblo dfanimalsftersp r zoitechalleng .



















































































































Figure 5.14: Expression of IL-2 receptor (CD 25) on PBM.
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5.15b from animal 859). Increased levels of CD45RB cells were seen in the
periphery of animals suffering from acute theileriosis only after treatment. The
increased numbers of blasting cells in the periphery were associated with CD45RB
phenotype at this stage (a representative fig. 5.15c from animal 841).
5.4 DISCUSSION
The parasitological reactions within groups were highly variable as described in
detail in chapters 4 and 6. Animals having a pre-existing allogeneic response
displayed variable parasitological reactions, after primary inoculation of the cell line
or secondary sporozoite challenge, even within a group. Differences in the
parasitological reactions between animals might have resulted from variation in the
kinetics of parasite development and dissemination within and between groups of
animals. This could arise either because of varying effects of the pre-existing
allogeneic response on the parasite transfer to the recipient's cells, or because of
differences in the susceptibility of animals. On the whole, animals either displayed
mild parasitological reactions or no reactions after cell line immunisation. Animals
could broadly be divided into three groups after sporozoite challenge on the basis of
the severity of ensuing clinical reactions. The first being animals which were immune
and only exhibited mild reactions and the second group was of animals which showed
moderate reactions but recovered. The third group was of animals which suffered
from acute theileriosis and were either treated or destroyed. The kinetics of various
lymphocyte subpopulations were more related to the severity of ensuing
parasitological reactions than to the dose of cell line used for immunisation, level of
pre-existing allogeneic response at the time of immunisation or interval between
immunisation and challenge. Further, the wide range of pre-infection total and
differential cell counts and baseline FACS data impeded proper analysis of the results
and demonstration of any statistically significant facts. The results from each animal
are, therefore, presented individually. More emphasis is laid on qualitative kinetic
trends than actual figures in the results and discussion.
Leucopenia has been reported in the animals undergoing acute T. annulata
infection after natural or experimental sporozoite challenge (Sharma & Gautam, 1971;
Laiblin, 1978; Preston et al., 1992a). However, Hooshmand-Rad (1976) reported
little or no change in the TLC and total lymphocytes after infection with infected
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Figure 5.15: Expression of CD45RB on PBM.
147
blood. The effect of cell line immunisation on circulating leucocytes has not been
very well defined. Leucopenia was also a consistent finding in most of the animals
in this study after cell line immunisation as well as after sporozoite challenge. Cell
line immunisation produced a mild leucopenia of a short duration in the inoculated
animals. Very mild leucopenia was seen even in the skin grafted animals which did
not show any parasitological reactions. However TLC values returned to normal very
quickly and earlier in these animals than those reacting mildly after cell line
immunisation. This difference probably could be attributed to the fact that the animals
not showing any parasitological reactions after cell line immunisation only produced
a mild allogeneic response against the MHC antigens of the inoculated cell line.
Whereas, the animals showing mild parasitological reactions first produced an
allogeneic response followed by an antiparasite immune response. The fall in
peripheral blood leucocytes in these animals was associated with the loss of
circulating memory/activated phenotype (CD45RB) cells from the periphery. It is
possible that the cells of memory/activated phenotype have migrated to the lymph
node or other body compartments, where the parasite infected cells are present, for
immune effector function.
Leucopenia was very severe after sporozoite challenge, especially in the animals
showing acute symptoms of the disease. Animals immune to sporozoite challenge also
showed mild leucopenia following challenge. All these observations suggest that a
drop in TLC is a common finding after primary or secondary T. annulata infection,
induced either by sporozoites or parasite infected cell lines, affecting both
lymphocytes and granulocytes. Monocytes are usually not involved in the loss of
white blood cells from the circulation after T. annulata infection. The severity of
leucopenia was dependent on the ensuing parasitological reactions. Similar findings
have been reported earlier in animals infected with varying doses of T. annulata
sporozoites (Preston et al., 1992a). The development of severe leucopenia is a
particular characteristic finding during T. parva infection (Wilde, 1967).
The mild transient lymphocytopenia in the animals reacting mildly to the cell line
immunisation was caused by the disappearance of CD2+ cells corresponding to CD4+
and CD8+ cells from the periphery. B cells also contributed towards lymphocytopenia
to a lesser degree in some animals exhibiting mild reactions after cell line
immunisation. The level of CD4+ cells returned to normal values quickly, whilst the
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early drop in CD8+ cells was followed by a gradual increase in their numbers in the
peripheral blood. This usually exceeded the normal values between day 8-20 to a
stage where CD4:CD8 ratios were below unity indicating the development of a CD8
dependent immune response. Animals inoculated with T. annulata infected cell lines
have been reported to express a strong cytotoxic response in the periphery between
day 9 to 23 (Innes et al., 1989a). Initially the cytotoxic response was directed against
the allogeneic MHC antigens of the immunising cell line followed by an MHC class
I restricted response against autologous T. annulata infected cells. The kinetics of the
development of cytotoxic responses in the peripheral circulation observed by Innes
et. al. (1989a), matches the kinetics of CD8+ cells observed in animals becoming
immune after inoculation of a cell line in these experiments. This confirms that CD8+
cells play a major role in the development of immunity after cell line immunisation.
Increased levels of circulating CD8+ cells were also observed in immune animals
after sporozoite challenge and in seriously sick, sporozoite challenged naive animals
but only after treatment. These observations are also compatible with an earlier report
that MHC class I restricted parasite specific cytotoxic T lymphocytes appear in the
circulation of animals recovering from T. annulata infection after sporozoite challenge
(Preston et al., 1983).
Lymphocytopenia was severe in animals exhibiting acute symptoms of the disease
after sporozoite challenge and usually affected all the lymphocyte subpopulations
except monocytes. Animals immune to sporozoite challenge only exhibited transient
lymphocytopenia caused by a decline in circulating CD4+ cells, B cells and in some
animals by y8 T cells. Total CD8+ cells and monocytes were usually unaffected
initially in the immune animals and exhibited an increase in the later stages. Similar
findings have been reported earlier after inoculation of graded doses of T. annulata
sporozoites in the batches of taurine and taurine x Sahiwal {Bos indicus) calves
(Preston et al., 1992a). Lethal infections were associated with severe leucopenia
because of a continued absence of pan T cells, mature T cells, CD4+ cells, CD8+
cells, B cells and monocytes. In sublethal infections, monocytes, CD8+ cells and B
cells generally remained in the blood, increasing gradually in number.
Development of immunity to tropical theileriosis mainly seems to be cell
mediated. Antibodies reacting with the macroschizont and piroplasm stages of the
parasite have been consistently observed (Preston & Brown, 1985; Ahmed et al.,
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1988; Kachani et al., 1992b), but inoculation of sera from immune cattle could not
protect naive animals from T. annulata infection (Dhar & Gautam, 1978; Samad et
al., 1984a). However, sera from immune animals can neutralise sporozoite infectivity
(Gray & Brown, 1981) and block sporozoite entry into the host cells in vitro (Preston
& Brown, 1985). Although it does not recognise any determinant on the surface of
parasite infected cells (Shiels et al., 1989), indicating that the humoral response might
only be partially important in engendering protection. On the other hand, several
reports provide evidence for the development of cell mediated immunity against
tropical theileriosis. Earlier reports have shown reactions to intradermal inoculation
and inhibition of leucocyte migration in response to T. annulata piroplasm antigen in
the immune animals (Singh et al., 1977). Samad et al. (1984b) demonstrated an initial
decrease in E-rosette forming cells in the peripheral blood for the first two weeks
after immunisation against T. annulata with infection and treatment method followed
by an increase thereafter reaching a maximum by the fourth week. Development of
immunity in cell line immunised animals has also been shown to be associated with
an increase in E-rossette forming cells in the periphery (Chaudhri & Subramanian,
1992). Further, a transient appearance of the cytotoxic activity directed against the
autologous parasite infected cells has been reported in the immune animals undergoing
sporozoite challenge (Innes et al., 1989a; Chaudhri & Subramanian, 1992). Similar
patterns of an increase in the circulating CD8+ cells were observed after sporozoite
challenge of immune animals in these experiments.
The level of monocytes in the peripheral blood usually increased after cell line
immunisation in the animals reacting mildly and after sporozoite challenge in the
immune animals. Adherent cells isolated from the peripheral blood of calves
immunised using either schizont infected cell lines or sporozoites, have been shown
to exhibit a strong cytostatic effect in vitro on autologous as well as allogeneic
parasite infected cell lines (Preston & Brown, 1988).
The observations from these experiments and in vitro bioassays mentioned above
(Innes et al., 1989a; Preston & Brown, 1988) suggest that protective immunity
against T. annulata is mediated by a transient development of CD8+ cytotoxic T
lymphocytes and a sustained presence of cytostatic macrophages in the peripheral
circulation. However, adoptive transfer experiments have not been undertaken to
directly evidence the reliance of immunity on CD8+ cells and/or cells of
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monocytes/macrophages lineage during T. annulata infection. Recently adoptive
transfer of purified responding CD8+ cells from efferent lymph of an immune animal
to its naive twin prevented the development of T. parva infection in the recipient.
These results provide direct evidence for CD8+ cell mediated protective mechanism
in T. parva infection (McKeever et al., 1994). It may be assumed that CD8+ cells
also protect against T. annulata infection in a similar fashion.
Development of immunity against T. annulata was associated with the appearance
of CD25+ cells along with increased levels of MHC class II+ cells and CD45RB
cells, in the peripheral blood, after cell line immunisation as well as sporozoite
challenge. The expression of MHC class II and CD25 are considered to be markers
of activated T cells (Greene et al., 1986; Glimcher & Kara, 1992). However, the
appearance of CD25+ cells was seen earlier than the increase in the levels of MHC
class II+ and CD45RB" cells. Many CD25+ cells were reported to appear in the
draining lymph node on day 4 after sporozoite infection in naive animals which
disappeared from the node by day 8 (Campbell et al., 1994b). Experiments in this
chapter demonstrated the presence of these cells in the peripheral circulation after day
6 of sporozoite infection. Detailed studies on the expression of activation markers on
various lymphocyte subpopulations in the peripheral blood was not done which could
have provided a better understanding of T cell activation during the course of
infection. The immune response after inoculation of parasite infected cell line or
sporozoites is initiated in the draining lymph node, therefore, study of efferent lymph
draining the site of inoculation provides a better indication of the development of
immunity as shown in the next two chapters.
Decline in TLC values and levels of other lymphocyte subpopulations from the
periphery observed after cell line immunisation or sporozoite challenge may not
represent an actual drop of these cells from the body of an animal. Lymphocytes
continuously enter and exit lymphoid and non-lymphoid organs using blood as a
traffic route (Pabst & Binns, 1989). In the human body, blood only represents about
2% of the total lymphocytic pool and is assumed to be the same in animals. Small
alterations in organs containing many lymphocytes, such as lymph nodes and spleen,
and also non-lymphoid organs such as lungs, can cause major alterations in the
circulating lymphocytes (Westermann & Pabst, 1990). Initial pathology and parasite
development after cell line immunisation or sporozoite challenge takes place in the
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draining lymph node leading to its multifold enlargement (Samantaray et al., 1980;
Ouhelli et al., 1989; Preston et al., 1992a). The antigen stimulation of a lymph node
leads to elevation in the blood flow and increased entry of lymphocytes into the node
(Hay & Hobbs, 1977; Mackay et al., 1992b). The mild leucopenia induced after cell
line immunisation or sporozoite challenge in immune animals is more likely to be the
effect of increased lymphocyte entry into the draining node. This was further
supported by the observations that the number of cells with memory/activated
phenotype decreased during this period. The mAb used for distinction of naive and
memory phenotype (CC 76), only discriminates naive and memory cells of CD4
lineage efficiently and not CD8+ cells (Howard et al., 1991b). Memory T cells
recirculate selectively from blood to peripheral tissues to lymph node via afferent
lymph (Mackay etal., 1990). Further, a selective non-random migration of CD4+ and
CD8+ cells from lymph nodes to blood via efferent lymph has been well documented
in response to an antigen (Bujdoso et al., 1989b; Mackay et al., 1992b).
Severe loss of leucocytes during acute T. annulata infection cannot be solely
attributed to migration of cells, from peripheral blood to lymphoid tissues, because
normal levels of circulating leucocytes never return to normal in these animals.
Further, the ratio of cells with naive and memory phenotype was not disturbed, until
treatment of these animals, indicating a loss of both circulating naive and memory
cells. Large numbers of cells with memory phenotype appeared in the circulation after
treatment. Campbell et al. (1994b) reported a total destruction of the lymph node
architecture by day 10 of sporozoite inoculation in naive animals. Many cells
undergoing apoptosis were observed in the draining lymph nodes after sporozoite
infection in the naive animals. The parasite seems to induce destruction of leucocytes
during the course of an acute infection by inducing programmed cell death in the T
cells. This might be explained by looking at the activation of T cells in response to
the parasite locally in the draining lymph node. Attempts have been made to address
some of these questions in the following chapters by examining the cells exiting the
draining node via the efferent lymphatics.
Changes in the lymphocyte subpopulations were not accompanied by a decline
in circulating monocytes/macrophages, which were shown to be important in the
development of immunity to T. annulata (Preston & Brown, 1988). An increase in
the circulating monocytes observed in these experiments is in accord with the above
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findings. An important point to take into consideration is that, unlike lymphocytes,
monocytes do not recirculate between lymph, blood and tissues (Springer, 1994). The
kinetics of circulating monocytes, therefore, provides a true representation of these
cells in the body.
Experiments reported in this chapter showed that reduction in the levels of
circulating CD4+ and B cells mainly leads to leucopenia in response to T. annulata
infection, followed by less involvement of CD8+ cells and y8 T cells. Cells of the
monocyte/macrophage lineage were least affected. Leucopenia is very severe in
animals suffering from acute theileriosis after inoculation of sporozoites. Naive
animals after cell line immunisation or immune animals after sporozoite challenge
only exhibit a mild and transient leucopenia. A transient increase in the levels of
circulating CD8+ cells initially followed by a sustained increase in monocytes/
macrophages was associated with recovery, after cell line immunisation and
sporozoite challenge, indicating that immunity against T. annulata is mediated by
CD8+ cells and monocyte dependent mechanisms. During the course of parasite
development after cell line immunisation or sporozoite challenge, T cell activation
markers appeared transiently on PBM. These changes were not observed in skin
grafted animals where no parasitological reactions were seen after cell line
immunisation.
Initial pathology and development of immunity takes place in the draining lymph
node after inoculation of T. annulata sporozoites or cell line. Cells leaving the
draining node reflect the immunological events occuring in the node and are
responsible for dissemination of immune effector cells to other body compartments.
Further experiments, reported in the next two chapters, concentrated on the study of
parasite dissemination and development of immunity in the efferent lymph of the node
draining the site of T. annulata sporozoite challenge or cell line immunisation.
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CHAPTER 6
Kinetics of Theileria annulata infection and T cell
activation in the efferent lymph of cattle
Objectives:
1. To study the kinetics of parasite dissemination in lymph efferent from the
node draining the site of lethal T. annulata infection with sporozoites.
2. To investigate changes taking place in various lymphocyte subpopulations in
efferent lymph from the draining node during T. annulata infection.
3. To characterise activation of T cells in response to the parasite in order to
understand how immunity develops.
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6.1 INTRODUCTION
Following sporozoite infection with T. annulata or T. parva, multinucleate
macroschizonts appear initially in the nearest draining lymph node. However in the
case of T. parva, two days after the first appearance, almost similar numbers of
schizonts can be seen in all the nondraining lymph nodes (Jarret et al., 1969;
DeMartini & Moulton, 1973a; Radley et al., 1974; Emery, 1981b; Morrison et al.,
1981b). On the other hand, schizonts are seen only in the draining lymph node after
T. annulata infection and can also be isolated from liver, spleen, kidneys, lungs and
abomasum during the later stages of the disease (Neitz, 1957). Only a few infected
cells are rarely seen in the nondraining lymph nodes (Sergent et al., 1945; Neitz,
1957; Samantaray et al., 1980; Preston et al., 1992a).
Parasite specific cytotoxic T cell and humoral responses are seen in animals
immunised with cell lines or recovering from infection with sporozoites (Preston et
al., 1983; Preston & Brown, 1985; Innes et al., 1989a; Kachani et al., 1992a).
However, severe infection with sporozoites in naive animals may quickly lead to
death without development of protective immunity. Earlier studies in this laboratory
had shown great difficulty in generating and maintaining T. annulata specific T helper
and cytotoxic cells in vitro because of apoptosis by T cell lines after 3-4 weeks in
culture (Campbell et al., 1994b; A.K. Nichani & R.L. Spooner, unpublished
observation). All these in vitro and in vivo studies were carried out on cells from the
peripheral blood of animals which is only a traffic route for circulating lymphocytes
(Trnka & Cahill, 1980). Immunological events observed in the peripheral circulation
are diluted and may not reflect cellular changes taking place immediately upon
introduction of an antigen via the intradermal or subcutaneous port of entry. The
nature of early interactions between the pathogen and the host effector cells is very
important in determining the outcome of infection. Immunohistochemical studies on
lymph node sections following T. annulata sporozoite inoculation have revealed that
T cell activation was taking place in atypical places and at the wrong times. CD25 +
cells for instance observed in the medulla on day 4 had disappeared by day 8
(Campbell et al., in press). In the previous chapter (chapter 5), transient appearance
of CD25+ cells was observed in animals after cell line immunisation as well as after
sporozoite challenge. To further understand the pathogenesis of T. annulata infection
and generation of immunity against the parasite, it was decided to study changes
155
taking place in the draining lymph node in vivo using efferent lymphatic cannulation.
There have been extensive studies in sheep for the understanding of in vivo
immune responses following development of techniques for cannulating efferent
lymphatics draining the individual lymph node (Hall & Morris, 1962). This technique
enabled extensive studies on lymph node function and development of nodal immune
responses to various micro-organisms (Hall et al., 1967; Smith & Morris, 1970;
English et al., 1977; Issekutz, 1985; Huang et al., 1991; Bird et al., 1993; Buxton
et al., 1994) and exogenous protein antigens (Hall & Smith, 1971; English et al.,
1977; Hall et al., 1980; Hopkins et al., 1981a; Bujdoso et al., 1989b; Hopkins et al,
1993) in sheep. Surprisingly, reports of similar approach for studies of in vivo
immunology and development of immune responses in cattle are scarce, apart from
a few reports on the pathogenesis and immunology of T. parva infection (DeMartini
& Moulton, 1973b; Emery 1981a). The kinetics of T. parva infection in the lymph
efferent from the draining prefemoral node and nondraining lymph nodes were
described (Emery, 1981b). T. parva infected schizonts were detected in efferent
lymph 8 days after challenge, coinciding with a dramatic increase in output of
lymphoblasts. Emery & McCullagh (1980a) compared skin graft reactions between
chimaeric twins in the draining efferent lymphatics of prefemoral and popliteal lymph
node of cattle. Kinetics of the dissemination of Trypanosoma congolense and
development of humoral responses in the lymph efferent from the node draining the
site of local skin lesions induced by the parasite were studied (Akol & Murray, 1986).
Responses induced included a 2-3 fold increase in the volume of lymph, up to a 10-
fold increase in cell output and appearance of neutralising antibodies. In an earlier
report, Brownlie & Scott (1979) established optimal culture conditions for in vitro
stimulation of bovine ELL with phytohaemagglutinin. Kinetics of MHC class I
restricted cytotoxic T lymphocytes in efferent lymph of an immune cattle following
T. parva sporozoite challenge has recently been described (McKeever et al., 1994).
These cells could mediate immunity as shown by adoptive transfer from immune to
a naivemonozygotic twin undergoing lethal infection. Immunological events occurring
in the lymph nodes draining the site of antigen deposition and inflammatory lesions
are reflected by cell contents of the efferent lymph draining that node (Trnka &
Cahill, 1980; Bujdoso et al., 1989b).
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In these experiments, we examined the kinetics of parasite dissemination in
efferent lymph draining the site of an acute T. annulata infection with sporozoites.
Some of the cellular and molecular events occurring within the lymphatic vessel in
relation to the progression of the disease were characterised. Cellular traffic from the
draining lymph node was monitored to investigate T cell activation and function as
a step towards understanding how immunity is generated against the parasite.
6.2 MATERIALS AND METHODS
6.2.1 Cattle
Five Friesian x Brown Swiss or Friesian x Charollais calves aged 3-8 months
were used in this study (table 6.1). Efferent lymphatic draining the prescapular node
was cannulated. Animals 903 and 928 were infected with T. annulata by s/c
inoculation of 0.1 t.e. GUTS (Gharb isolate) above the lymph node 24 hrs after
surgery to produce clinical theileriosis. These animals were treated with buparvaquone
(Butalex, Mallinkrodt Veterinary Ltd.) on day 10 and 11, respectively (McHardy et
al., 1985) as soon as the feed intake of the animals started to decline. Animal 264
(solidly immune to sporozoite challenge; chapter 4 for details) was inoculated with
2 t.e. GUTS 24 hrs after surgery and observed for 7 days. The animal was challenged
with 2 t.e. GUTS again 6 weeks later on the right side of the neck and the efferent
lymphatic of the draining lymph node cannulated on day 5 of challenge and observed
further. Observations on this animal after first challenge are mentioned as 264a and
after second challenge as 264b in the subsequent text. Animals 249 and 250 were not
given any inoculation after cannulation to collect baseline information.
Table 6.1:Details of animals used for lymphatic cannulation and sporozoite
inoculation.






903 Naive day -1 day 0 day -1 to 13
928 Naive day -1 day 0 day -1 to 13
264a Immune day -1 day 0 day -1 to 6
264b Immune day 5 day 0 day 5 to 17
249 Immune day -1 not done day -1 to 5
250 Immune day -1 not done day -1 to 4
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6.2.2 Cell lines
6.2.2.1 T. annulata infected cell lines
T. annulata infected cell lines were established in vitro by infection of bovine
PBM with T. annulata (Gharb) sporozoites as described in chapter 3.4.2 (Brown
1983). The resultant continuously growing cell lines were used as targets in
cytotoxicity assays and stimulators in proliferation assays.
6.2.2.2 Uninfected lymphoblasts
Uninfected lymphoblasts were established by stimulating PBM once with Con.
A and cultured further in MLC medium supplemented with 20% TCGF as described
in chapter 3.4.3. These cells were used as targets in cytotoxicity assays.
6.2.3 Cannulation of efferent lymphatic duct
The efferent lymphatic of the prescapular lymph node of animals mentioned
above was cannulated as described in detail in chapter 3.5. Lymph was collected in
plastic bottles containing 5-10 i.u./ml heparin (Leo Laboratories Ltd.) and antibiotics
(Gibco) to provide penicillin 20 i.u. and streptomycin 20 /xg per ml when full. The
bottle for lymph collection was changed 2-4 times a day depending upon the flow
rate. Lymph was collected for one hr every morning for use in various studies. The
rest was pooled aseptically and infused slowly into the animal through a jugular
cannula in order to minimise the loss of fluid and cells, to maintain fluid, electrolyte
and protein balances and not to interfere in the development of systemic immunity.
6.2.4 Infection
The sporozoites used to provide infection were prepared as a stabilate
(Cunningham et al., 1973) of H. a. anatolicum ticks infected with the Gharb stock
of T. annulata (Ouhelli, 1985) as described in chapter 3.4.2.2.
6.2.5 Clinical monitoring
The clinical condition of the animals was assessed by daily observation of their
general condition and rectal temperature (a febrile response being > 39.5°C).
Haematocrit and TLC were measured at regular intervals (chapter 3.6 for details).
Cytospin smears from efferent lymph were prepared daily and stained with Giemsa
for assessment of blasting cells and T. annulata infected schizonts. Blasting cells were
also assessed by FACS analysis on the basis of FSC vs SSC. The percentage of
piroplasm infected erythrocytes was assessed by Giemsa stained thin blood smears.
The number of total erythrocytes in the lymph was assessed initially on the basis of
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Giemsa stained cytospin smears. But was later measured by a Coulter Counter, when
the number of erythrocytes was very high in the lymph.
6.2.6 Cell preparation
ELL collected from indwelling cannulae were counted in a haemocytometer.
The viability of cells was always greater than 98% as assessed by Trypan blue dye
exclusion. Volume and cellularity of the lymph was measured after every collection
to calculate rate of lymph flow and cellular traffic. Cells collected freshly for one tu¬
rn the morning were used for flow cytometry, proliferation assays and cytotoxicity
assays. An aliquot of lymph was centrifuged at 800g for 15 min. and cell-free lymph
plasma supernate decanted and stored at -20°C for ILN-7 estimation. ELL and PBM
were separated on ficoll-hypaque as described in chapter 3 (3.4.2.1 & 3.4.5). Cell
free lymph supernate was collected at short intervals during the first two days after
infection. PBM from a different animal (free from T. annulata infection) were
cultured with this supernate to look for dissemination of sporozoites in the efferent
lymph. ELL and PBM were cultured in vitro in 24 well plates (Intermed, Nunc) to
isolate parasite infected cell lines for studying the kinetics of parasite dissemination.
6.2.7 Monoclonal antibodies
Various mAbs have been described in detail in chapter 3.8.1. Lollowing mAbs
were used for analysis of various lymphocyte subpopulations. IL-A26 for CD2+ cells,
IL-A12 for CD4+ cells, SBU-T8 for CD8+, IL-A29 for yd T cells and VPM 30 for
B cells. B cells expressing IgM on the surface were recognised by IL-A30, monocytes
and macrophages by IL-A24, MHC class II molecules by J 11, IL-2R a chain (CD25,
Tac antigen) by IL-A111 and CD45RB molecules on the cell surface by CC 76.
6.2.8 Immunofluorescent Staining
Various immunoconjugates and techniques used for indirect immunofluorescent
staining and flow cytometry have been explained in chapter 3.8. This technique was
used to analyze phenotypic changes in various lymphocyte subpopulations in ELL
following sporozoite infection. Two colour immunofluorescent staining on ELL was
carried out at regular intervals for studying T cell activation following sporozoite
infection. Cells were simultaneously incubated with two mAbs of different isotypes.
One mAb was used to identify CD4+ or CD8+ cells and the second for the expression
of CD25, MHC II, CD2 and CD45RB on the cells. This was followed by incubation
of cells simultaneously with two appropriate fluorescent secondary reagents.
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Acquisition and analysis on FACScan is described in detail in chapter 3.8.
6.2.9 Proliferation assays
These were essentially as described by Glass and Spooner (1990a) and detailed
in chapter 3.10. Briefly, ELL or PBM with irradiated PBM were incubated either
alone or with Con. A or Human recombinant IL-2 or irradiated autologous T.
annulata infected cells. Cell proliferation was measured after 72 hrs by a 6 hr pulse
with [3H] thymidine (Amersham) and uptake was assessed by liquid scintillation
counting.
T. annulata infected cells were cultured in vitro in 96 well flat bottom plates
(Intermed, Nunc) at 2xl04 cells per well in 100 /xl of TC medium with 100 /jl\ of
different dilutions of cell free lymph supernates (from day 0 & day 5) or bovine
recombinant IFN-y. Cell proliferation was measured after 48 hrs as described above.
6.2.10 Cytotoxicity Assay
Cytotoxic activity of ELL and PBM from the animals was assayed at regular
intervals after infection throughout the experimental period as described in chapter
3.9. Both parasite infected cells and uninfected blasts of known BoLA phenotypes
were chosen to provide targets.
6.2.11 Interferon-y assay
A solid phase sandwich ELISA (enzyme linked immunosorbant assay) using
mAbs specific for bovine IFN-y was used (Wood et al., 1990; Rothel et al., 1990)
to measure levels of ILN-y in efferent lymph using a ready made test kit (CSIRO,
Australia) as described in chapter 3.11.
6.3 RESULTS
6.3.1 Clinical reactions
The two control animals which were cannulated but not infected with T.
annulata (animals 249 & 250) showed no clinical reactions. The immune animal 264
also did not show any clinical reaction after the first or the second sporozoite
challenge. Feed and water intake was normal in these animals and they did not exhibit
any rise in rectal temp. Two naive animals (903 & 928) which were infected 24 hrs
after lymphatic cannulation developed severe clinical theileriosis. Both the animals
exhibited fever (rectal temp. > 39.5°C) from day 8 onwards (fig. 6.1a). Schizonts
were first seen in efferent lymph on day 6 and continued to rise thereafter (fig. 6. lb).
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Maximum schizonts were 36% in animal 903 and 10% in animal 928 on day 11.
Piroplasms appeared in both the animals on day 9. Maximum parasitaemia was 10%
in animal 903 and 2.5% in animal 928 (fig. 6.1c). Haematocrit (fig. 6. Id) and TLC
(data shown in chapter 5.3.2) decreased significantly with progression of the disease.
Both the animals were seriously ill and were, therefore, treated with buparvaquone
(Butalex) as soon as they began to go off feed. Animal 903 was treated on day 11 and
928 on day 10 after sporozoite infection.
6.3.2 Changes in the flow rate and cellularity of efferent lymph
The output of lymph from the prescapular lymph node draining the site of
infection is shown in fig. 6.2a. It remained more or less the same for the first four
days after sporozoite infection in the naive animals. Following enlargement of the
lymph node, lymph flow from the draining node increased significantly during the
progression of the disease. Output of fluid from the node was 37 ml and 28.6 ml per
hr before infection which increased to 232 ml and 220 ml per hr on day 10 in animals
903 and 928, respectively. It started to decline in one animal (928) after treatment,
but kept on increasing (300 ml per hr) in the second (903) even after treatment. There
was a marginal increase in the flow rate of lymph in animal 264 after the second
sporozoite challenge from day 6 (35.7 ml/hr) which peaked on day 8 (81.2 ml/hr) and
declined afterwards.
The output of lymphocytes in efferent lymph increased slowly after infection
for the first four days in the naive animals (fig. 6.2b). As enlargement of the lymph
node started on day 4, cell output was reduced (cell shutdown) in both the animals
up to day 6 (1.7xl08 cells/hr on day 0 & 0.65xl08 cells/hr on day 5 in animal 928)
followed by a rapid increase. Both animals exhibited a multifold increase in
lymphocyte output from the node after day 6 until treatment (17.8xl08 cells/hr on day
11 in animal 928), after which it started to decline. In the later stages, a significant
number of RBC appeared in the lymph on day 10 and their number kept on increasing
(data not shown). The cell output did not change greatly in the immune animal after
first challenge (day -1 to day 6). However the second challenge was accompanied by
an immense increase in the cell output peaking on day 7.
The initial increase in lymphocyte traffic in the naive animals was not
accompanied by changes in the proportion of blasting cells. However the second peak




l ■ 903 ♦ 928 X 264a X 264b A 249 O 250
b: Parasite infected cells in lymph
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Figure 6.1: Clinical and parasitological reactions in the animals after infection
with T. annulata sporozoites.
a: Rectal temperature. b: Parasite infected schizonts in the efferent lymph.
(-*): day of treatment.
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c: Piroplasms in blood
DAYS
■ 903 ♦ 928 X 264a X 264b
d: Haematocrit
DAYS
Figure 6.1: Clinical and parasitological reactions in the animals after infection
with T. annulata sporozoites.
c: Piroplasms in blood smears. d: Haematocrit values. (->): day of treatment.
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accompanied by a massive increase in the proportion of blasting cells (fig. 6.2c).
Maximum blasting cells were 87% in animal 903 and 91% in animal 928 as counted
from Giemsa stained smears. There were no significant changes in the proportions of
blasting cells in other animals. FSC vs SSC of the ELL also exhibited an increase in
the blasting cells in the naive animals after day 7 as marked by region 1 (Rl) in fig.
6.3a., whereas, no increase was observed in blasting cell population of the immune
animal (Rl of fig. 6.3b).
6.3.3 Kinetics of parasite dissemination
Culturing of cell free lymph supernates from animals after sporozoite
inoculation with PBM from another naive animal did not produce any T. annulata
infected transformed cell lines. Establishment of cultures in this manner was
attempted from naive as well as immune animals, in the period immediately following
sporozoite inoculation, to study dissemination of free sporozoites in efferent lymph.
Parasite infected cell lines were established in vitro from ELL (day 6 onwards) and
PBM (day 9 onwards) only from the naive animals. No parasite infected cell line
could be isolated from ELL or PBM of the immune animal. Schizonts were first seen
from day 6 onwards in Giemsa stained smears and their percentage continued to
increase after that. Identification of parasite infected cells was also carried out with
mAb 1C7 (Shiels et al, 1986a) from the first animal infected with sporozoites.
Detection of schizont infected cells was similar to the results obtained from Giemsa
stained smears. Therefore, results of only Giemsa stained smears are presented.
6.3.4 Changes in lymphocyte subpopulations in the efferent lymph
The kinetics of various lymphocyte subpopulations in efferent lymph of these
animals are shown in fig. 6.4a to 6.4h. Percentage of CD2+ cells in efferent lymph
started to increase from day 5 in the naive animals. More than 80% of the cells were
CD2+ from day 6-8 (fig. 6.4a). The initial increase of CD2+ cells was accompanied
by an increase in CD4+ cells until day 7 (fig. 6.4b) followed by an increase in CD8+
cells to day 10 (fig. 6.4c). Percentage of CD25+ cells increased sharply from day 7
(fig. 6.4f). With the appearance of parasite infected schizonts, the percentage of all
these cells decreased from day 10 onwards. But, after treatment with buparvaquone,
CD2+ cells started to rise again along with CD8+ cells, whereas, CD4+ cells and
CD25+ cells kept on decreasing. The percentage of y8 T cells decreased slightly




■ 903 ♦ 928 X 264a X 264b A 249 O 250
b: Cellularity
DAYS
Figure 6.2: Changes in the flow and cellularity of the efferent lymph after
infection with T. annulata sporozoites .
a: Flow rate, b: Cellularity. (-*): day of treatment.
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c: Blasting cells in lymph
DAYS
■ 903 ♦ 928 X 264a X 264b & 249 O 250
Figure 6.2: Changes in the flow and cellularity of the efferent lymph after
infection with T. annulata sporozoites.
c: Blasting cells in the efferent lymph. (-»): day of treatment.
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Forward scatter
Figure 6.3: Blasting cells in the efferent lymph as assessed by the FACScan. Forward scatter
(FSC) of the cells is represented on the X axis and side scatter (SSC) on the Y axis. The
blasting cells are highlighted in the region 1 (Rl) on the basis of their higher FSC & SSC.
a: Animal no. 928 (naive). b: Animal no. 264 (immune).
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on resting efferent lymph cells, but rose sharply from day 6 to 10, dropped on day
11 and increased again after treatment (fig. 6.4e). IL-A24+ cells appeared in the
efferent lymph from day 9 onwards corresponding to the appearance of infected cells
in the lymph (appendix, no. 13). The percentage of total B cells dropped to negligible
levels between day 5-10 corresponding to an increase in T cells (fig. 6.4g). IgM
positive B cells also dropped to negligible levels from days 5-9 and increased slightly
after that (fig. 6.4h). The changes in T cell subsets in the immune animal after both
sporozoite challenges were not very pronounced, apart from a slight increase in y8
T cells from day 11 onwards (fig. 6.4d). The percentage of B cells increased from
day 6-11 peaking on day 8 (fig. 6.4g), but the increase was not due to IgM bearing
cells (fig. 6.4h).
6.3.5 Activation of T cells
T cells started to express CD25 from day 7 in the naive animal. CD4+ cells
became CD25+ initially, followed by CD8+ cells (fig. 6.5al & 6.5bl). Only 5.7%
ELL expressed both CD4 and CD25 on day 0. Their percentage increased to 13.4%
by day 7. None of the CD8 cells expressed CD25 on day 0, and about 8% ELL
expressed both CD8 and CD25 between day 9-13. The Expression of CD25 on CD8
cells was less marked but sustained, and on CD4 cells was transient disappearing by
day 11. B cells and only a few CD4+ cells express MHC class II antigens in the
resting efferent lymph. Many T cells expressing MHC class II appeared in efferent
lymph on and after day 7. CD4+ cells also expressing MHC class II appeared only
transiently between day 7-9 and declined by day 11. These cells did not reappear after
treatment of the animal (fig. 6.5cl). All CD8+ cells were MHC class II negative in
the resting efferent lymph. Some CD8+ MHC class II+ cells started to appear in
efferent lymph on day 7 of infection and their number kept on increasing until day
11 (fig. 6.5dl). After treatment on day 11, most of the CD8+ cells expressed MHC
class II. y<5 T cells did not express MHC class II at any stage of the disease in
efferent lymph (data not shown). In the immune animal (264), expression of CD25
on CD4+ and CD8+ cells changed slightly after sporozoite challenge (fig. 6.5aII &
6.5bII). Expression of MHC class II increased slightly on both cell populations after
day 7 (fig. 6.5cII & 6.5dII).
All CD4+ and CD8+ cells normally express CD2 antigen. However, a




• 903 ♦ 928 X 264a X 264b & 249 O 250
b: CD4+ CELLS
DAYS
Figure 6.4: Changes in various lymphocyte subpopulations in the efferent lymph
after infection with T. annulata sporozoites.




■ 903 ♦ 928 X 264a X 264b A 249 O 250
d: WC1+T CELLS
DAYS
Figure 6.4: Changes in various lymphocyte subpopulations in the efferent lymph
after infection with T. annulata sporozoites.
c: CD8+ cells. d: WC1+ cells (y8 T cells). (-»): day of treatment.
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e: MHC 11+ Cells
DAYS
■ 903 ♦ 928 X 264a X 264b A 249 O 250
f: CD 25+ Cells
DAYS
Figure 6.4: Changes in various lymphocyte subpopulations in the efferent lymph
after infection with T. annulata sporozoites.
e: MHC class II+ cells. f: IL-2R7 (CD25) cells. (->): day of treatment.
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Figure 6.4: Changes in various lymphocyte subpopulations in the efferent lymph
after infection with T. annulata sporozoites.
g: VPM 30+ B cells h: IL-A30+ IgM bearing B cells. (-»): day of treatment.
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were observed which did not express CD2. The number of CD4+ CD2 cells slightly
increased on day 11. After treatment, all the CD4+ cells again expressed CD2 (fig.
6.5el). The loss of CD2 expression from CD8 cells was more marked than CD4
cells. A few CD8+ CD2 cells were observed on day 7 of infection in efferent lymph.
The number of CD8+ CD2" cells increased sharply by day 11 when about 60% of all
CD8 cells did not express CD2. As with the CD4+ cells all CD8+ cells expressed
CD2 after treatment (fig. 6.5fl). A few CD4+ CD2" cells were also seen in efferent
lymph of this animal on day 12 (fig. 6.5eII). However, CD8+ cells were always
CD2+ (fig. 6.5fII).
ELL from the naive animal contained 45.6% CD4 cells on day 0 of infection.
Out ofwhich 30.1 % expressed naive phenotype (CD45RB high) and 15.6% expressed
memory phenotype (CD45RB low) as shown in fig. 6.5gl. The percentage ofmemory
phenotype CD4 cells decreased to 9.3% by day 4, whereas naive CD4 cells increased
to 52.5%. Memory CD4 cells exited the node around day 7 which was followed by
depletion of both naive and memory CD4 cells from efferent lymph. Output of
memory CD4 cells remained more or less constant in the immune animal (fig. 6.5g2).
The decrease in CD4 cells corresponded to naive cells only.
6.3.6 Proliferative responses
The functional activation state of ELL was assessed by measuring their in
vitro proliferative efficiency in response to exogenous stimuli viz: Con. A and
recombinant human IL-2 as well as to autologous parasite infected cells. The ability
of ELL to proliferate in response to Con. A was greatly reduced during the course
of T. annulata infection in the naive animal (day 8 & 10 in fig. 6.6a). ELL
proliferated in response to exogenous IL-2 on day 8 when the cells had high
expression of CD25 and on day 12, when the animal exhibited some specific immune
response to the parasite after treatment. However, neither ELL nor PBM proliferated
in response to autologous irradiated T. annulata infected cells during the course of
infection (fig. 6.6a). ELL from the immune animal responded well to Con. A at all
stages, however, counts were comparatively lower on day 5 and 7 than days 0, 10,
14 and 17. Cell proliferation in response to IL-2 was higher on day 5 than other days.
There was some proliferation in response to autologous Theileria infected cells on all
the days tested and was slightly higher on days 7 and 10 (fig. 6.6b).
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Figure 6.5a: Dot plots of two colour immunofluorescent staining on ELL. CD4f cells
are expressed on the Y axis (FL2). IL-2R+ (CD25+) cells are expressed on the X axis
(FL1).
I: Animal no. 928 (naive). II: Animal no. 264 (immune).
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I: Animal no. 928 (naive). II: Animal no. 264 (immune).
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Figure 6.5b: Dot plots of two colour immunofluorescent staining on ELL. CD8 cells
are expressed on the Y axis (FL2). IL-2R' (CD25+) cells are expressed on the X axis
(FL1).
I: Animal no. 928 (naive). II: Animal no. 264 (immune).
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I: Animal no. 928 (naive). II: Animal no. 264 (immune).
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Figure 6.5c: Dot plots of two colour immunofluorescent staining on ELL. CD4+ cells are
expressed on the Y axis (FL2). MHC class II' cells are expressed on the X axis (FL1).
I: Animal no. 928 (naive). II: Animal no. 264 (immune).
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MHC clasa 11+ cells
Figure 6.5d: Dot plots of two colour iminunofluorescent staining on ELL. CD8r cells are
expressed on the Y axis (FL2). MHC class II+ cells are expressed on the X axis (FL1).
I: Animal no. 928 (naive). II: Animal no. 264 (immune).
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Figure 6.5e: Dot plots of two colour immunofluorescent staining on ELL. CD4 f cells are
expressed on the Y axis (FL2). CD2+ cells are expressed on the X axis (FL1).
I: Animal no. 928 (naive). II: Animal no. 264 (immune).
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I; Animal no. 928 (naive). II: Animal no. 264 (immune).
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Figure 6.5f: Dot plots of two colour immunofluorescent staining on ELL. CD8f cells are
expressed on the Y axis (FL2). CD2+ cells are expressed on the X axis (FL1).
1: Animal no. 928 (naive). II; Animal no. 264 (immune).
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I: Animal no. 928 (naive).
II: Animal no. 264 (immune).
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Figure 6,5g: Dot plots of two colour immunofluorescent staining on ELL. CD4f cells are
expressed on the Y axis (FL2). CD45RB' cells are expressed on the X axis (FL1).
I: Animal no, 928 (naive). II: Animal no. 264 (immune).
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a: Animal no. 928 (naive)
0 3 6 8 10 12 13
DAYS
□ control ■ CON. A 1 IL-2 8 Irr. TaA
b: Animal no. 264 (immune)
6
DAYS
Figure 6.6: Proliferative responses of ELL in response to various antigen stimuli in vitro.
Values represent the mean of quadriplicate counts,
a: Animal no. 928 (naive). b: Animal no. 264 (immune).
(Data shown for animal 264 for day 0 for animal 264 was after first cannulation and challenge, and the rest of
the data from day 5 to 17 was after second cannulation and challenge).
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6.3.7 Cytotoxicity assays
No cytotoxic activity was observed in ELL or PBM of naive animals during
the course of T. annulata infection in direct cytotoxicity assays against autologous T.
annulata infected cells (fig. 6.7). MHC class I restricted cytotoxic activity started to
appear only after treatment. Cytotoxic activity was 13.6% in ELL on day 12 and
11.6% in PBM on day 12 (40:1 effector:target ratio) against autologous parasite
infected cells in animal 928. The parasite specific MHC restricted cytotoxic activity
was seen after challenge of the immune animal between day 10 to 14. Peak cytotoxic
activity in ELL of immune animal was seen on day 10 (22.5% at 40:1 E:T ratio) and
in PBM on day 12 (15.4% at 40:1 E:T ratio) as shown in fig. 6.7.
6.3.8 Interferon-y assay
High levels of IFN-7 were detected in naive animals undergoing sporozoite
challenge from day 4 onwards at the same time as the cell shutdown (fig. 6.8a &
6.8b). The level of IFN-7 started to decrease with the appearance of parasite infected
cells in the lymph after day 9. Very low levels of IFN-7 were detected in lymph of
the immune animal from day 5-8, but was undetectable during the rest of the period.
IFN-y was undetectable in the lymph of the two uninfected animals. Lymph
supernates with high levels of IFN-y inhibited growth of T. annulata infected cell




Two naive animals (903 & 928) developed clinical theileriosis after infection
but animal 264 was solidly immune and did not show any reactions after the first or
second sporozoite challenges. The naive animals were challenged with only 0.1 t.e.
stabilate, whereas the immune animal was challenged with 2 t.e. stabilate on both
occasions. A dose of 0.1 t.e. was enough to produce clinical theileriosis. Challenge
experiments in chapter 4 were done with 1.0 t.e. stabilate where serious disease was
seen in some animals of group 2 and 3. This indicates that tick material used in all
these experiments was highly potent in producing clinical theileriosis. Sick animals
in chapter 4 exhibited fever from day 5 onwards.
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I □ ELL 928 H PBM 928 11 ELL 264 ■ PBM 264
Figure 6.7: Cytotoxic activity of ELL and PBM against autologous T. annulata infected cells in
cytotoxicity assays after infection with sporozoites.
The figures represent percent cytotoxicity at effector : target ratio 40:1 (Mean of duplicate counts).
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a: IFN -gamma in the efferent lymph after sporozoite challenge.
DAYS
■ 903 ♦ 928 X 264a X 264b A 249 O 2S0
b: Total IFN-gamma per hour in the efferent lymph after sporozoite challenge.
DAYS
Figure 6.8: Levels of IFN-y in the draining efferent lymph of animals
following infection with T. annulata sporozoites.
a:Levels of IFN-y expressed as ng per ml of lymph, b: Levels of IFN-y expressed
as ng per hour released in the efferent lymph. (—>): day of treatment.
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11 TaA alone □ lymph day 0 HE R-IFN-g Si Lymph day 5
Figure 6.9: Effect of recombinant bovine IFN-y and lymph supernate with high levels of IFN-y
on proliferation of T. annulata cells in vitro. (Values represent the mean of quadriplicate counts).
TaA alone: T. annulata infected cells in medium only.
Lymph day 0 and lymph day 5: T. annulata infected cells with lymph supernate from day 0 (IFN-y
level = negligible) and day 5 (IFN-y level = 117 ng/ml).
1. 100/xl/well; 2. 50/d/well; 3. 25 /d/well; 4. 12.5 /xl/well; 5. 6.25/xl/well. 6. 3.12/d/well.
R-IFN-g: T.annulata infected cells with serial dilutions of recombinant bovine IFN-y @ 100 /zl per
well of: 1. lOOng/ml, 2. 50ng/ml, 3. 25 ng/ml, 4. 12.5 ng/ml, 5. 6.25 ng/ml. 6. 3.12ng/ml.
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High levels of IFN-7 were detected in efferent lymph of naive animals from
day 4 onwards in the experiments mentioned in this chapter. It is very likely that
IFN-7 might be playing a role in pathology of the disease as has also been suggested
by Ahmed et al. (1993). IFN-y can stimulate macrophages to secrete high levels of
TNF-a. Repeated injections of recombinant bovine TNF-gi in cattle produce
symptoms of anorexia, depression and reversible debilitating condition (Bielefeldt
Ohmann et al., 1989). However, fever appeared from day 8 onwards in these
animals. Delay in fever may have occurred for two reasons; IFN-7 leaving in efferent
lymph was collected in bottles and infused back later into the animal. The effect
produced by immediate infusion may have been different from the slow release of the
cytokine in a normal response. The second reason could be the low dose of
sporozoites given to these animals.
6.4.2 Kinetics of the parasite dissemination
Examination of efferent lymph draining the site of acute T. annulata infection
revealed that infected cells entered the circulation via efferent lymph from day 6
onwards. In the sporozoite challenge experiments in chapter 4, schizonts were
detected in lymph node biopsies from day 5 onwards. The parasite infected cells
seemed to exit in efferent lymph immediately after their appearance in the lymph
node. However animals in chapter 4 were challenged with 1 t.e. GUTS as compared
to 0.1 t.e. GUTS used for naive animals in this experiment. The number of infected
cells in the lymph continued to increase in the following days as was seen in biopsy
smears in chapter 4. Parasite infected cells were isolated in culture from efferent
lymph from day 6 and in PBM from day 9 onwards, indicating that parasite
dissemination from the draining node to other parts of body takes place through the
efferent lymph. Similarly, T. parva infected cells have been reported to appear in
efferent lymph from day 8 of infection (Emery, 1981b) and have been shown to
disseminate through central lymph to the rest of the body (DeMartini & Moulton,
1973b).
The striking difference between the two parasites is that systemic spread of T.
parva infection occurs immediately after sporozoite challenge. Parasite infected cells
can be seen in most of distant lymph nodes and other lymphoid organs of the animal,
two days after the first appearance of schizonts in the local draining node, leading to
a generalised infection (Jarrett et al., 1969; DeMartini & Moulton, 1973a; Radley et
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al., 1974; Emery, 1981b; Morrison et al., 1981b). Presumably T. parva infected
schizonts exiting in efferent lymph enter the circulation and spread foci of infection
throughout the body of animal. However in the case of T. annulata, infected schizonts
are infrequently seen in the distant lymph nodes. A few schizonts can be seen in
liver, kidney, lungs and peripheral blood during the terminal stages of the disease
(Sergent et al., 1945; Neitz, 1957). It was, therefore, anticipated that T. annulata
infection might be confined to the draining lymph node initially as a localised
condition. Immunohistology of the draining lymph node on day 10 of infection
showed only abundant parasite infected cells with total destruction of lymphoid
architecture (Campbell et al., 1994c). Dissemination of infected schizonts in the
efferent lymph raises a question about fate of infected cells exiting the node and their
role in the pathogenesis. An important pathological lesion of the disease is "punched
up" necrotic ulcers in abomasum and the parasite can be isolated from the liver,
spleen, lungs and kidneys during the terminal stages (Sergent et al., 1945; Neitz,
1957; Uilenberg, 1981b). These are probably the site of predilection for infected cells
exiting in efferent lymph. T. annulata infected cells, when injected s/c in SCID mice,
formed tumours at the site of inoculation. Some infected cells were found to
infilterate to other tissues mainly to kidneys and lungs (Fell & Preston, 1993), further
confirming selective migration of T. annulata infected cells to these organs.
The differences in migration between infected cells of T. annulata and T.
parva might be explained by the ability of the two parasites to infect different host
cell subpopulations. In vitro studies have shown that T. annulata preferentially infects
cells of macrophages/monocytes lineage (Spooner et al., 1989; Innes et al., 1989b;
Glass et al., 1989; Campbell et al., 1994a) and T. parva transforms T cells (Baldwin
et al., 1988a). Recirculation and homing patterns of T cells and macrophages are
different. T cells recirculate either from the blood through tissues into lymph node
and back to blood, or from the blood to lymph node through HEV to efferent lymph
and back to blood (Mackay et al., 1992b). Monocytes emigrate from the blood stream
into the tissues in response to molecular changes on the surface of blood vessels but
do not recirculate (Trnka & Cahill, 1980; Springer, 1994). Cells of the macrophage
or monocyte lineages do not normally exit in efferent lymph (Cahill et al., 1978;
Mackay et al., 1988). Although it is not exactly known whether these two parasites
infect the same cell subpopulations in vivo as they do in vitro. Large numbers of IL-
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A24+ cells appeared corresponding to the exit of T. annulata infected cells in efferent
lymph. Most T. annulata infected lines cultured in vitro are IL-A24+ (Glass &
Spooner, 1990b; Campbell et al., 1994a), which detects a determinant on
macrophages (Ellis et al., 1988). Presumably the parasite infected cells exiting the
node also expressed the marker. Sporozoite infection and transformation by both
parasites induce phenotypic changes on the cell surface (Spooner et al., 1988;
Campbell etal., 1994a). The loss or expression of different markers may further alter
the migration, recirculation and homing patterns of these cells. Further studies on the
phenotype of cells infected in vivo and molecular changes induced by the two
parasites, on transformation of cells, could be useful in understanding the migration
of infected cells and consequently pathogenesis.
The failure to detect or culture T. annulata infected cells from efferent lymph
of the immune animal, after sporozoite challenge at any stage, indicates that
protective immunity against the parasite was effected in the draining lymph node. On
the other hand, infected cells from the naive animals could be cultured from day 6
onwards corresponding with appearance of the infected cells in efferent lymph.
Parasite infected cells could not be isolated before day 6 from efferent lymph
indicating that sporozoite infected lymphocytes perhaps do not exit in efferent lymph
until transformed to schizonts. However, infected cells were grown in vitro from
lymph node cells collected by surgically extirpating the draining lymph nodes on day
2 and 4 after infection (J.D. Campbell, unpublished observations). Culturing of lymph
supernates collected at different time intervals immediately after inoculation of
sporozoites with PBM from another animal did not produce any parasite infected cell
line. Sporozoites are very efficient in infecting and transforming PBM in vitro
(Brown, 1987). Therefore, it seems unlikely that free sporozoites reach the efferent
lymph. These observations suggest that the parasite is localised to the draining lymph
node until schizonts are formed. However, other observations in our laboratory do
not support this postulate as animals inoculated with sporozoites above the prescapular
lymph node developed clinical theileriosis even after removal of the draining lymph
node on day 2 or 4 (J.D. Campbell & R.L. Spooner, unpublished observations).
Similarly, animals inoculated with T. annulata infected cell lines still became carriers
of infection even after removal of the draining lymph node on day 4 and 9, (P. Goel
&R.L. Spooner, unpublished observations). There could be two possibilities; the first
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being that the parasite material inoculated above the prescapular lymph node had
drained to some other lymph node, or that a different path other than the efferent
lymph exists for dissemination of the parasite.
In the light of these observations, the mode of parasite dissemination needs to
be investigated further and could be studied by two approaches. The first could be
infusion of parasite material via a cannulated afferent lymphatic and then following
it in the lymph node and efferent lymph so that danger of drainage to other lymph
nodes is overcome. If an antigen is inoculated via afferent lymphatic and all of the
efferent lymph is drained, the response should be confined to the infused node,
leaving the rest of the animal immunologically virgin in respect to the antigen used
(Trnka & Cahill, 1980). Blood supply in a normal node only provides one way
migration of cells from blood to lymph (Hall et al., 1967; Smith et al., 1974).
However, cannulating an intact afferent lymphatic would be technically difficult. The
second approach could be to label the parasite material with DNA based fluorescent
dyes and monitor the migration of cells containing fluorescence in various
immunological compartments of the animal body (Horan et al., 1990). A potential
problem with this approach could be the dilution of fluorescent material with
multiplication of the parasite.
6.4.3 Cell shutdown
A dramatic decrease in lymphocyte output commonly known as the
phenomenon of "cell shutdown" frequently but not invariably occurs soon after a
lymph node has been challenged with an antigen (Hall & Morris, 1965b; Cahill et al.,
1976; Hopkins et al., 1981a; Hein & Supersaxo, 1988; Mackay et al., 1992b). Cell
shutdown was observed around day 4-6 of infection in the naive animals as indicated
by a very low cell output in efferent lymph, but not in the immune animal. In the
case of T. parva infection, a slight depression in total cell output was observed in the
period immediately after sporozoite challenge followed by increased cell output over
the next 6 days (Emery, 1981b). Cell shutdown in the lymph node has been reported
to be a normal response to secondary antigenic stimuli, but can also occur shortly
after primary challenge before an immune response to the antigen has developed. This
can be induced by complement activation (McConnell & Hopkins, 1981) leading to
increased secretion of PGE2 by macrophages in the node (Hopkins et al., 1981b).
Elevated levels of corticosteroids can also be associated with decreased lymphocyte
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traffic through the lymph nodes (Hall, 1986). IFN-a2a can be involved in regulating
lymphocyte output from the nodes (Hein & Supersaxo, 1988). The cell shutdown has
also been shown to occur on primary infections with live viruses in sheep (Smith &
Morris, 1970; Issekutz, 1985; Bird etal., 1993). However, mechanisms controlling
the changes in output of lymphocytes from a lymph node undergoing an immune
response are not fully understood.
Cell shutdown observed in the two naive animals undergoing acute theileriosis
was not observed immediately after inoculation of sporozoites as reported to occur
in the literature (Trnka & Cahill, 1980; Hopkins et al., 1981b), but was observed
between day 4-6 corresponding to the initial development of schizonts. During cell
shutdown, subcapsular and paracortical regions are densely packed with lymphocytes
and there is accumulation of cells around blood vessels in the medulla suggesting
continued entrance of lymphocytes into the node during cell shutdown (Hein &
Supersaxo, 1988). Accumulation of small T cells and large macrophage like cells in
medullary sinuses in the draining lymph node was observed during T. annulata
infection (Campbell et al., 1994b). Some T. annulata infected cell lines have been
reported to produce IFN type 1 (a/jS) like activity (Entrican et al., 1991). Cell
shutdown in these experiments might be IFN mediated as suggested by Hein &
Supersaxo (1988) which could be secreted by activated CD4 cells or newly
transformed parasite infected cells. However, involvement of other mediators cannot
be ruled out as these were not studied in these experiments.
6.4.4 Flow rate and cellularity
Flow rate of lymph in efferent lymphatics draining the site of T. annulata
infection increased 8-10 fold after day 5 in naive animals and coincided with the
enlargement of lymph nodes. The rate of lymph flow has been shown to increase by
2-3 fold around 8-12 days after acute T. parva infection in cattle (Emery, 1981b). A
two fold increase in flow of lymph has also been reported on days 5-6 in sheep during
Chlamydia psittaci infection which declined to pre-infection levels in the following
days (Huang et al., 1991). There is a marked increase in the blood supply during
antigen stimulation resulting in an increase in lymphocyte entry to the node (Hay &
Hobbs, 1977). Whether increased blood flow is mediated by release of cytokines or
vasoactive substances is not known. However, high levels of IFN-7 were observed
between day 5-9 corresponding to the onset of increase in the lymph flow, which
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might be a contributing factor. The kinetics of other potential mediators like
prostaglandins (Trnka & Cahill, 1980; Hopkins etal., 1981b), macrophage migration
inhibitory factors (Hay, 1973), mitogenic factors (Hay et al., 1973) were not studied.
Suitable assay techniques for other bovine cytokines secreted by parasite infected cells
or activated T cells were not available, which might be responsible for enlargement
and later haemorrhages of the lymph node.
There was a multifold increase in total cell output from the node following cell
shutdown in naive animals. It has been suggested that cells exiting the node after
antigen stimulation comprise lymphocytes which entered the node during cell
shutdown and those generated within the node in response to the antigen (Hay &
Hobbs, 1977). Total cell output from the node also increased transiently in the
immune animal peaking on day 7-8 and started to decline thereafter. An increase in
total cell output from the draining lymph node (maximum 8x10s per hr) has also been
observed after infection with T. parva (Emery, 1981b). Other micro-organisms in
sheep like Chlamydiapsittaci (Huang et al., 1991) and Toxoplasma gondii (McColgan
et al., 1987; Buxton et al., 1994) have also been shown to cause increased cell output
from the node. However, the increase has not been as enormous as observed in these
experiments or after T. parva infection. This might partially be because of a strong
T cell proliferation induced by the parasites (Morrison et al., 1981a) and also shown
to occur in response to T. annulata (Glass & Spooner, 1990b; Campbell et al.,
1994c).
Another important observation was the appearance of large numbers of
blasting cells in efferent lymph of naive animals after sporozoite infection, which
constituted more than 80% of lymph cells. This also included many parasite infected
schizonts during later stages of the infection. A strong lymphocyte proliferation in
response to T. annulata seemed to contribute in the increased output of total and
blasting cells from the node. Appearance of blasting cells of similar levels in efferent
lymph (Emery, 1981b) and tracheal and thoracic duct (DeMartini & Moulton, 1973b)
has also been reported during T. parva infection. A transient appearance of blasting
cells in the efferent lymph has been observed in sheep in response to vaccinia virus
(Issekutz, 1985), Maedi-visna virus (Bird et al., 1993), Toxoplasma gondii infection
(McColgan et al., 1987), Chlamydia psittaci infection (Huang et al., 1991) in sheep.
However blasting cells were reported to appear in the efferent lymph only transiently
191
in these infections. In contrast, these kept on increasing in the efferent lymph during
both T. annulata and T. parva infection in cattle until the later stages of the disease.
Blasting cells observed in these experiments were mainly T cells, further confirming
that T. annulata induces a strong lymphoproliferation in the lymph node as also
reported earlier for both the parasites (Morrison et al., 1981b; Campbell et al.,
1994b). Strong proliferation of cells exiting in efferent lymph corresponded
histologically to distention of medullary sinuses with accumulation of small and
blasting cells. This was followed by disappearance of the existing germinal centres
with no sign of de novo germinal centre formation in the node and appearance of
large areas of dead cells, some small lymphocytes and discrete areas of blasting cells
(Campbell et al., 1994c). Increase in T cell output from the draining node is in
contrast to leucopenia observed in the peripheral blood during acute T. annulata
infection (Laiblin, 1978; Preston et al., 1992a; this thesis, chapter 5). The parasite
seems to induce a strong proliferation in lymphocytes in the draining lymph node
followed by apoptosis, as T cells and particularly CD4 cells are specifically depleted
from the peripheral circulation.
6.4.5 Activation of T cells
Phenotypic changes in various lymphocyte subsets of efferent lymph after T.
annulata infection in the naive animals revealed an initial increase in CD2+ cells
corresponding with an increase in CD4+ cells after day 5. A large number of these
cells were CD25+ and MHC class II+. This was followed by an increased output of
CD8+ cells with high expression of MHC class II and CD25. Similarly, blasting
CD4+ cells were reported to appear in efferent lymph from day 6 followed by a
switch to CD8+ cells around day 9 or 10 in sheep after infection with a live
incomplete strain of Toxoplasma gondii (Innes et al., 1992b). A non-random
migration of T lymphocytes in efferent lymph has been suggested following
ovalbumin or BCG challenge to the node, with initial increase in CD4+ cells followed
by CD8+ cells (Bujdoso, et al., 1989b; Mackay et al., 1992b). However, CD8+ cells
exiting the node from naive animals, despite showing activation markers, did not kill
autologous infected cells in cytotoxicity assays. MHC class I restricted parasite
specific cytotoxic cells were seen only transiently in the efferent lymph after treatment
of these animals. Activated T cells have been reported to be lymphoblastoid and
expressing MHC class II and CD25 (Greene et al., 1986; Glimcher & Kara, 1992),
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whereas resting T cells usually do not express MHC II and CD25. Many CD25+ cells
were observed in sections of the draining node on day 4 but not on day 8 and 10
following T. annulata infection. CD25+ T cells were seen in the medulla with loss
of germinal centres from the node suggesting that activated CD4+ cells were not
capable of providing help to B cell follicles for formation of the germinal centres
(Campbell et al., 1994b). However, high levels of IFN-y were being secreted in the
node at this stage. In the event of a normal protective immune response against the
parasite, activated CD4+ cells should interact with interdigitating cells in the
paracortex (McKeever etal., 1992) or B cell follicles to initiate formation of germinal
centres (Bogen et al., 1993). However in these experiments, T cells seemed to be
nonspecifically stimulated by the parasite in the medulla, which exited in the efferent
lymph allowing proliferation of parasite infected cells in the node. Functional assays
on these cells have further shown that these cells were not specific for parasite
antigens.
6.4.6 Role of IFN-y in the lymphocyte activation and pathogenesis
High levels of IFN-y were observed corresponding to an initial increase in
CD4+ cells with increased MHC class II and CD25 expression. Low levels of IFN-y
were also observed in efferent lymph of immune animal after challenge. An earlier
report also showed that IFN-y is secreted in efferent lymph from the node during
primary responses to protein and polysaccharide antigens (Emery et al., 1990).
Increased levels of IFN-y were also detected transiently after secondary challenge of
the immune animal. IFN-y has been reported to induce MHC class II expression on
T cells and regulate production and secretion of IL-2 (Schreiber et al., 1989). IFN-y
also induces MHC class II expression on macrophages (Benoist & Mathis, 1990;
Dalton et al., 1993) and activates them to produce TNF-a, which can exert cytostatic
and necrotic effects on some target cells (Sugarman et al., 1985; Aiyer et al., 1986).
A similar protective mechanism appears to be operative in tropical theileriosis as
sustained presence of cytostatic macrophages in the circulation of calves recovering
from the disease has been reported (Preston & Brown, 1988; this thesis, chapter 5).
There is evidence for activation of adherent cells and PBM by IFN-y to secrete TNF-
a (Preston et al., 1992b).
Interestingly, levels of IFN-y in efferent lymph decreased with appearance of
the parasite, which suggests that it is not produced by infected cells. Most of T.
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annulata infected cell lines maintained in vitro also do not produce IFN-y, whereas
most of T. parva cell lines do (Entrican et al., 1991; DeMartini & Baldwin, 1991;
Ahmed et al., 1993). Blasting CD4 cells perhaps produce this cytokine, as appearance
of blasting CD4 cells correlates very well with the peak of IFN-7. Further cell sorting
studies are needed to establish the phenotype of cells secreting this and other
cytokines and their effect on T cell activation and parasite control. Anti-viral activity
of IFN-y is well known. It has recently been shown to inhibit growth of Toxoplasma
gondii as well in vitro (Oura et al., 1993; Johnson et al., 1993). IFN-y seems to
inhibit growth of T. annulata infected cells in vivo. As soon as parasite infected cells
are transformed in the node, IFN-y some how shuts down probably because activated
CD4+ cells exit the node and are replaced by CD8+ cells. The inhibitory effect of
IFN-y on infected schizonts diminishes and further proliferation of schizonts
continues. This hypothesis is supported by the inhibitory effect of recombinant bovine
IFN-y and IFN-y rich lymph supernate on T. annulata transformed cell lines in vitro
observed in these experiments. Bovine recombinant IFN-y and bovine recombinant
TNF-a are reported to inhibit establishment of trophozoite infected cell cultures in
vitro (Preston et al., 1992b).
6.4.7 Loss of CD2 adhesion molecule
It seems that animals infected with T. annulata mount a T cell activation
response initially as evident from the appearance of activated CD4 cells followed by
CD8 cells. However, increasing multiplication of the parasite in the lymph node
seems to induce an inappropriate proliferation and not activation of T cells as many
blasting CD4 and CD8 cells were observed to lose CD2 expression with the
progression of the infection. These cells expressed MHC class II but had lost CD25
expression. Further, ELL lost responsiveness to Con. A and exogenous IL-2
stimulation in vitro during the latter stages of the infection. This was not because the
cells were already committed to parasite specific antigens as they did not proliferate
in vitro in response to autologous parasite infected cells. These observations suggest
a state of T lymphocyte unresponsiveness as previously reported to be induced in
some viral infections either because of anergy or suppressor lymphocyte activity
(Reinherz et al., 1980; Carney et al., 1981; McChesney & Oldstone, 1989; Graters
& Miedema, 1992). Although efferent lymph from the naive animal contained
abundant CD8+ cells, these were CD2 and did not kill autologous parasite infected
194
cells in chromium release assays until treatment. Similar CD8+ CD2" cells have also
been observed during T. parva infection, but their function was not established (E. A.
Innes, N.D. MacHugh & W.I. Morrison, unpublished observations). Induction of
CD8+ T cell activation in a defective maturation state has also been reported in HIV
infection in man (Pantaleo et al., 1990; Salazar-Gonzalez et al., 1985) and SIV
infection in rhesus monkeys (Reimann et al., 1991). The circulating CD8+ MHC
class II DR+ cells in HIV-infected patients did not express CD25. These cells could
not be stimulated in vitro to proliferate in response to mitogens and other stimuli,
even in the presence of additional IL-2 or IL-4 (Pantaleo et al., 1990). Cattle seem
to mount a similar defective activation in response to T. annulata infection where
CD8+ cells become MHC class II+ but are CD25 negative and lose expression of
CD2, an important adhesion molecule for their function. The CD2 molecule binds to
LFA-3 to mediate CTL-target cell adhesion and conjugate formation, leading to
activation of the cell for its effector function, which is independent of antigen
recognition by the TCR (Bierer et al., 1989). The number of cells bearing this
defective phenotype increased with dissemination of the parasite in the efferent
lymph. ELL were also unresponsive to other exogenous stimuli at this stage,
suggesting this to be a parasite induced phenomenon which encourages its
dissemination. On the other hand, only a few CD4+ CD2" cells were observed in the
immune animal on day 12, and CD8+ cells were always CD2+. MHC class II and
CD25 expression was induced on a few CD8+ cells during day 7 to 12 of the
challenge. Functional assays on the ELL revealed parasite specificity indicating
stimulation of a normal secondary immune response. Unresponsive lymphocytes have
been recorded in the acute response to Epstein-Barr virus and cytomegalovirus
(Reinherz et al., 1980; Carney et al., 1981) because of activation of TH2+ type T
cells (suppressor T cells). TH, and TH2 subsets are not well characterised in cattle.
High levels of IFN-y in the lymph of naive animals suggests a THj like activation of
T cells initially leading to anergy in these experiments.
In summary, experiments reported in this chapter suggest that T. annulata
sporozoites induce a strong lymphoproliferation in the draining lymph node of the
naive animals leading to an enormous increase in output of fluid and cells from the
node. Cell output from the node increased transiently in the immune animal as well,
but output of fluid was unaffected after challenge with sporozoites. A period of cell
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shutdown was observed in the naive animals, corresponding to the initial
transformation of schizonts in the node. This was followed by a massive output of
blasting cells from the node along with exit of parasite infected cells. Blasting cells
were not observed in the immune animal. Schizonts were seen in efferent lymph of
the naive animals as soon as they were expected to appear in the lymph node. Parasite
isolation in culture was possible from efferent lymph earlier than from peripheral
blood, indicating that the parasite is disseminated to the rest of the body through
efferent lymph. Large amounts of IFN-7 were observed in efferent lymph which
might be responsible for some of the pathology of the parasite.
Phenotypic analysis of ELL showed an increase in T cell output which initially
comprised CD4+ cells followed by a huge output of CD8+ cells. Naive animals
initially seemed to mount a normal T cell activation response after sporozoite
challenge in the form of transient CD25 and MHC class II expression on CD4 cells,
followed by a strong proliferation of CD8+ cells with high expression of MHC class
II but not CD25. However, these cells were not parasite specific as evident from the
functional assays. Parasite specific T cells were observed in the immune animal after
day 7, but only after treatment in the naive animals. The parasite induced an
inappropriate proliferation and nonspecific activation of T cells in the lymph node as
the cells lost CD2 expression, an important adhesion molecule for normal T cell
effector function.
These experients provided an understanding of nonspecific T cell activation
induced by the parasite during acute infection, when a parasite specific immune
response is not generated. Inoculation of a T. annulata infected cell line in an animal
produces a parasite specific immune response. In the final chapter of this thesis,
development of local immune response in the efferent lymph of the node draining the
site of cell line immunisation was studied in comparison to the responses generated
in the presence of allograft responses, in order to understand the generation of
immunity against the parasite.
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CHAPTER 7
Kinetics of parasite dissemination and T cell activation in the
efferent lymph during immunisation with a T. annulata
infected cell line in naive and skin grafted animals.
Objectives:
1. To investigate the kinetics of parasite development and dissemination in the
lymph efferent from the node draining the site of immunisation with an
allogeneic T. annulata infected cell line.
2. To study the dynamics of various lymphocyte subpopulations in the lymph
efferent from the node draining the site of cell line immunisation in relation
to the development of immunity.
3. To characterise T cell activation in response to immunisation with an
allogeneic T. annulata infected cell line.
4. To study the effect of a pre-existing allogeneic response on parasite and cell
dynamics in the efferent lymph after cell line immunisation.
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7.1 INTRODUCTION
Theileria annulata infected cell lines have extensively been used as vaccines
in cattle to control tropical theileriosis in endemic areas. Inoculation of an allogeneic
cell line initially produces a response against MHC antigens of the immunising cell
line followed by a parasite specific immune response in the recipient animals (Innes
et al., 1989a). Transfer of parasite from the donor cell line to cells of the recipient
is an important pre-requisite for effective cell line immunisation (Pipano et al., 1977;
Brown et al., 1978a; Innes etal., 1989a; this thesis, chapter 4). Little is known about
the mode of the parasite transfer and dissemination of the parasite infected cells. The
initial cellular interactions and activation of various lymphocyte subpopulations
leading to the development of immunity after cell line immunisation are not very well
understood.
Previous studies have shown a transient appearance of MHC class I restricted
cytotoxic T lymphocytes (Innes et al., 1989a) and a more sustained macrophage
mediated cytotoxic activity against the parasite infected cells (Preston & Brown, 1988)
after immunisation with T. annulata infected cell lines. A transient increase in
circulating CD8+ cells and sustained presence of monocytes/macrophages in the
peripheral blood were observed after cell line immunisation during these
investigations (chapter 5). In chapter 6, progression of acute theileriosis was found
to be associated with a non-specific activation of T cells leading to loss of CD2, an
important adhesion molecule, on the cell surface. The cells activated during acute
theileriosis resulting from inoculation of sporozoites displayed no evidence of parasite
specificity in the functional assays.
Cells leaving in efferent lymph from an antigen primed node reflect
immunological events occurring in the lymph node and are responsible for systemic
dissemination and amplification of the local immune responses (Trnka & Cahill,
1980; Bujdoso et al., 1989b; Mackay et al., 1992b). The experiments in this chapter
were, therefore, undertaken to investigate kinetics of parasite dissemination, changes
in cell dynamics and T cell activation in the lymph efferent from the node draining
the site of immunisation with a T. annulata infected cell line in naive animals.
Critical analysis of the effect of a pre-existing allogeneic response on cell line
immunisation against T. annulata in chapter 4 revealed that development of parasite
specific immunity after cell line immunisation was blocked in some animals. Cell
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dynamics in the peripheral blood were mostly unaltered in the animals which did not
develop immunity to the parasite after immunisation with a cell line. Experiments
were therefore further extended to investigate the kinetics of cellular changes in the
efferent lymph after cell line immunisation in animals already exhibiting a strong
allogeneic response.
7.2 MATERIAL AND METHODS
7.2.1 Animals and experimental design
Four calves (1 Friesian, 1 Hereford & 2 Friesian x Charollais) aged 3-7
months were used in these experiments. BoLA types of the animals were determined
by microlymphocytotoxicity (Spooner et al., 1979a) as described in chapter 3.2 to
ensure that BoLA types of the recipient animals were different from the animal
chosen as the skin donor and to produce the immunising cell line (animal 10769;
BoLA type A10/A11). Allogeneic immune responses were generated in animals 838
and 841 by implantation of skin collected from animal 10769 (details in chapter 3.3).
Animals 933 and 859 were not skin grafted. The efferent lymphatic draining the
prescapular lymph node of all the four animals was cannulated as described in chapter
3.5. The animals were inoculated s/c with lxlO6 cells of T. annulata (Hissar) infected
immunising cell line 24 hours after surgery above the prescapular lymph node.
7.2.2 Cell lines
T. annulata infected cell lines were established in vitro by infection of PBM
with sporozoites as described previously (Brown, 1983) and detailed in chapter 3.4.
The cell line from the skin donor animal was used to immunise animals after
cannulation of the efferent lymphatic. The cells of this line were also used as
stimulators in proliferation assays and MLC, and as targets in cytotoxicity assays to
measure the allogeneic response. Autologous T. annulata infected cells were used as
targets in the cytotoxicity assays and as stimulators in the proliferation assays and
MLC to evaluate the parasite specific immune responses.
Uninfected lymphoblastoid cell lines were generated from all these animals by
stimulating PBM once with Con. A (Sigma) and cultured further in MLC medium
containing a supplement of 20% TCGF as described in detail in chapter 3.4.3. These
cells were used as target cells in the cytotoxicity assays.
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7.2.3 Cannulation of efferent lymphatic duct
The efferent lymphatic of the prescapular lymph node was cannulated as
described in detail in chapter 3.5. Lymph was collected into plastic bottles containing
5-10 i.u./ml heparin (Leo Laboratories Ltd.) and antibiotics (Gibco) to provide
penicillin 20 i.u. and streptomycin 20 /xg per ml when full. The bottle for lymph
collection was changed 2-3 times a day depending on the flow rate. Lymph was
collected for one hr every morning for use in various studies. The rest of the lymph
was pooled aseptically and infused slowly into the animal through a jugular cannula
to minimise the loss of fluid and cells, to maintain fluid, electrolyte and protein
balance and not to interfere in development of the immune response.
7.2.4 Clinical monitoring
The clinical condition of the animals was assessed by observations on their
general condition, rectal temperature (a febrile response being > 39.5°C) daily,
haematocrit and TLC at regular intervals (chapter 3.6). Cytospin smears from efferent
lymph were prepared daily and stained with Giemsa for assessment of blasting cells
and T. annulata infected schizonts. Blasting cells were also assessed by FACS
analysis using FSC vs SSC to identify large cells. Percentage of piroplasm infected
erythrocytes was assessed by Giemsa stained thin blood smears. Details of the clinical
reactions are presented in chapter 4 and are discussed very briefly in this chapter.
7.2.5 Cell preparation
ELL collected from indwelling cannulae were counted in a haemocytometer.
The viability of the cells was always greater than 98% as assessed by Trypan blue
dye exclusion. Volume and cellularity of the lymph was measured after every
collection to calculate rate of lymph flow and cellular traffic. Freshly collected ELL
for one hr in the morning and PBM were purified on ficoll-hypaque (Lymphoprep)
as described in chapter 3.4.2.1 and 3.4.5. These cells were used for flow cytometry,
proliferation assays and cytotoxicity assays and as responders in MLC. An aliquot of
lymph was centrifuged at 800g for 15 min. and cell-free lymph plasma supernate was
decanted and stored at -20°C for IFN-7 estimation. ELL and PBM were cultured in
vitro in 24 well plates (Intermed, Nunc) to isolate parasite infected cell lines for
studying the kinetics of dissemination of parasite infected cells. Cultures were
established daily from ELL and every 2-3 days from PBM.
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7.2.6 Monoclonal antibodies
Various mAbs have been described in detail in chapter 3.8.1. The following
mAbs were used for analysis of various lymphocyte subpopulations. IL-A26 for CD2+
cells, IL-A12 for CD4+ cells, SBU-T8 for CD8+ cells, IL-A29 or CC 15 for y8 T
cells, VPM 30 for B cells. B cells expressing IgM on the surface were recognised by
mAb IL-A30. IL-A24 for monocytes and macrophages, J 11 or IL-A21 for surface
MHC class II molecules, IL-A111 for CD25 (IL-2 receptor a chain, Tac antigen) and
CC 76 for CD45RB molecules on the cell surface.
7.2.7 Immunofluorescent Staining
Various immunoconjugates and techniques used for indirect immunofluorescent
staining and flow cytometry have been explained in chapter 3.8. This technique was
used to analyze phenotypic changes in the ELL following cell line immunisation. Two
colour immunofluorescent staining was done at regular intervals to investigate T cell
activation in ELL. One mAb was used to identify CD4+ or CD8+ cells and the
second mAb of a different isotype for staining CD25, MHC class II, CD2 or
CD45RB molecules on the cell surface. This was followed by simultaneous incubation
of cells with two appropriate fluorescent secondary reagents as described previously.
7.2.8 Mixed lymphocyte culture (MLC)
ELL and PBM were cultured in vitro with irradiated autologous T. annulata
infected cells or cells used for immunisation, in 6x10 ml well plates (Interned, Nunc)
for five days, in MLC medium at regular intervals after cell line immunisation. Each
well contained 5 ml of ELL or PBM at 4xl06 cells per ml, 2.5 ml of irradiated (5000
rads) autologous PBM at 4xl06 cells per ml and 2.5 ml of irradiated (7500 rads)
parasite infected autologous or immunising cells at 4xl05 cells per ml to give a
responder vs stimulator ratio of 20:1. The stimulated cells were used, after five days,
as effector cells in the cytotoxicity assays to measure allogeneic and parasite specific
cytotoxic activity.
7.2.9 Proliferation assays
These were essentially as described by Glass and Spooner (1990a) and detailed
in chapter 3.10. Briefly, ELL or PBM with irradiated PBM were incubated either
alone or with Con. A or Human recombinant IL-2 or irradiated autologous T.
annulata infected cells or irradiated cells used for immunisation in quadruplicate wells
of 96 well flat bottom plates. Cell proliferation was measured after 72 hours of
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incubation at 37°C in a 5% C02 incubator by a 6 hr pulse with [3H] thymidine
(Amersham) and the uptake was assessed by liquid scintillation counting.
7.2.10 Cytotoxicity Assays
The cytotoxic activity of freshly prepared ELL and PBM from the immunised
animals and after stimulation with irradiated cells for five days (7.2.8) was assayed
at regular intervals after immunisation throughout the experimental period.
Autologous parasite infected cells, autologous uninfected blasts, parasite infected
immunising cells, uninfected lymphoblasts from the animal used to create the
immunising cell line and BoLA mismatched parasite infected cells were chosen as
targets. The details of the technique are described in chapter 3.9.
7.2.11 Interferon-y assay
A solid phase sandwich ELISA (enzyme linked immunosorbant assay) using
mAbs specific for bovine ILN-y was used (Wood et al., 1990; Rothel et al., 1990)
to measure levels of ILN-y in the efferent lymph using a ready made test kit (CSIRO,
Australia) as described in chapter 3.11.
7.3 RESULTS
Efferent lymph cells were monitored as long as the cannulae kept flowing.
Once the cannula stopped, some of the observations were continued on PBM and
lymph node cells collected by a needle biopsy up to three weeks after cell line
immunisation. The cannula remained patent for 12 days in animal 933, 18 days in
859, 21 days in 838 and 9 days in 841.
7.3.1 Clinical reactions
The detailed clinical, parasitological and haematological reactions in these
animals after cell line immunisation are described in chapter 4. Briefly, animals 933
and 859 expressed mild parasitological reactions in the form of schizonts and
piroplasms after cell line immunisation. Out of the two animals expressing a pre¬
existing allogeneic immune response, one animal (838) exhibited very low levels of
schizonts in efferent lymph and piroplasms in blood smears similar to the other two
animals mentioned above. The second animal (841) did not show any parasitological
reactions. The size of the draining lymph node enlarged in animals 933, 859 and 838,
but no enlargement was observed in animal 841. On challenge with potentially lethal
T. annulata sporozoites, animals 933, 859 and 838 were immune but animal 841
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suffered from acute theileriosis (details in chapter 4).
7.3.2 Changes in the flow rate and cellularity of efferent lymph
The output of lymph from the prescapular node draining the site of cell line
immunisation is shown in fig. 7.1a. The flow rate increased slightly in all the animals
immediately after cell line immunisation and dropped back to normal by day 8 in the
three animals showing mild parasitological reactions after cell line immunisation. The
flow rate dropped back to normal on day 5 in animal 841 which showed no
parasitological reactions. The magnitude of increase was only 1.5-2 fold in all the
animals. A second peak of increase in the flow of lymph was observed in the animals
exhibiting parasitological reactions after day 11. The output of total lymphocytes in
the efferent lymph increased three fold in one animal (933), whereas, it was marginal
in animal 859 and 838 and only seen between day 6 to 9. The cell output from animal
841 which did not show any parasitological reactions decreased slightly after day 4
(fig. 7.1b).
Blasting cells (fig. 7.2a) were seen in cytospin smears prepared from the
efferent lymph from day 5 onwards in all the animals. Only a slight increase was seen
in animal 841. The other three animals which showed parasitological reactions after
immunisation exhibited two peaks of blasting cells. The first increase was observed
between day 6-11 and was associated with the development of an allogeneic response
against MHC antigens of the immunising cell line. The second increase was more
pronounced, started from day 13 and was associated with the parasite specific immune
response and dissemination of the parasite in the efferent lymph. A similar pattern of
blasting cells was seen when FSC vs SSC of ELL was examined on LACScan (R1 in
fig. 7.3a for animal 859 and 7.3b for 841).
7.3.3 Kinetics of the parasite dissemination
T. annulata infected cells appeared in the efferent lymph of animals 933, 859
and 838. No infected cells were seen in the animal 841 at any stage. Infected cells
were seen in animals 933 and 859 from day 11 and in 838 from day 16 onwards.
Maximum schizonts were always less than 1% of ELL in animals 933 and 838, and
2.5% in 859 (day 17) as shown in fig. 7.2b. Parasite infected cell lines could be
cultured from ELL on day 11-12 in animal 933, day 11-18 in animal 859 and day 16-
18 in animal 838. Parasite infected cells were isolated from PBM of animal 933 from
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Figure 7.1: Changes in the flow and cellularity of the efferent lymph after
immunisation with T. annulata infected cell line.
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Figure 7.2: Blasting and parasite infected cells in the efferent lymph after
immunisation with T. annulata infected cell line.
a: Blasting cells. b: parasite infected cells.
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Figure 7.3: Blasting cells in the efferent lymph after immunisation with T. annulata infected cell
line as assessed by the FACScan. FSC of cells is represented on the X axis and SSC on the Y
axis. Blasting cells are highlighted in the region 1 (Rl) on the basis of higher FSC & SSC. ELL:
(Efferent lymph lymphocytes). LNB: (Lymph node biopsy cells),
a: Animal no. 859 (naive). b: Animal no. 841 (skin grafted).
(The day 11, 13 & 18 figures for animal no. 841 are from lymph node biopsy cells).
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All the cell lines isolated from these animals were found to be of the recipient's origin
(animal's own infected cells) on BoLA typing. No cell line of the donor origin could
be isolated from ELL or PBM at any stage, despite very intensive sampling especially
for the first two days after immunisation.
7.3.4 Changes in lymphocyte subpopulations in the efferent lymph
The kinetics of various lymphocyte subpopulations in efferent lymph of
animals after immunisation is shown in fig. 7.4a to 7.4h. The percentage of total
CD2+ cells ranged between 61.9-82% in the resting efferent lymph of these animals.
It started to increase after day 4 of cell line immunisation peaking between day 6-8
and returned to resting levels by day 9 or 10. The increase in animal 841 which did
not show any parasitological reactions was only marginal from 80% to 87.5%. The
other three animals exhibited a second peak in the percentage of CD2+ cells starting
from day 11 or 12 to day 18 (fig. 7.4a). The first peak of CD2+ cells was associated
with an increase in the percentage of both CD4+ cells (fig. 7.4b) and CD8+ cells (fig.
7.4c), but the second peak was mainly associated with an increase in CD8+ cells.
Resting levels of CD8+ cells were 18.3% and 21.3% in animals 859 and 838,
respectively. A maximum of 55.4% and 59.9% CD8+ cells were observed in animal
859 on day 17 and 838 on day 18, respectively. The output of y<5 T cells slightly
declined in the efferent lymph after immunisation in all the animals and began to rise
from day 15 only in animal 838 (fig. 7.4d). There was a mild increase in MHC class
II+ cells immediately after cell line immunisation which declined by day 4, followed
by an increase from day 7 onwards which was prominent during the parasite specific
response (fig. 7.4e). Expression of CD25 on ELL increased in two animals
immediately after immunisation, whereas it was unaltered in the other two (fig. 7.4f).
A small increase was seen in the percentage of B cells in efferent lymph immediately
after immunisation between day 0-3 followed by a mild second increase between day
8-14 (fig. 7.4g & 7.4h).
7.3.5 Activation of T cells
The expression of CD25 first increased on CD4+ cells from day 9 followed
by CD8+ cells from day 15 after cell line immunisation (fig. 7.5a & 7.5b).
Expression of MHC class II on CD4+ cells slightly increased from day 13. However,
MHC class II expression increased significantly on CD8+ cells from day 13 after
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Figure 7.4: Changes in various lymphocyte subpopulations in the efferent lymph
after immunisation with T. annulata infected cell line.
a: CD2+ cells. b: CD4+ cells.
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Figure 7.4: Changes in various lymphocyte subpopulations in the efferent lymph
after immunisation with T. annulata infected cell line.
c: CD8+ cells d: WC1+ cells (y8 T cells).
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Figure 7.4: Changes in various lymphocyte subpopulations in the efferent lymph
after immunisation with T. annulata infected cell line.
e: MHC class II+ cells f: CD 25+ (IL-2R, a chain) cells.
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Figure 7.4: Changes in various lymphocyte subpopulations in the efferent lymph
after immunisation with T. annulata infected cell line.
g: VPM 30+ B cells h: IL-A30+ IgM bearing B cells.
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observed on day 0 as compared to 25.7% CD8+ MHC class II+ cells on day 18.
Increased expression of CD25 and MHC class II on T cells was mainly associated
with the parasite specific immune response and was less marked during the allogeneic
response against MHC antigens of the immunising cell line. Expression of these
activation markers on T cells was not observed in animal 841 which did not develop
any parasitological reactions after immunisation.
Resting CD4+ and CD8+ cells express CD2. A few CD4+ and CD8+ cells lost
CD2 expression during the second parasite specific phase of the immune response
(fig. 7.5e & 7.5f). Loss of CD2 expression from T cells after cell line immunisation
was less marked than observed after sporozoite inoculation in the naive animals as
reported in the chapter 6. Only 4.5% CD4+ CD2 and 9.9% CD8+ CD2" cells were
observed on day 18 in animal 859. Loss of CD2 expression on T cells was not
observed in ELL or lymph node biopsy cells of animal 841 which did not show any
parasitological reactions after immunisation.
An initial increase in the output of CD4+ cells was observed immediately after
immunisation. The increase was associated with the appearance of more CD45REC
(naive) CD4+ cells. The percentage of CD45RB (memory) CD4+ cells initially
declined to almost half in all the animals after immunisation up to day 9 during the
period of allogeneic response. The parasite specific response was associated with the
increase in CD45RB CD4+ (memory) cells and a gradual loss of CD4+ CD45RB+
(naive) cells (fig. 7.5g) indicating the development of a parasite specific response.
7.3.6 Proliferative responses
The functional activation state of ELL (fig. 7.6) and PBM (fig. 7.7) was
assessed by measuring their proliferative efficiency in response to Con. A, IL-2,
irradiated autologous T. annulata infected cells (Ta self) and irradiated parasite
infected immunising cells (TaH 769). Proliferative ability of ELL and PBM in
response to Con. A was greatly reduced after cell line immunisation. This effect was
more pronounced during the second parasite specific phase of the response. The
ability of these cells to proliferate in response to exogenous IL-2 increased gradually
after day 7 of immunisation. Increased proliferative responses were observed in
response to immunising cell line after day 7 and in response to autologous infected
cells after day 12. These changes in the proliferative responses to various stimuli
were associated only with animals exhibiting mild parasitological reactions after
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I: Animal no, 859 (naive). II: Animal no. 841 (skin grafted).
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Figure 7.5a: Dot plots of two colour immunofluorescent staining on ELL. CD4+ cells are
expressed on the Y axis (FL2). IL-2R+ (CD25) cells are expressed on the X axis (FL1).
I: Animal no. 859 (naive). II: Animal no. 841 (skin grafted).
(LNB: The day 13 & 18 figures for animal no. 841 are from lymph node biopsy cells).
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Figure 7.5b: Dot plots of two colour immunofluorescent staining on ELL. CD8+ cells are
expressed on the Y axis (FL2). IL-2R+ (CD25) cells are expressed on the X axis (FL1).
I: Animal no. 859 (naive). II: Animal no. 841 (skin grafted).
(LNB: The day 13 & 18 figures for animal no. 841 are from lymph node biopsy cells).
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Figure 7.5c: Dot plots of two colour immunofluorescent staining on ELL. CD4+ cells are
expressed on the Y axis (FL2). MHC class II+ cells are expressed on the X axis (FL1).
I: Animal no. 859 (naive). II: Animal no. 841 (skin grafted).
(LNB: The day 13 & 18 figures for animal no. 841 are from lymph node biopsy cells).
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I: Animal no. 859 (naive). II: Animal no. 841 (skin grafted),
MHO class 11+ cells
7
Figure 7.5d: Dot plots of two colour immunofluorescent staining on ELL. CD8+ cells are
expressed on the Y axis (FL2). MHC class II+ cells are expressed on the X axis (FL1).
I: Animal no. 859 (naive). II: Animal no. 841 (skin grafted).
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Figure 7.5e: Dot plots of two colour immunofluorescent staining on ELL. CD4+ cells are
expressed on the Y axis (FL2). CD2+ cells are expressed on the X axis (FL1).
I: Animal no. 859 (naive). II: Animal no. 841 (skin grafted).
(LNB: The day 13 & 18 figures for animal no. 841 are from lymph node biopsy cells).
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I: Animal no. 859 (naive). II: Animal no. 841 (skin grafted).
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-igure 7.5f: Dot plots of two colour immunofluorescent staining on ELL. CD8+ cells are
expressed on the Y axis (FL2). CD2+ cells are expressed on the X axis (FL1).
: Animal no. 859 (naive). II: Animal no. 841 (skin grafted).
LNB: The day 13 & 18 figures for animal no. 841 are from lymph node biopsy cells).
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Figure 7.5g: Dot plots of two colour immunofluorescent staining on ELL. CD4+ cells are
expressed on the Y axis (FL2). CD45RB"1" cells are expressed on the X axis (FL1).
I: Animal no. 859 (naive). II: Animal no. 841 (skin grafted).
(LNB: The day 13 & 18 figures for animal no. 841 are from lymph node biopsy cells).
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immunisation (fig. 7.6a & 7.7a for animal 933; fig. 7.6b & 7.7b for animal 838).
ELL and PBM from animal 841 which did not show any parasitological reactions
exhibited no variation in the proliferative ability to various stimuli after immunisation
(fig. 7.6c & 7.7c).
7.3.7 Cytotoxicity responses
Cytotoxic activity of ELL and PBM was measured against several target cells
in chromium release assays. Direct assays were done using freshly harvested ELL and
PBM as effector cells. The data presented in fig. 7.8 shows percent killing at effector
vs target ratio of 40:1. ELL and PBM were stimulated with irradiated autologous T.
annulata infected cells or irradiated parasite infected cells of the immunising cell line
for five days to enrich for cytotoxic effector cells. The stimulated cells were used as
effectors in chromium release assays against various targets. Fig. 7.9 shows percent
killing of target cells at 20:1 effector vs target ratio by using stimulated ELL or
stimulated PBM as effectors.
7.3.7.1 Direct assays
Cytotoxic activity directed against parasite infected cells used to immunise
animals was observed in freshly harvested ELL from day 5-6 and in PBM from day
7-8 onwards (fig. 7.8a & 7.8b). A similar degree of lysis was seen against uninfected
lymphoblasts derived from the animal which was used to generate the immunising cell
line and donate skin for implantation (data not shown). This indicated that cytotoxic
response was directed against ME1C antigens of the immunising cell line. Peak
cytotoxic activity against the allogeneic antigens of the immunising cell line appeared
between day 7-10 in ELL and 11-13 in PBM. The response began to wane by day 15
in the efferent lymph and by day 18 in the peripheral blood.
A moderate cytotoxic response started to develop against autologous T.
annulata infected cells from day 11-12 in the efferent lymph and day 12-13 in the
PBM (fig. 7.8c & 7.8d). Autologous uninfected blasts were not killed by ELL or
PBM at any stage indicating that the response was not directed against the blasting
cells (data not shown). Furthermore, a T. annulata infected cell line of a mismatched
BoLA type different from the BoLA type of the immunising cell line and recipient
animal was also not killed (data not shown) indicating it to be an MHC class I
restricted parasite specific response. The peak of the parasite specific response was
observed between day 15-18 in ELL and PBM. Animal 841 which did not show any
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a: ELL from animal no. 933
b: ELL from Animal no. 838
■ Control 11 Con. A ■ IL-2 □ TaH 769 H TaA self
c: ELL from animal no. 841
Figure 7.6: Proliferative responses of ELL in response to various antigen stimuli in vitro after
immunisation with T. annulata infected cell line.
Values represent the mean of quadriplicate counts.
a: Animal no. 933. b: Animal no. 838. c: Animal no. 841.
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a: PBM from animal no. 933
b: PBM from animal no. 838
c: PBM from animal no. 841
■ Control H Con. A H IL-2 □ TaH 769 H TaA self
Figure 7.7: Proliferative responses of PBM in response to various antigen stimuli in vitro after
immunisation with T. annulata cell line.
Values represent the mean of quadriplicate counts.
a: Animal no. 933. b: Animal no. 838. c: Animal no. 841.
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parasitological reactions after immunisation, exhibited only allogeneic cytotoxic
activity and no MHC class I restricted parasite specific killing.
7.3.7.2 Cytotoxic activity of stimulated cells
Stimulation of ELL or PBM with irradiated immunising cells or irradiated
autologous T. annulata infected cells helped in observing a magnified cytotoxic
response against allogeneic antigens of the immunising cell line and the parasite,
respectively (fig. 7.9). Stimulation of ELL or PBM with irradiated immunising cells
on day 0 of immunisation produced some allogeneic response in animals 838 and 841
as these animals had already been primed against MHC antigens by skin implantation
before immunisation (fig. 7.9a & 7.9b). The allogeneic response was not stimulated
from cells collected pre-immunisation from animals 933 and 859. The stimulated
allogeneic cytotoxic response gradually became stronger after immunisation in all the
four animals. ELL and PBM stimulated with irradiated autologous T. annulata
infected cells produced a very mild parasite specific cytotoxic response up to 7 days
after immunisation. Afterwards, the response gradually became stronger in all the
animals except animal 841, which never showed an amplified parasite specific
response (fig. 7.9c & 7.9d).
7.3.8 Interferon-y assay
Levels of ILN-y in the efferent lymph of animals after cell line immunisation
are shown in figure 7.10. ILN-y was detected in efferent lymph of animal 933 and
859 from day 2 to 7 after immunisation. The levels were very high in animal 933 as
compared to 859. Levels of ILN-y were undetectable in animals 838 and 841 at this
stage. Low levels of ILN-y were detected again in the efferent lymph of animals 859
and 838 from day 12 onwards during the parasite specific phase of the response. ILN-
y was not detectable in the efferent lymph of animal 841 throughout the experiment.
7.4 DISCUSSION
Two naive animals (933 & 859) exhibited mild parasitological reactions after
cell line immunisation. It has been well documented in the literature that animals
inoculated with allogeneic T. annulata infected cell lines develop mild parasitological
reactions and immunity to subsequent sporozoite challenge (Pipano, 1981; Ouhelli et
al., 1989; Brown, 1990). These two animals were subsequently immune to potentially
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Figure 7.10: Levels of IFN-y in the draining efferent lymph of animals after cell line
immunisation.
a: IFN-y expressed as ng per ml in the efferent lymph.
b: Levels of IFN-y expressed as ng per hour released in the efferent lymph.
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induced by skin implantation in the other two animals (838 & 841) before inoculation
of the parasite infected cell line derived from the skin donor animal. One of the
animals exhibited mild parasitological reactions after immunisation, but no parasites
were seen in the second animal, although similar titres of anti MHC antibodies were
evident in both the animals at the time of immunisation (chapter 4).
The three animals reacting mildly to the immunising cell line (2 naive & 1
skin grafted) displayed a biphasic immune response in the efferent lymph and
peripheral blood, the first directed against MHC antigens of the immunising cell line,
followed by a response directed against autologous parasite infected cells. Such a
biphasic response has earlier been reported in the peripheral blood after cell line
immunisation by Innes et al. (1989a). The animal 841 only showed an allogeneic
response after immunisation and no parasite specific response, indicating that the pre¬
existing allogeneic response blocked the generation of parasite specific immune
response. Innes (1988) and Preston & Brown (1988) also observed no parasite
development or boost in the parasite specific immune response when the animals were
reimmunised with the same allogeneic cell line used for first immunisation. Although
experiments in the above two reports were undertaken with different objectives,
indirect evidence that reimmunisation with the same cell line may not be useful in
boosting the parasite specific immune response was obtained. Observations on animal
841 and the experiments in chapter 4 clearly showed that development of the parasite
specific immune responses could be inhibited partially or completely by a pre-existing
allogeneic response.
Studies on the draining efferent lymph also revealed that the pre-existing
allogeneic response delayed or prevented the development of parasite after cell line
immunisation. T. annulata infected cells were isolated from efferent lymph of the two
naive animals from day 11 onwards after cell line immunisation. Infected cells were
isolated from only one of the other two animals (838) exhibiting a pre-existing
allogeneic response, only from day 16. No cell line was isolated from animal 841,
showing complete prevention of parasite development. Furthermore, schizonts were
observed in the efferent lymph only for 3 days (day 16-18) in animal 838 (skin
grafted) as compared to 9 days (day 11-19) in animal 859 showing that the parasite
development was delayed in the former. It is possible that most of the infected cells
were destroyed immediately after immunisation by the pre-existing allogeneic
227
response diluting parasite load in the animal body. If so, the parasite took longer to
attain detectable levels. This allowed enough time for the development of a parasite
specific immune response, and in turn cleared the parasite soon after its appearance.
Parasite infected cell lines were isolated from efferent lymph a few days before these
could be isolated from PBM. This observation was consistent with the lymphatic
system being a route for transfer of the parasite from the draining lymph node to
other body organs, as observed in chapter 6 after sporozoite inoculation and reported
to occur for T. parva (Emery, 1981b).
T. annulata infected cell lines isolated from the efferent lymph expressed the
BoLA type of the recipient animals, indicating that the infected cells exited in the
efferent lymph only after parasite transfer. An important pre-requisite for the
development of parasite specific immune response after cell line immunisation is that
the parasite must transfer from donor cells to the cells of the recipient (Pipano et al.,
1977; Brown, 1981; Innes et al., 1989c; this thesis, chapter 4). Cell lines of donor
origin were never isolated from efferent lymph or peripheral blood at any stage. The
place and mode of parasite transfer and phenotype of recipient's cells infected by the
parasite is not known. This is an important topic for future research to further
understand the cellular interactions leading to the development of a biphasic immune
response after cell line immunisation. The precise role of the allogeneic responses on
development of immunity against the parasite at the time of first or second
immunisation could only be elucidated after finding an answer to these questions.
These findings would also be important in understanding the development of
immunity after cell line immunisation against T. parva. Immunisation with allogeneic
T. parva infected cells is only possible by inoculation of as high as 107 to 109 cells
(Pirie etal., 1970; Brown etal., 1971; Brown etal., 1978a; Brown, 1981; Morrison
et al., 1981a), whereas, immunisation against T. annulata could be effective with as
low as 102 (Ouhelli et al., 1989) or 101 (Brown, 1990) allogeneic infected cells.
The present experiments indicate that parasite transfer takes place somewhere
between the site of inoculation of the cell line and the draining node as only infected
cells of the recipient origin were isolated in the efferent lymph. A few parasite
infected cells were observed in the lymph node biopsies after inoculation of lxlO8
allogeneic T. parva infected cells for the first four days and then around day 10
(C.G.D. Brown, unpublished observations). It seems likely that schizonts observed
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for the first four days were of donor origin followed by the appearance of recipient
infected cells later. These observations and the results in this chapter suggest that the
parasite is confined to the draining lymph node until development of the infected cells
of recipient origin. This is in contrast to the finding that parasite development took
place even after surgical removal of the draining lymph nodes after day 4 and 9
following immunisation with allogeneic T. annulata infected cell line before
appearance of schizonts of the recipient origin (P.K. Goel & R.L. Spooner, pers.
comm.). If infected cells are confined to the draining lymph node, removal of the
node should have stopped further parasite development and spread. The cell line was
inoculated subcutaneously in that experiment. In that instance, as with these studies,
there is a possibility that some of the inoculated cells were drained to some other
lymph node. Further studies by inoculation of labelled parasite infected cells through
intact afferent lymphatics and following their dissemination might help in
understanding the development of the parasite in the recipient and the mode of
parasite transfer.
Interestingly, the cell shutdown in the draining lymph node, as reported to
occur frequently after antigen challenge (Hall & Morris, 1965b; Hopkins et al.,
1981b) and also observed after inoculation of sporozoites in the naive animals
(chapter 6), was not seen after immunisation with the parasite infected cell line in any
of the animals. Total lymphocyte output was reported to remain relatively constant
for the first 150 hrs, followed by a marked elevation afterwards, in the efferent lymph
from the prefemoral node draining skin allografts (Emery & McCullagh, 1980a).
Inoculation of the allogeneic parasite infected cell line is directly comparable to the
response generated against a skin allograft as both instances lead to generation of a
graft rejection response in the lymph node. Migration of cells from the lymph node
was selective in these experiments, as evidenced by a decline in CD4+ cells of the
memory phenotype (CD45RB ) soon after immunisation, followed by a gradual
increase in memory CD4 cells and decrease in naive CD4 cells after day 7. It has
been shown earlier that initiation of primary immune responses to a protein antigen
in the lymph node was followed by exit of CD4+ memory cells via efferent lymph
into the blood (Mackay et al., 1990).
Increase in the flow of lymph in the efferent lymphatics was observed in two
naive animals after immunisation during the early allogeneic phase of the response.
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This was not observed in the other two animals which had been presensitized to the
MHC of the immunising cell line. Increase in the flow rate, which was marked in one
of the two naive animals, was associated with about a three fold increase in the cell
output and high IFN-7 levels during the allogeneic phase of the response. The smaller
increase in the flow rate of the second animal was associated with about a two fold
increase in the cellularity and marginal increase in the levels of IFN-7 in the efferent
lymph at this time. Perhaps the severity of these reactions was related to level of the
ensuing allogeneic reactions, as cytotoxicity assays revealed a very strong allogeneic
response in the former and only a mild response in the second naive animal. An
increase in the flow rate and output of total and blasting cells in the efferent lymph
was also reported after inoculation of allogeneic lymphocytes in the draining area or
afferent lymphatics of the node (Emery & McCullagh, 1980b).
The second parasite specific phase of the immune response was associated with
almost a two fold increase in the flow of lymph in the animals while they underwent
mild reactions to immunisation, but the total cell output was almost unchanged. A
transient increase in the output of lymph has also been reported in sheep after
infection with Chlamydia psittaci (Huang et al., 1991) and a strain of Toxoplasma
gondii which does not establish persistent infection (Buxton et al., 1994). The
increased flow rate was probably attributable to the enlargement of the lymph node
and increase in blood supply to the node as suggested by Hay & Hobbs (1977) and
also discussed in chapter 6.
A biphasic output of blasting cells was observed in the efferent lymph of
animals exhibiting mild parasitological reactions after cell line immunisation. The first
peak of blasting cells corresponded to the allogeneic response against MHC antigens
of the immunising cell line. The second peak was stronger and coincided with the
appearance of parasite specific cytotoxic response. The percentage of blasting cells
increased above 50% along with very low levels of IFN-y in the efferent lymph.
Blasting cells have been reported to appear in the draining efferent lymph in response
to various micro-organisms (Emery, 1981b; Issekutz,1985; McColgan et al., 1987;
Huang et al., 1991; Bird et al., 1993; Buxton et al., 1994). A massive output of
blasting cells was observed in response to inoculation of T. annulata sporozoites
leading to acute clinical theileriosis (chapter 6). These blasting cells were not involved
in controlling the infection as cytotoxicity and proliferation assays on ELL did not
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reveal parasite specificity as discussed in chapter 6.
Allogeneic responses were shown to be induced in peripheral blood around day
9 after inoculation of animals with a T. annulata infected BoLA mismatched cell line.
The specificity of the cytotoxic response changed, becoming directed against
autologous parasite infected cells around day 13 (Innes et al., 1989a). Similar kinetics
of the cytotoxic response in the peripheral blood were observed after immunisation
in animals reacting mildly to the cell line. The cytotoxic response in the efferent
lymph appeared earlier, was stronger and more short lived than that detected in the
peripheral blood, indicating that the initiation of immune response takes place in the
draining lymph node. The biphasic cytotoxic response associated with two peaks of
blasting cells and CD8+ cells in the efferent lymph reflected a change in the antigens
being presented to the immune system. The first response reflected specificity to the
allogeneic antigens of the immunising cell line. After parasite transfer and infection
of the recipient's cells, the immune response received a second priming by parasite
specific antigens in the context of self MHC. A similar biphasic cytotoxic response
was observed in peripheral blood of the animals after inoculation of 107 or more T.
parva infected allogeneic cells (Emery et al., 1982).
Phenotyping of ELL revealed a change in the initial dominance from CD4+
cells to CD8+ cells during the course of the immune response. Similar findings in the
efferent lymph have been reported after immunisation with an incomplete strain of
Toxoplasma gondii tachyzoites (Innes et al., 1992b) and infection with Chlamydia
psittaci (Huang et al., 1991) in sheep. Increased output of CD8+ cells in efferent
lymph is in accord with increased levels of circulating CD8+ cells in the peripheral
blood as shown in chapter 5 and also reported earlier in animals recovering from T.
annulata sporozoite infection (Preston et al., 1992a). It has been shown earlier that
cells exiting in the efferent lymph are responsible for systemic dissemination of the
immune response (Fahy et al., 1980; Trnka & Cahill, 1980). Transfer of syngeneic
thoracic duct leucocytes from a calf immune against T. parva to its naive chimaeric
co-twin has been shown to provide resistance to lethal sporozoite challenge (Emery,
1981a). In a recent report, increase in the precursor frequency for T. parva specific
MHC class I restricted cytotoxic T lymphocytes was observed in the efferent lymph
of an immune animal undergoing sporozoite challenge. Adoptive transfer of purified
CD8+ cells from ELL of the immune animal at this stage prevented the development
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of disease in its naive monozygotic twin undergoing a potentially lethal infection
(McKeever et al., 1994). Similar experiments have not been done with T. annulata
specific CD8+ cells, but the kinetics of the cytotoxic responses observed here suggests
that the same would also be true for T. annulata.
Expression of activation markers in the form of MHC class II and CD25 on
T cells (Greene et al., 1986; Glimcher & Kara, 1992) slightly increased during the
phase of allogeneic response. The increase in the expression of activation markers
was more marked during the parasite specific phase of the response. Many CD4+ and
CD8+ cells expressed MHC class II after activation but CD25 appeared only on a few
cells. Expression of MHC class II but not CD25 on T cells has been shown to be a
defective maturation state appearing in response to various lentivirus infections
(Panteleo et al., 1990; Reimann et al., 1991; Bird et al., 1993). However,
responsiveness of ELL and PBM to in vitro stimulation with IL-2 gradually increased
and specific cytotoxic activity appeared after cell line immunisation indicating the
activated state of the cells. ELL and PBM were less responsive to Con. A after
immunisation, but their responsiveness to irradiated immunising cells and autologous
infected cells gradually increased. This indicates that cells exiting in the efferent
lymph were already committed either to allogeneic antigens of the immunising cell
line or the parasite antigens and were, therefore, less responsive to Con. A. This is
in contrast to the observations in chapter 6 where both ELL and PBM were less
responsive to all exogenous stimuli during the period of acute clinical theileriosis after
inoculation of sporozoites, which seemed to be either because of lymphocyte anergy
or suppression.
All the above observations on ELL and PBM after immunisation with
allogeneic T. annulata infected cell lines demonstrate the development of a normal
immune response which is dominated by a cytotoxic T cell response. However during
the parasite specific phase of the response, a few CD4+ and CD8+ cells not
expressing CD2 were also observed. The percentage of CD4+ or CD8+ cells not
expressing the CD2 molecule was very low in contrast to the appearance of large
numbers of CD4+ and CD8+ cells with loss of CD2 expression observed during acute
T. annulata infection with the sporozoites (chapter 6). Loss of CD2 expression on T
cells was also observed during T. parva infection (E.A. Innes & G. Lamb,
unpublished observations, reported in Innes et al., 1992a). As discussed in chapter
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6, loss of CD2 expression was associated with a non-specific activation of T cells by
T. annulata, leading to some kind of suppression where T cells neither responded in
vitro to irradiated parasite infected cells nor to other exogenous stimuli like Con. A
and IL-2. The parasite was also able to cause non-specific stimulation at least in some
T cells after cell line immunisation, although the amount of parasite load was very
low in these animals. Nevertheless, a parasite specific cytotoxic T cell response also
developed.
The two animals implanted with skin developed similar levels of allogeneic
response, but parasite transfer to the recipient's cells took place only in one animal
which was immune to subsequent sporozoite challenge. The pre-existing allogeneic
response did not allow parasite development in the second animal which was fully
susceptible to the sporozoite challenge. Why these two animals showed different
responses after cell line immunisation despite similar pre-existing allogeneic response
is not clear and could not be explained from these experiments. It has been previously
shown that animals inoculated with killed T. annulata infected cells developed
antibody titres to a schizont antigen, but were not immune on sporozoite challenge
(Pipano et al., 1977). More studies are required to understand how parasite transfer
takes place and what is the precise role of allogeneic response on the parasite infected
cells used for immunising the animals. Further, it is important to know which cells
are infected by the parasite during the parasite transfer. There is a possibility that a
mild allogeneic response is beneficial for the parasite transfer as it would attract
immunologically active cells to the site of infection or the draining lymph node.
Alloreactive cytotoxic cells generated against MHC antigens of the immunising cell
line perhaps only destroy the infected cell but not the parasite within it, which is able
to infect other cells. If that is the case, reimmunisation with an increased dose of
allogeneic T. annulata infected cells might enable some parasites to transfer into the
recipient's cells. However, it was recently shown that reimmunisation of calves with
lxlO6 allogeneic T. annulata infected cells seven months after the first immunisation
with lxlO4 cells did not boost immunity (Ouhelli et al., 1994). Possibly cell numbers
in the range of 107-109 would be required for effective cell transfer at the time of
reimmunisation as is needed for the first immunisation against T. parva (Pirie et al.,
1970; Brown et al., 1971; Brown et al., 1978a; Brown, 1981; Emery et al., 1982).
The results presented in this chapter showed that animals immunised with
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lxlO6 T. annulata infected cells exhibited a mild increase in the output of lymph and
total cells from the node. The output of blasting cells from the node showed a
massive elevation showing two peaks of the blasting cells. The first corresponded to
an allogeneic response against MHC antigens of the immunising cell line and the
second was associated with the parasite specific response. Parasite infected cells of
the recipient origin appeared in efferent lymph from day 11 onwards, but cells of
donor origin were never isolated and established in culture. Isolation of parasite
infected cells from the efferent lymph was accomplished earlier than peripheral blood,
further confirming that parasite dissemination after cell line immunisation also takes
place through efferent lymph. A biphasic increase in the output of CD8+ cells in
efferent lymph was observed after cell line immunisation. The increase was more
pronounced during the second parasite specific phase than the first allogeneic phase.
A few T cells expressed CD25 as compared to many T cells expressing MHC class
II. ELL and PBM exhibited increased proliferation in response to in vitro stimulations
with human recombinant IL-2, irradiated autologous T. annulata infected cells and
irradiated immunising cells. Cytotoxic responses against MHC antigens of the
immunising cell line followed by MHC class I restricted parasite specific cytotoxicity,
were observed in both efferent lymph and peripheral blood. However, a few CD4+
and CD8+ cells not expressing CD2 were also observed during the second parasite
specific phase of the response. At this stage, CD25 and MHC class II expression on
T cells increased. The inhibition of parasite development after cell line immunisation
as a result of the pre-existing allogeneic response was not associated with T cell





Theileria annulata infected macroschizont cell lines have been widely used as
vaccines in endemic areas to control tropical theileriosis (Hashemi-Fesharki & Shad-
Del, 1973; Wenshun et al., 1973; Stepanova et al., 1977; Pipano, 1977; Singh,
1992). However, the duration of immunity engendered by these vaccines is poorly
defined. Immunity has been shown to decline after vaccination (Pipano, 1977; Ouhelli
et al., 1994) and reimmunisation is recommended in some countries (Pipano, 1978).
It would be particularly relevant in areas where the disease season is very short and
endemic stability does not exist. All the animals do not encounter ticks to get a boost
in immunity during a particular season. This situation has been reported in Morocco
where only 15.6% animals were infected by ticks in one season, as shown by
seroconversion (Flach & Ouhelli, 1992). The cell lines of T. annulata used as
vaccines for control of the disease in endemic areas are invariably allogeneic to the
recipient animals. Some evidence in the literature suggests that reimmunisation with
the same cell line may not be effective (Pipano, 1978; Ouhelli et al., 1994). It could
arise because of the allograft responses induced against MHC antigens of the
immunising cell line after first vaccination. Experiments in this thesis were initiated
to address this question i.e. to elucidate the effect of a previously generated allogeneic
response on immunisation with a T. annulata infected cell line.
It has been shown earlier that allograft reactions produced by T. annulata
infected cell lines are similar to the responses produced by skin grafting (Kachani &
Spooner, 1992). These findings were exploited further and developed as a model to
study reimmunisation in these experiments. The allograft responses generated after
first cell line immunisation were imitated either by inoculation of uninfected
leucocytes or by skin grafting. This was followed by inoculation with a T. annulata
infected cell line which acted as the second immunisation. The development of
immunity was assessed by challenging the animals with a potentially lethal dose of
sporozoites.
Allogeneic responses generated by the inoculation of uninfected leucocytes
were very mild as compared to the strong responses after skin grafting. The animal
showing a mild allograft response, induced by the inoculation of uninfected cells, was
immune to lethal sporozoite challenge following immunisation with lxlO6 T. annulata
infected cells. In contrast, animals exhibiting a strong anti MHC response induced by
skin grafting exhibited variable reactions on cell line immunisation. Of the skin
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grafted animals, one out of three inoculated with lxlO6 infected cells and all three
inoculated with lxlO4 infected cells were not immunised. The parasite did not transfer
into cells of the recipient from the immunising cells and the animals suffered from
an acute disease on sporozoite challenge. The pre-existing allogeneic response
prevented the appearance of parasitological reactions and development of immunity
after cell line immunisation. The two other animals which became immune despite
an allogeneic response, exhibited delayed parasitological reactions and presumably
development of immunity.
The ability to isolate parasite infected cell lines from the peripheral blood after
cell line immunisation was also delayed or prevented in the presence of a pre-existing
allograft response. This ability correlated with protection on sporozoite challenge.
Animals were fully susceptible to sporozoite challenge if no parasite infected cell line
could be isolated after immunisation. There is an indirect evidence in the literature
that transfer of the parasite from inoculated cells to the cells of the recipient is
important for the development of immunity against T. annulata as well as T. parva
(Brown et al., 1978b; Emery et al., 1982; Innes et al., 1989a). This was conclusively
demonstrated by the experiments in this thesis. Where no parasite infected cell line
was isolated, as after immunisation from some of the skin grafted animals, such
animals were fully susceptible on sporozoite challenge.
Although the importance of allograft responses in the development of
immunity during immunisation with T. annulata infected cell lines was highlighted
in these experiments, similar levels of allograft responses were found to prevent
parasite transfer and the development of immunity in some animals but not in others.
The mechanism of this interference is not understood because of lack of knowledge
of the cellular interactions between the parasite and various lymphocyte
subpopulations. We know little about the cellular events leading to the development
of immunity after cell line immunisation and subsequent sporozoite challenge. Further
studies in this thesis thus concentrated on attempts to understand the dynamics of
parasite dissemination and activation of various lymphocyte subpopulations. To do
this, changes occurring in peripheral blood and lymph efferent from the node draining
the site of T. annulata cell line immunisation and sporozoite challenge were
monitored, in skin grafted and non-skin grafted (naive) animals.
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Peripheral blood acts as a traffic route for circulating leucocytes and,
therefore, can provide useful information on the involvement of various cell
subpopulations in the development of immunity (Westermann & Pabst, 1990). The
dynamics of various leucocyte subpopulations in peripheral blood revealed that mild
and transient leucopenia was a common finding, after immunisation with T. annulata
infected cell lines or challenge of immune animals. In contrast, leucopenia was severe
and progressive in susceptible animals developing acute disease after sporozoite
challenge. A very small and transient fall in circulating leucocytes was also observed
in the skin grafted animals which showed no sign of parasite development after cell
line immunisation. Leucopenia was caused by a fall in the number of circulating
granulocytes and lymphocytes. In response to T. annulata infection, a fall in the
levels of circulating CD4+ cells and B cells is directly responsible for this
lymphocytopaenia, followed by lesser involvement of CD8+ cells and 78 T cells.
Cells of the monocyte/macrophage lineage were least affected.
In the convalescent animals, there was a transient increase in the total
circulating CD8+ cells initially, followed by a sustained increase in
monocytes/macrophages. These changes were associated with recovery in cell line
immunised animals and also after treatment in animals showing clinical theileriosis.
These observations further confirmed that immunity against T. annulata is mediated
by CD8+ cells and monocyte dependent mechanisms.
During the course of parasite development after cell line immunisation or
sporozoite challenge, T cell activation markers in the form of CD25 (IL-2R, a chain)
appeared transiently on PBM and the percentage of cells bearing a memory phenotype
(CD45RB ) increased. These changes were not observed in skin grafted animals where
no parasitological response was seen after cell line immunisation.
Initial pathology and development of immunity takes place in the draining
lymph node after sporozoite challenge or cell line immunisation. Cells leaving in the
efferent lymph of an antigen primed node reflect the immunological events occurring
in the node and disseminate immune effector cells to rest of the body (Trnka &
Cahill, 1980). Further experiments concentrated on understanding parasite
dissemination and T cell activation in the lymph efferent from the node draining the
site of sporozoite challenge or cell line immunisation.
T. annulata sporozoites induced a strong lymphoproliferation in the draining
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lymph node of naive animals, leading to a 8-10 fold increase in the output of fluid
and cells from the node. Cell output from the node also increased transiently in the
immune animal challenged with sporozoites, but output of fluid was unaffected.
Animals immunised with lxlO6 T. annulata infected cells only exhibited a mild and
transient increase (1.5 to 2 fold) in the output of lymph and total cells from the node.
Infection with sporozoites in naive animals induced a period of cell shutdown
corresponding to the initial appearance of schizonts in the node. This was followed
by a massive output of blasting cells (more than 80% of total ELL on day 10)
accompanied by the exit of parasite infected cells in the efferent lymph. Only a few
blasting cells were observed in the immune animal. In the cell line immunised
animals, output of blasting cells from the node increased gradually, showing two
peaks. The first corresponded to an allogeneic response against MHC antigens of the
immunising cell line and the second was associated with a parasite specific response.
The maximum proportion of blasting cells in efferent lymph was about 50 % during
the second phase. A slight increase in the output of lymph and blasting cells was also
observed in the skin grafted animals which showed no parasitological reactions after
cell line immunisation.
Schizonts appeared in the efferent lymph of naive animals after sporozoite
challenge from day 6 onwards, very shortly after they would be expected to appear
in the lymph node. Infected cells were not observed in the immune animal. As judged
by isolation of parasite in vitro, the cell line immunised animals showed infected cells
of recipient origin in efferent lymph from day 11 onwards. Infected cells of donor
origin were never isolated. Appearance of schizonts was delayed to day 16 in one of
the skin grafted animals after cell line immunisation and completely prevented in the
other. Isolation of parasite infected cells in the efferent lymph was accomplished
earlier than from peripheral blood, indicating that the parasite dissemination takes
place through efferent lymph to the rest of the body.
Large amounts of ILN-y were observed in efferent lymph, coinciding with the
cell shutdown in naive animals undergoing acute disease after sporozoite challenge.
This was followed by comparatively lower levels of ILN-y detected during the course
of infection, which might be responsible for some of the initial pathology. Two low
level peaks of ILN-y were observed in naive animals after cell line immunisation. The
first transient and relatively stronger peak was observed between day 2-7, followed
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by very low levels of IFN-7 after day 12 which corresponded to the appearance of
the parasite. IFN-7 was not detected in the skin grafted animal not responding to the
cell line immunisation.
Phenotypic analysis of ELL showed an increase in T cell output, which
initially comprised CD4+ cells, followed by a massive output of CD8+ cells after
sporozoite challenge or cell line immunisation of naive animals. A biphasic increase
in the output of CD8+ cells was observed after cell line immunisation. The increase
was more pronounced during the second parasite specific phase than the first
allogeneic phase.
Naive animals initially seemed to mount a parasite specific T cell activation
response after sporozoite challenge in the form of transient CD25 and MHC class II
expression on CD4+ cells, followed by a strong proliferation of CD8+ cells with high
expression of MHC class II but not CD25. In cell line immunised animals, few CD4+
and CD8+ cells expressed CD25. In contrast, many T cells which were mainly CD8+
cells expressed MHC class II, mainly during the parasite specific phase of the
response.
Functional assays on ELL and PBM from calves undergoing acute theileriosis
after sporozoite challenge revealed that the response of these cells was not parasite
specific. The cells showed no parasite specific cytotoxic activity and were less
responsive to exogenous Con. A, IL-2 or irradiated autologous infected cells in vitro,
as if in a state of suppression. Parasite specific T cells were observed in the immune
animal and after treatment in naive animals. On the other hand, ELL and PBM from
cell line immunised animals exhibited increased proliferation in vitro in response to
stimulation with IL-2, irradiated autologous T. annulata infected cells or irradiated
immunising cells. Cytotoxic responses were observed against MHC antigens of the
immunising cell line followed by MHC class I restricted parasite specific cytotoxicity.
The parasite induced an inappropriate proliferation and abnormal activation of
T cells in the lymph node after sporozoite challenge as T cells gradually lost CD2
expression with the progression of the disease. CD2 is an important adhesion
molecule for normal T cell effector function and is required for initial binding with
LFA-3 on target cells (Bierer et al., 1989). Loss of CD2 expression was more
pronounced on CD8+ than CD4+ cells. In cell line immunised animals, a few CD4+
and CD8+ cells not expressing CD2 were also observed during the second parasite
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specific phase of the response along with appearance of normal immune effector cells.
At this stage, CD25 and MHC class II expression on T cells increased. Inhibition of
the parasite development after cell line immunisation, as a result of the pre-existing
allogeneic response, was not associated with T cell activation in response to the
parasite and only allogeneic responses were observed.
These experiments show that pre-existing allograft immune responses,
generated in animals after first cell line immunisation, may block parasite transfer and
further development or enhancement of immunity against T. annulata on second
immunisation with the same cell line. The situation at the time of reimmunisation with
the same cell line against T. annulata looks similar to primary cell line immunisation
against T. parva where a large number of cells are required for parasite transfer.
These observations are of immediate importance in endemic areas where T. annulata
infected cell culture vaccines are being used, or their application is planned for the
future. They are even more relevant in countries where animals are regularly moved
between theileriosis free and endemic areas. It may not be advisable to reimmunise
the animals with the same cell line as that used for first vaccination. The problem
might be overcome by using cell lines with different MHC phenotypes. However,
further experiments will be needed to confirm the effectiveness of using different cell
lines before recommending it for field conditions. Alternatively, parasite infected cell
lines lacking MHC expression might be useful as these would not induce an allograft
response. Some T. parva infected MHC class I and class II negative cell lines have
been generated (A.J. Teale, pers. comm.), but similar T. annulata infected lines are
not available.
Leucopenia, corresponding to the severity of parasitological reactions, as a
result of loss of both circulating polymorphonuclear cells and mononuclear cells, was
observed after sporozoite challenge and after cell line immunisation of naive animals.
However, studies on the efferent lymph exhibited an increase in the total cell output
from the lymph node draining the site of infection, as a result of T cell proliferation
in that node. The parasite seemed to induce a non-specific proliferation and
inappropriate activation of T cells as it was not associated with normal T cell
activation markers. Appearance of CD25 was transient, T cells lost CD2 expression
and activated CD4+ cells did not express the memory phenotype during the course
of acute disease. Some non-specific T cell activation was also observed in cell line
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immunised animals corresponding to the small parasite load. The non-specifically
activated T cells are possibly destroyed by apoptosis leading to a decrease in the
circulating leucocytes.
This study provided more understanding of parasite dissemination and some
of the cellular and molecular interactions leading to development of immunity against
T. annulata, in the efferent lymph and peripheral blood, both after sporozoite
challenge and cell line immunisation. The findings are relevant for T. parva and other
apicomplexan parasites of man and animals like Plasmodium where these type of
studies may not be possible. Similar experiments in animals exhibiting a pre-existing
allograft response only showed that parasite transfer after cell line immunisation can
be delayed or prevented. This observation cautions against repeated use of the same
allogeneic cell line for boosting immunity under field conditions. The precise
mechanism, which prevents the development of parasite specific immune response
because of the presence of an allograft response, was not determined. An
understanding of the mechanism of parasite transfer from donor cells to the cells of
the recipient would be a high priority topic for future studies. This would help in
improving control measures for T. annulata and also help in defining and developing
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APPENDIX
1. Hanks balanced salt solution
HBBS supplied in powder form (Gibco BRL, Life technologies) containing
phenol red was reconstituted with deionised distilled water. Sodium bicarbonate
(Fisons) was added at the rate of 0.35g per litre and the pH of the HBBS solution was
adjusted to 6.8 with a pH meter (Russell pH limited) using IN HCL or IN NaOH.
The final volume was made up to 100 ml to make lOx (10 times concentrated) HBSS
solution. It was sterilised by filtration (0.22/jl, Millipore Corporation) and stored at
4°C until required. The solution was made up to lx before use by addition of
sterilised distilled water.
2. Complement
Pooled rabbit sera collected from a commercial slaughterer was used as a
source of complement. Batches of complement were screened for lack of inherent
cytotoxicity and for potency in the microlymphocytotoxicity test using test cells and
antisera of known reactivity. Suitable batches of complement were then stored at -
70°C until required in the test.
3. Eosin dye
A 5 % w/v stock solution of Eosin powder (Koch Light Laboratories Ltd) in
HBSS was prepared and stored at -20°C in 1 ml aliquots. The solution was thawed
just before use.
4. Fixing solution
Fixing solution was prepared by adding 5 ml of 0.15M disodium hydrogen
phosphate (Fisons) in deionised distilled water to 95 ml of formalin (40%
formaldehyde in 0.9% saline) and was stored at room temperature.
5. Acid citrate dextrose
ACD consisted of 2.5% D-Glucose (Fisons) and 2.05% di-sodium hydrogen
citrate (Fisons) in distilled water. The solution was autoclaved and added to 20 ml
vacutainers or 500 ml bottles for collection of blood at 1 ml for 4 ml of blood (4 ml
ACD & 16 ml blood in 20 ml vacutainer; 100 ml ACD & 400 ml blood in the
bottle).
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6. Ammonium chloride lysis solution
It consisted of two solutions: Solution A, 0.16M Ammonium Chloride
(Fisons); Solution B 0.17M Tris (Fisons). Both the solutions were prepared separately
in distilled water, autoclaved and stored at room temperature. Solution A and B were
warmed to 37°C and mixed in a ratio of 9:1 just before use. Blood was centrifuged
at 1500g for 20 min., supernate plasma was discarded. To 15 ml cell pellet, 35 ml
of mixture of sol. A and B was added. The tubes were incubated for a few min. in
37°C water bath until colour of the solution became black. It was centrifuged at 300g
for 10 min. in a refrigerated centrifuge. The cell pellet was washed twice with PBS
by centrifugation at lOOg for 10 min.
7. Phosphate buffer saline
PBS consisted of 0.9% Sodium Chloride, 0.107% di-Sodium Hydrogen
Phosphate and 0.051 % Sodium di-Hydrogen Orthophosphate (all Fisons) w/v aqueous
solution in distilled water. The pH of the solution was adjusted to 7.2 using IN HC1
or IN NaOH, autoclaved and stored at room temperature.
8. Complete tissue culture medium
Theileria annulata infected cell lines were established and maintained in sterile
TC medium comprising RPMI-1640 with 25mM Hepes (Gibco BRL), 2mM L-
glutamine (Gibco BRL) and supplemented with 10% FCS (Meriden), 100 i.u. per ml
penicillin and 100 \xg per ml streptomycin (Gibco) as described by Brown (1983).
Aliquot of TC medium were tested for sterility before use in cultures.
9. Mixed lymphocyte culture medium
MLC medium was used for mixed lymphocyte culture of PBM or ELL with
irradiated self T. annulata cell cultures, initiation and maintenance of uninfected
lymphoblastoid cell lines and proliferation assays. The medium contained RPMI 1640
(Gibco BRL) supplemented with 25mM Hepes, 2mM L-glutamine (Gibco BRL),
5xl0"5 M 2-mercaptoethanol (BDH) and supplemented with 10% foetal calf serum
(Imperial) and 50 /xg/ml gentamycin (Gibco BRL) as described by Glass and Spooner
(1990). Aliquots of MLC medium were tested for sterility before use.
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W1 1,8,83,112,151 A15 A8.2 105,152
A2 2,62,64,65,115 A16 38,43,131,114
A3 39 W17 W6.1 12,92,93
W4 82,117 A18 W6.2 81,86,113
A5 7,90 A19 W6.4 100
A6 9,10,66,75,97 A20 78,121
A7 11,67,68,132 A21 107,123
A8 13 W25 111,132
A9 14,140 A31 99,127
A10 69,71 A32 40,124,126
All 73,76,110,102 W36 121
A12 47,133 W50 85
A13 5,136,109 BoLy R' 94
A14 A8.1 80,138
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13: appearance of IL-A24+ cells in the efferent lymph after infection with T. annulata
sporozoites or parasite infected cell line.
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The effect of anti MHC response on cell line immunisation against
Theileiia annulata
Anil Nichani, AFRC, LAPGR, Roslin, Midlothian, EH25 9PS
Theileria annulata infected lymphoblastoid cells have been successfully used as a live vaccine
which produces a strong cytotoxic response and complement fixing antibodies against the
allogeneic MHC antigens along with an anti parasite immune response. However, the
histocompatibility barrier does not jeopardise infection and primary immunisation against
T. annulata. The duration of immunity after cell line immunisation is not clearly known and
re immunisation is sometimes recommended. However, it is not clear whether the anti MHC
response interferes in the parasite transfer and development of immune response at the time of
reimmunisation. This experiment was undertaken to see the effect of preformed anti MHC
response on cell line immunisation by immunising animals against MHC antigens and later
inoculating T. annulata infected cell lines and challenging with stabilate of T. annulata
sporozoites. The role of preformed anti MHC response on cell line immunisation against T.
annulata will be discussed.
Proceedings of a meeting "Tropical Theileriosis research: current status",
held at University of York, 29-30 March, 1993. p. 12.
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V 649 CHANGES IN T CELL SUBSETS IN' EFFERENT LYMPH
OF CATTLE DURING Theikria annulala INFECTION
A K Nichani and R.L. Spooner, Division of Molecular Biology, AFRC
Roslin Institute (Edinburgh), Roslin, Midlothian, EH25 9PS. U.K.
Theilena annulala is a protozoan parasite which causes a senous
lymphoproliferative disease of cattle: Tropical theileriosis in tropical and
subtropical countries. The parasite is transmitted by licks of the genus
Hyalomma and preferentially invades monocytes/macrophages and B cells.
Much of the pathology and lymphoproliferation lakes place in the lymph
node draining the site of infection. We are studying immune responses
to the parasite in the efferent lymph of the draining lymph node in a
potentially lethal infection as a model for understanding immunity to
intracellular parasites. The parasite induces strong lymphoproliferation
and the blasting cells start appearing in the efferent lymph after day 6 of
infection. Initially, the blasting cells are CD4+ followed by a strong
proliferation of CD8 cells Most of the blasting cells are IL-2R + as well
at this stage. The resting T cells in the efferent lymph are MHC class II
negative, but majority of blasting CD4 and CD8 cells have high MHC
class II expiession as well. However, the CD8 cells do not kill
autologous parasite infected cells. The cells proliferate strongly in
response to con A and exogenous IL-2, but don't proliferate in response
to irradiated autologous Theileria infected cells. These findings are
discussed in relation to the progression of the infection. Further studies
on the function of the various activated cell populations are in progress
Journal of Cellular Biochemistry. S18D: 422.
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ALLOGENEIC IMMUNE RESPONSES CAN BLOCK THE DEVELOPMENT OP IMMUNITY
FOLLOWING CELL LINT! IMMUNISATION AGAINST THEJLERIA Ah'KULATA
A.K. Nichani1, P. Millar1, M.R Maxwell1, G.W. Robertson1. C.GI). Brown' and R L. Spoooer1'.
1. Roslin Institute (Edinburgh), Roslin, Midlothian, EH25 9PS. UK., 2. CTYM, Easter bush, Roslin,
Midlothian, EH25 9RG, U.K.
T. annulate infected ceil lines have been used as vaccines against tropical theileriosis in several countries. The
inoculated animals produce a strong cytotoxic Tcell and humoral response against the allogeneic MHC antigens
of the immunising cell line followed by a parasite specific immune respor.se. The duration of immunity after cell
line immunisation is do< known. There is evidence that immunity to the parasite wanes and reimmunisalioo is
often recommended. However, it is not clear whether an allogeneic response generated after first immunisation
would interfere with development of immunity against the parasite at the lime of re immunisation with the same
cell line. These experiments were undertaken lo study the effect of pre-existing allogeneic response on cell line
immunisation. The animals were immunised against MHC antigens by inoculation of uninfected leucocytes Of
skin grafting and later immunised with a T. annulate infected cell line of the same BoLA type. A mild
allogeneic response generated by the leucocyte inoculation didn't affect the development of immunity following
cell line immunisation. But a strong allogeneic response generated by skin grafting, which mimics the response
produced by inoculation of the cell lines, interfered with the parasite transfer and development of a parasite
specific immune response when the animals were immunised with lx\(f cells. The allogeneic response generated
in this manner totally blocked parasite transfer at a lower immunising cell dose of lxlO4 cells where animals
suffered from acute disease on sporozoite challenge. These observations are of immediate importance in endemic
areas where cell lines of T. annulate schizonts are being used as vaccines to control the disease. The allogeneic
immune response generated in the animals after first immunisation with a cell tine might block development of
immunity against the parasite if the animals are reimmunised with the same cell line used for first immunisation.
European Union third coordination meeting on Tropical Theileriosis,
held at Antalya, Turkey, 4-9 October, 1994.
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RESPONSE TO THEILERJA ASNVLATA INFECTION IN EFFERENT LYMPH LEAVING THE
NODE DRAINING THE SITE OF INFECTION
A.K. Nichani'", S C. Craigmile', B.H. Thorp'. M. Ritchie', C.G.D. Brown1 and R.L. Spoooer1,
1. Roslin Institute (Edinburgh), Roslin, Midkxhian, EH25 9PS, UX., 2. CTYM. Easter bosh, Roslin,
Midlothian, EH25 9RG, U.K.
Following T. a/Aulaia infection, the initial pathology takes place in the nearest draining lymph node. We are
studying tie pathogenesis and T cell activation in the draining efferent lymphatics following sporozoite challenge
or allogeneic cell line immunisation to understand the development of immunity. During a potentially lethal
sporozoile challenge, the parasite induced strong lymphopro! iteration with a massive increase in output of
blasting cells in the efferent lymph from day 6 with a 5-10 fold increase in the Dow' rale and cell outpuL Parasite
infected lymphoblasts were seen from day 6 onwards. An initial increase in the percentage of CE>2* cells
corresponding with an increase in CD4' cells was observed from day 5. Many CDF cells expressed IL-2R
transiently and became MHC U*. This was followed by an increased output of blasting CDS* cells with high
MHC II expression. Blasting CDF and CDS" cells gradually lost CD2 expression with progression of the
infection. These cells were MHC class II* but had lost IL-2R expression suggesting an inappropriate activation
of T cells in response to the parasite. Efferent lymph cells were less responsive to Con. A or exogenous IL-2
stimulation in vitro during the later stages of infection. The cells didn't proliferate in vitro in response to
autologous parasite infected cells and didn't kill autologous parasite infected cells suggesting lymphocyte
unresponsiveness either due to anergy or suppression. The animals inoculated with a T. OMuhiia infected cell
line exhibited a 2A fold increase in the flow rate and cell output in the efferent lymph. Parasite infected cells
of recipient origin were seen from day 11 onwards, however cells of donor origin were never isolated. Two
peaks of blasting cells were observed, the first corresponded to an allogeneic response against MHC antigens
of the immunising ceil tine and the second was parasite associated. A few CDF and CDS' cells not expressing
CL/2 were also seen during the second parasite specific phase of the response. At this stage, EL-2R and MHC
II expaessicxi on T tells increased. The results indicate that T. annulaia induces an inappropriate proliferation
and not activation of T cells as T cells express normal activation markers but lose CD2 which is a very important
adhesion molecule, however both specific and nonspecific T cell activation is seen during immunisation with
ceil lines of infected schizonts which induces immunity to sporozoite challenge.
European Union third coordination meeting on Tropical Theileriosis,
held at Antalya, Turkey, 4-9 October, 1994.
289
